Artemisia scoparia and Metabolic Health: Untapped Potential of an Ancient Remedy for Modern Use

Abstract

Botanicals have a long history of medicinal use for a multitude of ailments, and many modern pharmaceuticals were originally isolated from plants or derived from phytochemicals. Among these, artemisinin, first isolated from Artemisia annua, is the foundation for standard anti-malarial therapies. Plants of the genus Artemisia are among the most common herbal remedies across Asia and Central Europe. The species Artemisia scoparia (SCOPA) is widely used in traditional folk medicine for various liver diseases and inflammatory conditions, as well as for infections, fever, pain, cancer, and diabetes. Modern in vivo and in vitro studies have now investigated SCOPA’s effects on these pathologies and its ability to mitigate hepatotoxicity, oxidative stress, obesity, diabetes, and other disease states. This review focuses on the effects of SCOPA that are particularly relevant to metabolic health. Indeed, in recent years, an ethanolic extract of SCOPA has been shown to enhance differentiation of cultured adipocytes and to share some properties of thiazolidinediones (TZDs), a class of insulin-sensitizing agonists of the adipogenic transcription factor PPARγ. In a mouse model of diet-induced obesity, SCOPA diet supplementation lowered fasting insulin and glucose levels, while inducing metabolically favorable changes in adipose tissue and liver. These observations are consistent with many lines of evidence from various tissues and cell types known to contribute to metabolic homeostasis, including immune cells, hepatocytes, and pancreatic beta-cells. Compounds belonging to several classes of phytochemicals have been implicated in these effects, and we provide an overview of these bioactives. The ongoing global epidemics of obesity and metabolic disease clearly require novel therapeutic approaches. While the mechanisms involved in SCOPA’s effects on metabolic, anti-inflammatory, and oxidative stress pathways are not fully characterized, current data support further investigation of this plant and its bioactives as potential therapeutic agents in obesity-related metabolic dysfunction and many other conditions.

Introduction

Rising obesity rates around the globe are driving an epidemic of metabolic syndrome (MS) and type 2 diabetes (T2DM), and novel therapeutic interventions are needed. Because the pathogenesis of obesity-related metabolic dysfunction is multifactorial and complex, diverse strategies have been employed to hinder its development and manifestations, namely stimulating insulin production in pancreatic beta-cells, inhibiting hepatic glucose output, reducing glucose reabsorption in the kidney, and enhancing peripheral glucose uptake and insulin sensitivity (1). The molecular mechanisms driving these effects include inhibition of ATP-sensitive potassium channels in pancreatic beta-cells to stimulate insulin release, activation of the glucagon-like peptide-1 (GLP-1) receptor or inhibition of dipeptidyl peptidase-4 activity to enhance incretin signaling and lower circulating glucose levels, and activation of the peroxisome proliferator-activated receptor-gamma (PPARγ) in adipocytes to improve insulin sensitivity in peripheral tissues (2–5). Type 1 diabetes (T1DM), which represents only about five percent of diabetes mellitus cases, results from the progressive destruction of pancreatic beta-cells and consequent inability to produce insulin. Therefore, interventions to improve insulin sensitivity are ineffective for T1DM, and insulin replacement is currently the only glucose-lowering pharmacological treatment available (6). In addition to strategies for controlling glycemia, treatment of both T1DM and T2DM also includes management of diabetic complications such as kidney disease, cardiovascular disease, and retinopathy.

The first-line medication for T2DM, metformin, is a synthetic derivative of the phytochemical galegine, first isolated from Galega officinalis. This plant, also known as French lilac or goat’s rue, was used medicinally in medieval Europe for many ailments, including symptoms that are now attributed to T2DM (7). Metformin reduces hepatic glucose production via mechanisms that have not been fully elucidated. While it is known that metformin activates adenosine monophosphate (AMP)-activated protein kinase (AMPK) in the liver, there is evidence that several AMPK-independent mechanisms are likely to be involved in its metabolic impacts (4, 8). These include inhibition of mitochondrial respiration and of the gluconeogenic pathway (8–12). In addition, metformin’s glucose-lowering activity may be partially mediated through effects on the gut (13–15). Therefore, although metformin has been used clinically for over half a century, there is still significant debate around its precise mechanisms of action.

Across the world, plants have been used medicinally for centuries, and many pharmaceuticals are derived from natural products. Even now, factors such as availability, cost, or cultural practices drive the continued use of botanical products as supplements or alternatives to pharmaceuticals. Although rigorous and thorough investigation is often lacking, many plants are currently being screened or studied both in vitro and in vivo to assess their bioactivities and efficacy. One such plant, Artemisia scoparia (SCOPA), has a long history of medicinal use in much of Asia and Central Europe to treat liver diseases, inflammatory conditions, and diabetes, among other ailments. The genus Artemisia comprises hundreds of species, some of which are among the most widely used medicinal plants across the world (1, 2). Perhaps the best known product of the genus is the anti-malarial drug artemisinin, whose isolation from Artemisia annua was awarded the Nobel Prize for Physiology or Medicine in 2015 (3). Other medicinal species include A. capillaris, A. absinthum, A. argyi, A. capillaris and A. dracunculus, but there are many more (4–6). Modern studies have now established that extracts from SCOPA exert a wide range of effects in many cell types and animal models. In addition, many individual bioactive compounds responsible for these effects have been identified. This review describes the traditional folk medicine uses of SCOPA and examines what is currently known about its effects in various animal models and cell types, with a focus on findings relevant to metabolic health. We also discuss individual compounds in SCOPA and their wide range of effects, including the potential to attenuate metabolic dysfunction, particularly in the context of diet-induced obesity. Although SCOPA has not been studied in T1DM, some of its reported actions suggest that it may mitigate diabetic complications in addition to improving glycemic control. Such effects could be beneficial in T1DM as well as T2DM.

Even in the absence of a fully elucidated mechanism of action, identifying additional agents, like metformin, from natural products with therapeutic potential against metabolic dysfunction is of great value in fighting the growing epidemics of obesity, MS, and T2DM. Thus, an overarching goal of this review is to compile and evaluate anecdotal and mechanistic studies of A. scoparia’s ability to modulate metabolic function. We also aim to demonstrate the potential of bioactives from A. scoparia for modern clinical and/or complementary use to support metabolic health, while highlighting the significant need for additional studies to evaluate mechanism(s) of action on a molecular level.

Ethnopharmacology and Traditional Medicinal Uses of A. scoparia

SCOPA is one of the most widely used medicinal plants across many parts of Asia, and modern ethnobotany studies have documented its many indications in Afghanistan, Pakistan, Saudi Arabia, Iran, and China for conditions such as liver, gallbladder, and digestive disorders; various infectious and inflammatory diseases; ear pain; cardiovascular conditions; and diabetes and hyperglycemia (7–33). One example of the ethnopharmacological documentation of SCOPA is a study conducted in the Upper Neelum Valley of Pakistan, in which data collected from interviews were analyzed and individual plants or medicinal indications were assigned quantitative ethnobotanical indices. SCOPA was determined to have a high use value in this population (21). Reported indications and formulations for SCOPA in traditional folk medicine are shown in Table 1 and Figure 1. It is notable that many of these are common to distinct populations in diverse regions.

Figure 1

SCOPA is very prominent in Traditional Chinese Medicine (TCM), particularly for its hepatoprotective and choleretic effects. Its uses are extensively described in the canon of TCM literature (41–44) and cited in the current Chinese Pharmacopoeia (35). “Artemisia scopariae herba” (ASH), or “Yinchen”, refers to the dried aerial parts of SCOPA or of its close relative, Artemisia capillaris, with the two plants being used interchangeably for its preparation. A decoction of Yinchen is the principal constituent of many TCM formulae, in which ASH is combined with other herbal products. Importantly, a distinction is made between ASH from small Spring seedlings (Mian Yin Chen) and that from flowering plants in late Summer (Yen Chin Hao), each preferable for treating distinct sets of ailments (41, 45). Chemical analyses of ASH have confirmed that its constituents vary greatly depending on the time of harvest (36, 46). While TCM preparations are derived from the aerial parts of SCOPA, the roots of the plant are used in Pakistan (27) and the use of its flowers has been reported in Iran (16).

Effects of A. scoparia on Determinants of Metabolic Health

Metabolically Favorable Effects of A. scoparia in Experimental Models of Obesity and Diabetes

As mentioned above, the use of SCOPA in folk medicine for diabetes and hyperglycemia has been amply documented. A 2016 study found that administration of SCOPA during the second trimester of pregnancy improved insulin sensitivity, fasting plasma glucose levels, and circulating adiponectin levels in patients with gestational diabetes (47). With the exception of that study, SCOPA has not been evaluated in humans for effects on measures of metabolic health such as insulin sensitivity, glycemic control, or cardiovascular risk factors. Likewise, few animal studies have been conducted to examine SCOPA’s metabolically relevant effects. However, in a mouse model of diet-induced obesity (DIO) and insulin resistance, SCOPA administration by gavage or supplementation of diet was found to improve insulin sensitivity as measured by homeostatic model assessment for insulin resistance (HOMA-IR) or insulin tolerance test (ITT) (48–50). Circulating levels of triglycerides, free fatty acids (FFAs), glycerol, and insulin (fasting) were reduced, while adiponectin levels were increased (49–51). In liver, SCOPA supplementation reduced hepatic triglyceride and cholesterol content and enhanced insulin-induced phosphorylation of the signaling proteins insulin receptor substrate (IRS-1), insulin receptor subunit beta (IRβ), protein kinase B (AKT1), and RAC-beta serine/threonine protein kinase (AKT2) (50). Moreover, adenosine monophosphate (AMP)-activated protein kinase (AMPK) activity was enhanced and expression levels of genes involved in de novo lipogenesis were reduced by SCOPA in liver, consistent with the observed improvements in hepatic lipid accumulation (50). SCOPA also had pronounced effects in adipose tissue (AT), where it was shown to robustly enhance insulin-induced phosphorylation of AKT protein in epididymal, but not retroperitoneal or inguinal, white adipose tissue (WAT) depots (49). Levels of monocyte chemoattractant protein 1 (MCP-1), an inflammatory cytokine known to be highly expressed in obesity and insulin resistance, were also significantly reduced in SCOPA-treated animals (48).

Pro- and Anti-Adipogenic, and Anti-Lipolytic Effects of A. scoparia in Adipocytes

As described above, an ethanolic extract of SCOPA has metabolically favorable effects in a mouse model of DIO, including improvements in adipose tissue function. This same extract has been shown to enhance adipogenesis of 3T3-L1 cells, a widely used model to study adipocyte differentiation, as measured by both lipid accumulation and adipogenic gene expression (48). A recent study has revealed that SCOPA can promote adipogenesis in the absence of 3-isobutyl-1-methylxanthine (MIX), a key component in the classic adipocyte differentiation cocktail, and SCOPA significantly induces the expression of several PPARγ target genes, also regulated by MIX, that enhance lipid accumulation during adipogenesis. These data suggest that SCOPA’s adipogenic effects are partially mediated by increased PPARγ activity (52). Another research group investigating individual compounds isolated from a different SCOPA extract reported that 4 of the 19 compounds tested significantly inhibited lipid accumulation in 3T3-L1 cells during differentiation, while other compounds enhanced adipocyte development (53). In this study, no total or parent extracts of SCOPA were tested. A third laboratory observed inhibition of lipid accumulation in 3T3-L1 cells with their crude SCOPA extract as well (54). These apparent discrepancies illustrate three great challenges that accompany the study of botanical extracts: Individual compounds have complex interactions and often fail to mirror effects observed with the parent extracts; plants from different geographic regions, grown in different conditions or harvested at different times of the year may have very different chemical compositions; and variable extraction methods across studies make it impossible to confidently compare results.

Given that obesity drives insulin resistance and diabetes, interventions to reduce fat mass have been pursued as a means to counter obesity-associated metabolic disease. Lowering adiposity through increased energy expenditure or reductions in food intake can indeed have favorable metabolic effects. However, adipogenesis is typically impaired, not enhanced, in obese and insulin resistant states, and limiting adipose tissue expansion in conditions of positive energy balance by inhibiting adipocyte development is generally considered detrimental, as it promotes dyslipidemia and ectopic lipid accumulation (55). This point is underscored by the fact that drugs such as the thiazolidinediones (TZDs), which stimulate adipogenesis via PPARγ activation, are potent insulin sensitizers (56). Since TZDs have fallen out of use in recent years due to significant side effects, efforts are ongoing to identify natural product partial agonists of PPARγ to combat metabolic syndrome (57–60). Researchers investigating SCOPA in adipocytes have employed these alternate strategies (inhibition or promotion of adipogenesis) and have therefore focused on different bioactivities in SCOPA. It should be noted that unlike the pro-adipogenic extract described above, SCOPA extracts that were found to inhibit adipogenesis have not been evaluated in vivo for effects on insulin sensitivity, lipid metabolism, or glycemic control.

Obesity and insulin resistance result in abnormally high rates of lipolysis in the fed state, driven by the impaired action of insulin to inhibit lipolysis, as well as by the chronic inflammation characteristic of obese states (61). As mentioned previously, SCOPA supplementation in the food of high-fat diet-fed mice lowered circulating FFAs and glycerol, consistent with reduced lipolysis rates in adipose tissue (62). In cultured adipocytes, inflammation-associated lipolysis was inhibited in the presence of this same SCOPA extract, indicating that SCOPA has cell-autonomous antilipolytic activity in adipocytes. Interestingly, lipolysis induced by adrenergic stimulation or unstimulated basal lipolysis were not altered by SCOPA (62). A different SCOPA extract has been shown to modestly increase lipolysis in adipocytes under basal conditions but was not tested in inflammatory conditions (63). Given that unstimulated lipolysis rates are very low, this observation may not be relevant in the context of obesity, where inflammatory cytokines drive high lipolysis rates.

Hepatoprotective Effects of A. scoparia

Liver and gallbladder conditions including jaundice and cholestasis are among the illnesses most commonly treated with Yinchen (A. scoparia or A. capillaris). Research aimed at characterizing these hepatoprotective and choleretic properties has focused mostly on TCM formulations containing Yinchen in combination with other herbs, or on individual compounds isolated from Yinchen, rather than on the Artemisia extracts. However, two studies by Gilani et al. have demonstrated that SCOPA extract could attenuate liver injury induced by acetaminophen in mice (64) or by carbon tetrachloride in rats (65). Hepatic glucose output and lipid metabolism are major contributors to the regulation of circulating glucose and lipid levels, and thus liver function is key in preserving metabolic homeostasis. Likewise, metabolic dysregulation in obesity can lead to ectopic lipid accumulation in liver and non-alcoholic fatty liver disease (NAFLD). It is therefore plausible that beneficial effects of SCOPA in liver could preserve glycemic control and maintain appropriate circulating lipid levels in conditions of hepatic stress or, conversely, protect the liver from the deleterious effects of obesity and insulin resistance. This is supported by the mouse DIO study described above, in which SCOPA improved insulin sensitivity and reduced hepatic lipid accumulation (50).

Anti-Inflammatory and Antioxidant Effects of A. scoparia

Obesity and T2DM are considered inflammatory states. Infiltration of macrophages and altered resident immune cell populations in adipose tissue promote inflammation and insulin resistance (66, 67). Many conditions treated by SCOPA in TCM or folk medicine have an inflammatory component [(41) and Table 1], and SCOPA has been shown to have anti-inflammatory properties in a wide range of conditions, including inhibition of heat-induced protein denaturation in vitro (68) and reducing inflammatory cytokine production, cell infiltration, and edema in carrageenan-induced acute inflammation in rats and mice (69, 70). Similarly, topical application of SCOPA diminished clinical symptoms, cell infiltration, inflammatory cytokine levels, caspase-1 activity in lesions, and circulating levels of histamine in a mouse model of atopic dermatitis (71). Reductions in markers of adipose tissue inflammation in DIO mice have also been observed with SCOPA supplementation (48, 49). In addition, there are abundant data showing anti-inflammatory actions of SCOPA in cultured cell lines relevant to metabolic function. In lipopolysaccharide (LPS)-stimulated RAW 246.7 murine macrophages, an ethanolic SCOPA extract, previously found to attenuate lipolysis and markers of adipose tissue inflammation, also inhibited the expression of several inflammatory genes (72). In this same cell line, a different ethanolic extract reduced nitric oxide (NO) production in cells treated with LPS and interferon gamma (IFNγ) (53), while a methanolic extract from a third source failed to inhibit NO release from LPS-treated RAW 264.7 cells (63). Although the reason for this discrepancy cannot be ascertained, the three studies investigated extracts prepared from different plant material originating from diverse geographic locations, using various extraction methods and solvents, and tested at different doses; one or more of these factors could explain these seemingly conflicting results. Similar studies were conducted in isolated bone marrow-derived macrophages (BMDM) from mice, in which NO, inducible nitric oxide synthase (iNOS), and inflammatory cytokine levels were all reduced by SCOPA treatment in stimulated cells (69). Comparable effects of SCOPA have been observed in the THP-1 human monocyte cell line, undifferentiated 3T3-L1 murine preadipocytes, and in the HMC-1 human mast cell line (69, 73). Moreover, reduced pro-inflammatory NF-κB promoter activation in IL-1β-treated pancreatic beta-cells, which are also vulnerable to obesity-related inflammation, has been observed in response to SCOPA (72). Taken together, these data from multiple models and treatment conditions clearly indicate that SCOPA is a potent anti-inflammatory agent and that it can antagonize inflammation in conditions consistent with metabolic dysregulation.

Oxidative stress plays an important role in insulin resistance, the progression to diabetes, and diabetic complications. Indeed, hyperglycemia induces the production of reactive oxygen and nitrogen species, and the resulting oxidation of lipids, proteins, and DNA mediates diabetic complications such as neuropathy, nephropathy, retinopathy, and vascular damage. Although oxidative stress occurs in response to hyperglycemia, it can also drive metabolic dysfunction, as it hinders insulin signaling and glucose uptake in cultured adipocytes, myocytes, and vascular smooth muscle cells (74–80). Mechanisms involved in these effects have been attributed to mitochondrial dysfunction, inhibition of insulin signaling proteins, and negative modulation of the expression and translocation of the glucose transporter GLUT-4 [reviewed in (80)]. Furthermore, reactive oxygen species (ROS) have a range of deleterious effects on pancreatic beta-cell function, including increased apoptosis, reduced beta-cell neogenesis, mitochondrial dysfunction, and impaired insulin secretion (78, 81). Finally, oxidative stress can contribute to insulin resistance by activating inflammatory pathways (80). Essential oils and extracts of SCOPA have been reported to have antioxidant and free radical-scavenging properties (82–85), which could be consistent with improvements in metabolic function. Studies and reviews of SCOPA’s anti-inflammatory and antioxidant effects are shown in Table 2.

Cardiovascular Effects of A. scoparia

Metabolic syndrome is a cluster of risk factors for cardiovascular disease and diabetes. Obesity, insulin resistance, and diabetes promote hypertension, hyperlipidemia, and vascular damage, thereby increasing risks of coronary artery disease, stroke, and peripheral vascular disease. SCOPA has been used as an anti-hypertensive, a vasodilator, and an anti-hypercholesterolemic agent in traditional medicine (Table 1), and data from modern studies have been consistent with these historical uses. As is the case for SCOPA’s hepatoprotective properties, investigations have focused on SCOPA-containing TCM preparations or on single compounds isolated from SCOPA, but Cho et al. have shown that diet supplementation with an aqueous SCOPA extract lowered blood pressure and produced other favorable effects in spontaneously hypertensive rats (88). Beneficial effects included reductions in angiotensin converting enzyme (ACE) activity, angiotensin II (AngII) levels, and lipid peroxidation in serum. Given these observations, it is plausible that SCOPA’s effects on the cardiovascular system could mitigate some of the complications of metabolic syndrome or diabetes. Studies showing cardiovascular effects of SCOPA appear in Table 2.

Effects of Bioactive Compounds Found in A. scoparia

Coumarins

SCOPA is rich in plant coumarins (93). The three related coumarins scoparone (6,7 - dimethoxycoumarin), scopoletin (7-hydroxy-5-methoxycoumarin), and esculetin (6,7 - dihydroxycoumarin) are found in many Artemisia species and are considered major components of SCOPA (36, 41). Many coumarins have potent anti-inflammatory or antioxidant effects that account for a wide range of bioactivities (94). In addition, natural and synthetic coumarins are under investigation as promising treatments for many conditions, cancer in particular (95–102). The therapeutic potential of these coumarins is supported by molecular docking analyses (94, 103–112) and structure-activity relationship (SAR) studies (111, 113–117).

Scoparone

Scoparone, a prominent compound in TCM preparations, has long been known to have hypotensive and vasodilatory properties (118–125) and has been found to have several additional favorable cardiovascular effects, including inhibition of ACE activity in vitro (126) and reduction in AngII-induced myocardial changes in rodents, cultured myocytes, and cardiac fibroblasts (127, 128). Furthermore, there is evidence that scoparone can mitigate cardiac ischemia/reperfusion injury in in vitro and in vivo settings (129). Scoparone also has anti-atherogenic effects including the inhibition of vascular smooth muscle cell proliferation and migration (130, 131), inhibition of platelet aggregation (132), and the attenuation of atherosclerotic plaque formation and dyslipidemia in hyperlipidemic diabetic rabbits (133, 134). One study also found that scoparone decreased peroxisome proliferator-activated receptor gamma (PPARγ) activity, expression of PPARγ target genes, and lipid accumulation in differentiating 3T3-L1 adipocytes (135). In cultured rat mesangial cells, high glucose-induced production of extracellular matrix proteins was reduced with scoparone treatment (136), a finding with potential implications for renal diabetic complications.

As is the case for SCOPA extracts and traditional preparations, hepatoprotective effects have been reported for scoparone in NASH (137, 138) and in conditions of hepatotoxicity or liver injury induced by carbon tetrachloride or alcohol (139–141). Consistent with folk uses of SCOPA in the treatment of jaundice and cholestasis, scoparone also promotes bilirubin clearance through activation of the constitutive androstane receptor (CAR) (142). Interestingly, CAR activation has been shown to improve insulin sensitivity, glucose metabolism, and hepatic lipid accumulation in leptin-deficient ob/ob mice (143), and to prevent obesity, insulin resistance, and hepatic steatosis in HFD-fed mice (144). CAR agonism has been proposed as a therapeutic target for obesity, insulin resistance, and diabetes (142–146). In a recent study, a panel of natural and synthetic coumarin derivatives was screened for the ability to activate CAR, and scoparone was found to improve glucose tolerance in leptin receptor-null db/db mice (147).

Anti-inflammatory and antioxidant properties of scoparone have been demonstrated in a wide range of conditions, and some of the pathways impacted by these effects have been described. Studies in the murine RAW 264.7 macrophage cell line demonstrated that scoparone could attenuate the LPS- or IFNγ-induced production of inflammatory cytokines, as well as iNOS and cyclooxygenase 2 (COX2) protein levels and corresponding NO and prostaglandin E2 (PGE2) release (148). Similar results were obtained in a human monocyte cell line, in which scoparone attenuated phorbol-12-myristate-13-acetate (PMA)-induced inflammatory cytokine production by inhibiting nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation (149).

In a mouse model of acute lung injury, pulmonary edema, histological changes, and LPS-mediated inflammatory cytokine production were improved by scoparone in vivo, while in vitro experiments in alveolar macrophages revealed that the compound’s anti-inflammatory effects were mediated through the toll-like receptor 4 (TLR4)/NFκB pathway (150). Anti-inflammatory effects of scoparone in a rat model of colitis have also been reported (151), while in BV2 microglial cells, scoparone attenuated LPS-induced neuroinflammatory responses by blocking interferon regulatory factor 3 (IRF3) and extracellular signal-regulated kinase (ERK) activation (126). In a mouse model of acute seizures, scoparone preserved blood-brain barrier integrity, prevented inflammation and apoptosis, and inactivated the phosphoinositide 3-kinase (PI3K)/AKT signaling pathway in vivo. This same study determined that scoparone could also inhibit astrocyte activation elicited by LPS (152).

In addition to interfering with inflammatory pathways, scoparone has been shown to provide protection from oxidative stress, as demonstrated in 2,2-diphenyl-1-picrylhydrazyl (DPPH) and lipid peroxidation assays in vitro (151, 153), and to inhibit production of ROS and preserve antioxidant enzyme activity in response to several types of oxidative stressors (154, 155). Antioxidant activity has also been implicated in scoparone’s ability to protect against kidney damage elicited by the chemotherapeutic agent cisplatin (156), to reduce markers of pancreatic fibrosis in cultured pancreatic stellate cells (157), and to prevent osteoclast differentiation and bone resorption in vitro (158).

Effects of scoparone have been observed in many other systems and models, including immunosuppressive functions associated with autoimmunity, allergies, and graft rejection (159, 160); neurite outgrowth and dopamine synthesis and release in the PC12 neuronal cell line (161–163); proliferation and migration of cancer cells (105, 164); bactericidal, antifungal, and antiparasitic properties (165–167); promotion of melanogenesis; and activation of the cystic fibrosis transmembrane conductance regulator (CFTR) (168, 169). Table 3 presents a summary of the wide range of bioactivities attributed to scoparone.

Scopoletin

Scopoletin is a naturally fluorescent compound found in many plants (191, 214, 215, 246). It is a substrate for peroxidases, which convert scopoletin to non-fluorescent compounds, and has thus been widely used for many decades, in combination with horseradish peroxidase, as the basis for high-sensitivity hydrogen peroxide detection assays (495–498). Several studies have demonstrated scopoletin’s antioxidant capabilities in vitro, using common cell-free methods such as the DPPH, Trolox equivalent antioxidant capacity (TEAC), ferric reducing ability of plasma (FRAP), or beta-carotene/bleaching assays, while superoxide, hydrogen peroxide, nitric oxide, and peroxynitrite are among the reactive species shown to be effectively scavenged by scopoletin (114, 180, 216–223, 247). Hepatoprotective antioxidant effects of scopoletin have also been observed in cultured HepG2 cells and primary hepatocytes (154, 200), however one study failed to detect significant antioxidant activity for scopoletin (499).

Given the important role of oxidative stress in the etiology of numerous disorders, it is not surprising that some of scopoletin’s favorable effects in disease states are attributed to its antioxidant properties. For example, scopoletin has been reported to have antioxidant effects in hyperthyroid-induced hyperglycemia in rats (224), as well as in oxidant-induced hemolysis of rat erythrocytes (225). The brain is particularly vulnerable to oxidative stress, which is known to be central to many neurodegenerative conditions (500). A study performed in mouse brain homogenates revealed that scopoletin strongly inhibited the oxidative protein modifications induced by copper (226), which can contribute to the pathologies associated with atherosclerosis, Alzheimer’s disease (AD), and Wilson’s disease (501–503). A recent study examined several aspects of oxidative stress involved in the pathogenesis of Parkinson’s disease (PD) and showed that scopoletin attenuated depletion of cellular reduced glutathione or ATP, inhibited ROS generation, and prevented cell death in oxidative conditions in vitro (227). These findings were extended to a Drosophila mutant model of PD, where scopoletin treatment reduced accumulation of mitochondrial ROS and promoted recovery from degenerative phenotypes (227). Several other studies have shown that scopoletin can prevent oxidative injury in models relevant to diseases such as PD and AD. These include prevention of oxidative injury and induction of antioxidant gene expression in HT-22 and SHSY-5Y cells (248, 249), as well as inhibition of monoamine oxidase activity (106, 250).

One important contributor to oxidative stress in many cell types is the xanthine oxidase (XO)/xanthine dehydrogenase (XDH) system (201, 504, 505). XO activity in the liver produces uric acid, which is released into circulation and excreted by the kidney. Hyperuricemia, due to excessive uric acid production in the liver or impaired clearance in the kidney, causes accumulation of uric acid crystals in joints (gout) and in the kidney. Scopoletin shows inhibitory activity in enzymatic assays of XO in vitro (506). Additionally, scopoletin administered either by intraperitoneal injection or by oral gavage of scopoletin-loaded micelles was shown to correct hyperuricemia in mice through two separate mechanisms, namely inhibiting hepatic XO activity and enhancing uric acid excretion by the kidney (201, 202). Notably, XO activity is associated with obesity-related metabolic dysfunction, and XO inhibitors typically prescribed for gout or hyperuricemia are proving to be effective in mitigating cardiovascular and renal complications of diabetes (504, 507, 508).

In addition to antioxidant effects, scopoletin has potent anti-inflammatory activity. Numerous studies have demonstrated the ability of scopoletin to diminish the production of proinflammatory mediators such as cytokines and eicosanoids in many cell types, including macrophages, mast cells, fibroblasts, and platelets (228–237). In vivo effects of scopoletin in rodent ear or paw edema models and in models of inflammatory conditions such as arthritis, gastro-esophageal disease, gastric ulcers, gout, pleurisy, pancreatitis, as well as nociceptive or analgesic properties, have also been described (215, 237–242, 291, 509, 510). Mechanisms involved in scopoletin’s anti-inflammatory effects include negative regulation of inflammatory signaling pathways and inhibition of lipoxygenase and cyclooxygenase enzyme activities (214, 239, 243, 247, 280, 281). Scopoletin’s anti-inflammatory properties have also been implicated in its effects on various pathologies, particularly in the realm of immunity, as it has been shown to regulate complement pathway activation, mast cell degranulation, as well as several aspects of innate, humoral, and adaptive immune function, suggesting potential roles in allergies, asthma, and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis (175, 251, 282–288, 511).

Scopoletin has been studied in several models of neurological dysfunction and has an array of favorable effects. Some of these are at least partly attributable to its antioxidant or anti-inflammatory properties, like reducing inflammation-induced anxiety in mice or attenuating neural deficits, brain edema, and inflammatory cytokine production in intracerebral hemorrhage in rats (252, 253). In addition, several groups have demonstrated scopoletin’s ability to inhibit acetyl- and butyryl-cholinesterases in vitro (110, 247, 254–257, 512) and in vivo (258). Antidepressant, anti-psychotic, and anti-amnesic effects were also observed in behavioral studies in mice (246, 258–261). A study investigating anticonvulsant effects of Benkara malabarica (Linn.) root extract found that scopoletin inhibited GABA transaminase activity (262). Consistent with this finding, molecular docking analysis has demonstrated affinity of scopoletin for both GABA transaminase and for the GABA-A receptor (252). The anticonvulsant drug vigabatrin is an irreversible inhibitor of GABA-T, and there is convincing evidence that it is effective in attenuating anxiety symptoms (513). Formation of amyloid beta peptide 42 (Aβ42) and α-synuclein fibrils, processes central to the pathogenesis of AD and PD respectively, have both been shown to be inhibited by scopoletin (109, 110). These actions are likely complementary to the antioxidant mechanisms described above (227) in combatting neurodegenerative diseases. Finally, scopoletin improves neuronal plasticity, as measured in ex vivo electrophysiological assays, and exerts neuroprotective activity in a rat spinal cord injury model (263, 264).

In conditions related to metabolic health, scopoletin acts favorably on many pathways in vivo, as well as in various cell types and experimental conditions. In animal models of diet-induced obesity, diabetes, or alcohol-induced metabolic dysfunctions, scopoletin restored insulin sensitivity, reversed disruptions in circulating lipids, glucose, insulin, and inflammatory cytokines, while also attenuating lipid accumulation and fibrosis in liver, restoring adiponectin levels in white adipose tissue, and reducing oxidative stress in the pancreas (181–187). Consistent with these in vivo observations, scopoletin has been shown to mitigate insulin resistance and improve metabolic functions in cultured hepatocytes, adipocytes, and pancreatic beta-cells (184, 185, 188, 514). In vitro assays have revealed that enzymes involved in glucose homeostasis (protein tyrosine phosphatase 1b, α-glucosidase and α-amylase) or in diabetic complications (aldone reductase) are inhibited by scopoletin (108, 116, 180, 184, 187, 189, 190). While effects described above are likely to improve cardiovascular health in the context of metabolic syndrome, scopoletin also acts directly on the heart and vasculature. Scopoletin has antihypertensive actions (126, 191–193), anti-atherosclerotic capabilities (132, 194–196), and vascular spasmolytic/vasodilatory effects (191, 193, 197–199).

Scopoletin is a compound of interest in cancer research, as it has been shown to have apoptotic, cytotoxic, anti-proliferative, anti-angiogenic, and anti-metastatic activities in various cancer cell lines (97, 203–212). Efforts are ongoing to develop synthetic derivatives of scopoletin and to characterize and improve its bioavailability and pharmacokinetic properties (96). Finally, a handful of other bioactivities have been reported for scopoletin, among them the promotion of melanogenesis (296–298) and osteoprotective (292, 293), antitussive (515), gastrokinetic (294), and antimicrobial properties (165, 265–278, 516), as well as anti-aging effects in skin and lung fibroblasts (289, 290).

It is notable that many of the same signaling pathways are modulated by scopoletin across the wide variety of experimental models and conditions in which it has been investigated. Scopoletin can activate the AMPK pathway (181, 182, 186, 263, 514) and the PI3K/AKT pathway (184, 186, 188, 514), and inhibit the inflammatory TLR4/myeloid differentiation factor 88 (MyD88) and NF-κB pathways (94, 181, 183, 233, 237, 241, 251, 252, 517, 518). There is also substantial evidence that scopoletin can inhibit the MAPK pathway in a variety of cell types (199, 235, 237, 241, 252, 290, 297).

Esculetin

Like scoparone and scopoletin, esculetin’s well-documented antioxidant and anti-inflammatory properties are central to its beneficial effects in biological systems (226, 350–355, 384, 519). A broad range of inflammatory or oxidative conditions have been shown to be impacted by esculetin. These include lung injury and fibrosis (356, 357, 520); fibromyalgia (521); neuronal oxidative stress (522); psoriasis (523); arthritis (358); nociception (359); colitis (360); allergy, immunity, and asthma (282, 354, 380–383); and sepsis (361). The effects of esculetin on numerous cancer cell types have been extensively studied (94, 321–342, 519, 524, 525) and are the basis for efforts to develop novel therapeutics (98, 341). Neuroprotective and behavioral actions of esculetin have also been described (111, 299, 367–371, 526–528). Selected publications highlighting these effects of esculetin are featured in Table 3.

Flavonoids and Chromones

Flavonoids are highly abundant compounds in all plants; they are extensively studied for various bioactivities and have a wide range of effects in many biological systems. Numerous flavonoids have been identified in SCOPA, however their relative abundance varies widely among plants and extracts from different sources (36, 41). Since there exists abundant literature regarding the bioactivities of flavonoids, we will present only a subset of the most commonly reported, most abundant, or most thoroughly investigated flavonoids in SCOPA. As a representative example, cirsmaritin has been shown to have anti-proliferative, anti-metastatic, and anti-carcinogenic effects in cancer cell lines (529–534), diabetes- and metabolism-related effects (535–537), as well as anti-inflammatory, antioxidant, and antimicrobial properties (538–543). Studies have also demonstrated that cirsimaritin can modulate neurological, immune, and digestive functions (544–548), and attenuate renal injury (549, 550). Additional activities of selected flavonoids are shown in Table 3.

The chromone capillarisin is known as a major constituent of Artemisia capillaris. It is also relatively abundant in SCOPA but is not known to be a bioactive constituent of other plants. There are multiple reports of anti-inflammatory and antioxidant effects of capillarisin (444–448, 551), which has also been shown to inhibit tumor cell invasion, inhibit signaling transducer and activator of transcription 3 (STAT3) activation, slow cell growth, and promote apoptosis in various cancer cell lines (440, 441, 443, 552). Other reported effects of capillarisin include anti-asthmatic activity (451) and promotion of penile erection in a rabbit model (450). Studies of capillarisin and its derivatives that are found in SCOPA are summarized in Table 3.

Phenolic Acids

Chlorogenic acid, caffeic acid, 3,5-dicaffeoylquinic acid, and 4,5-dicaffeoylquinic acid are related phenolic acids found in many plants or, in the case of caffeic acid, all plants. Chlorogenic acid and its derivatives are abundant in SCOPA and have been shown to mediate some of SCOPA’s effects (71, 73, 85). Unlike the ubiquitous chlorogenic acid derivatives, prenylated coumaric acids (PCAs) are not common in plants, and the most thoroughly characterized of these compounds, artepillin C, drupanin, and baccharin, have been primarily studied from Brazilian green propolis (476, 553–555). The most prominent bioactivities of chlorogenic acids and PCAs are presented in Table 3. Although not all studies of SCOPA’s chemical constituents have detected PCAs, capillartemisin B and drupanin have been identified in SCOPA (53, 556–558), and additional PCAs have been reported in Artemisia capillaris (559, 560). PCAs are not considered major constituents of SCOPA, however several of them have been isolated from a SCOPA extract with potent adipogenic activity (556, 557). Fractions of this extract that were most effective in promoting adipogenesis were rich in PCAs, and activity was confirmed for three PCAs isolated from these fractions, including two co-purified isomers of a novel PCA, termed “cis-scopa-trans-coumaricin” and “cis-scopa-cis-coumaricin”. Like the PCAs from SCOPA, PCAs from propolis can activate PPARγ, promote adipocyte differentiation, and mitigate obesity-associated metabolic dysfunction (472–474, 561–563). Given that these compounds have not been reported in SCOPA extracts found to inhibit adipogenesis, the presence or absence of PCAs is a plausible explanation for the seemingly divergent effects of SCOPA on adipocytes in studies using different extract preparations. Interestingly, a unique enzyme has recently been isolated from A. capillaris that catalyzes two successive prenylations of p-coumaric acid to yield artepillin C, with drupanin as a mono-prenylated intermediate (564). It appears likely that an equivalent enzyme may exist in SCOPA and in other plants that synthesize these compounds.

Bridging the Gap: SCOPA as a Modern Intervention to Promote Metabolic Health

We have reviewed multiple lines of evidence for metabolic benefits of SCOPA. However, these data have emerged in a piecemeal fashion, and comprehensive studies to adequately assess SCOPA as a therapeutic or preventive intervention for metabolic dysfunction are lacking. One ethanolic SCOPA extract has been shown to have beneficial effects on adipose tissue function, hepatic lipid accumulation, and insulin sensitivity in a mouse model of DIO (48–50), and a different extract was found to attenuate gestational diabetes in a small human study (47). Ethnopharmacological data, as well as the broad range of bioactivities of SCOPA observed in various cell lines and disease models, also provide strong rationale to investigate SCOPA in humans with obesity or metabolic syndrome. The widespread medicinal use of SCOPA in many parts of the world suggests favorable safety and toxicity profiles, however these have not been formally studied, and such data will be needed in the assessment of SCOPA’s potential as a therapeutic intervention. For example, since SCOPA is known to affect hepatic function and to increase whole-body insulin sensitivity in mice, adverse effects in the liver or risk of hypoglycemia are potential concerns. Given the high variability in the chemical composition of SCOPA extracts, their rigorous characterization, using unbiased and standardized methods will also be crucial in interpreting results from different extracts and in guiding pharmacokinetic evaluation of potential therapeutic extracts. In our view, details of extract composition reported for SCOPA are generally insufficient, and greater efforts are required to characterize extracts that are being studied for the promotion of metabolic health. Repositories of serum and tissue samples from in vivo studies would also be helpful in laying the groundwork for pre-clinical or translational studies. Differences in biological effects and chemical composition among various SCOPA preparations could also serve as a resource for correlating constituent compounds with bioactivity.

SCOPA’s reported hepatoprotective and antioxidant properties, as well as its beneficial effects on cardiovascular parameters are consistent with favorable metabolic effects but have not been investigated in the context of human metabolic disease. In addition, SCOPA’s potential effects in many cell types and experimental models relevant to obesity or metabolic syndrome have not yet been interrogated. These include measures of insulin sensitivity or glucose uptake in skeletal muscle cells, glucose output from hepatocytes, and insulin secretion from pancreatic beta-cells. SCOPA’s ability to mitigate diabetic complications is also unknown, although its documented antioxidant and anti-inflammatory effects suggest that it may protect against the consequences of chronic hyperglycemia. All these aspects of SCOPA bioactivity merit more systematic assessment in conditions of metabolic dysfunction. Finally, mechanisms responsible for SCOPA’s pleiotropic actions remain only partially explored. As described in this review, SCOPA or its constituent compounds have been shown to regulate various signaling pathways or enzyme activities, but the molecular players, mechanistic details, and implications of these effects remain to be elucidated. Thus, a wide range of experimental observations offer promising evidence of SCOPA’s metabolic benefits, but critical pieces of data are needed to realize its full promise as a bona fide therapeutic.

Conclusion

The historical and anthropological importance of botanicals in health and disease is unquestionable. Not only are plants used in folk medicine applications around the world, but they are also consumed as nutritional supplements and are the origin of many modern pharmaceuticals. Despite the successes of synthetic drug development, there is great value in investigating complex botanical extracts for several reasons. First, there is a need to characterize and evaluate botanicals in current use. A cross-sectional study conducted between 2002 and 2012 reported that 18% of adults in the US use dietary supplements (565). According to the American Botanical Council, sales of botanical supplements topped 8.8B$ in 2018 and were on the rise (abc.herbalgram.org). This market is largely unregulated, and rigorous studies addressing the safety, modes of action, and efficacy of such supplements are desirable. Second, synergistic interactions between phytochemical compounds are common, and individual constituents often fail to recapitulate activities of their parent botanical extracts (566, 567). Third, the thorough study of complex botanical extracts enables the identification of novel and unique lead compounds that may not otherwise emerge or that may be challenging to synthesize, as in the case of the PCAs reported in Artemisia species including SCOPA.

This review of SCOPA’s ethnopharmacology, bioactivities, and constituent compounds reveals a remarkable range of traditional uses and experimental data and provides a valuable example of both the potential and the difficulties of studying complex botanical extracts. Indeed, we have described promising in vivo and in vitro data supporting SCOPA’s use for many pathologies, in particular hepatic diseases and obesity-related metabolic dysfunction, as well as proven effects of individual compounds found in SCOPA. Figure 1 illustrates the principal findings related to SCOPA. We have also presented seemingly contradictory data regarding the adipogenic effects of SCOPA, with studies showing both pro- (48, 49, 556, 557) and anti- (53, 54, 63) adipogenic activities. However, analysis of the pro-adipogenic extract and fractions revealed the presence of PCAs, known to promote adipogenesis, while these compounds were not reported in extracts that inhibited adipogenesis.

To be sure, investigation of botanical extracts is a challenging endeavor due to the enormous complexity of the mixtures, the considerable variability in extract composition from different plants of the same species (36, 46, 568, 569), the potential for unpredictable experimental artifacts (570), the imperfect methods for detecting constituent compounds, and the biased nature of investigations based on the research interests and priorities of different investigators. However, increasingly sophisticated preparatory, analytical, and computational methods are helping to overcome these difficulties. In order to enhance the reliability and translatability of natural products research, the National Center for Complementary and Integrative Health (NCCIH) has spearheaded the development of comprehensive good practices for pre-clinical investigation of natural products (567). We fully support these principles and encourage further study of the bioactivities of Artemisia scoparia, particularly in metabolism research, in accordance with these guidelines.

Funding

This publication was supported by the National Center for Complementary & Integrative Health and the Office of Dietary Supplements of the National Institutes of Health (NIH) under Award Number P50AT002776 which funds the Botanical Dietary Supplements Research Center of Pennington Biomedical Research Center and the Department of Plant Biology and Pathology in the School of Environmental and Biological Sciences (SEBS) of Rutgers University.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

• 1

  BoraKSSharmaA. The Genus Artemisia: A Comprehensive Review. Pharm Biol (2011) 49:101–9. doi: 10.3109/13880209.2010.497815

  • CrossRef
  • Google Scholar

• 2

  BishtDKumarDKumarDDuaKChellappanDK. Phytochemistry and Pharmacological Activity of the Genus Artemisia. Arch Pharm Res (2021) 1:3. doi: 10.1007/s12272-021-01328-4

  • CrossRef
  • Google Scholar

• 3

  TuY. Artemisinin—A Gift From Traditional Chinese Medicine to the World (Nobel Lecture). Angew Chemie - Int Ed (2016) 55:10210–26. doi: 10.1002/anie.201601967

  • CrossRef
  • Google Scholar

• 4

  TanRXZhengWFTangHQ. Biologically Active Substances From the Genus Artemisia. Planta Med (1998) 64:295–302. doi: 10.1055/s-2006-957438

  • CrossRef
  • Google Scholar

• 5

  AbadMJBedoyaLMApazaLBermejoP. The Artemisia L. Genus: A Review of Bioactive Essential Oils. Molecules (2012) 17:2542–66. doi: 10.3390/molecules17032542

  • CrossRef
  • Google Scholar

• 6

  Abad MartínezMJDel OlmoLMBTiconaLABenitoPB. The Artemisia L. Genus: A Review of Bioactive Sesquiterpene Lactones. In: Studies in Natural Products Chemistry. Amsterdam, Netherlands: Elsevier B.V. (2012) 37 p. 43–65. doi: 10.1016/B978-0-444-59514-0.00002-X

  • CrossRef
  • Google Scholar

• 7

  YoussefRSA. Medicinal and Non-Medicinal Uses of Some Plants Found in the Middle Region of Saudi Arabia. J Med Plants Res (2013) 7:2501–13. doi: 10.5897/JMPR12.798

  • CrossRef
  • Google Scholar

• 8

  ParveenUpadhyayBRoySKumarA. Traditional Uses of Medicinal Plants Among the Rural Communities of Churu District in the Thar Desert, India. J Ethnopharmacol (2007) 113:387–99. doi: 10.1016/j.jep.2007.06.010

  • CrossRef
  • Google Scholar

• 9

  SherHBussmannRWHartRDe BoerHJ. Traditional Use of Medicinal Plants Among Kalasha, Ismaeli and Sunni Groups in Chitral District, Khyber Pakhtunkhwa Province, Pakistan. J Ethnopharmacol (2016) 188:57–69. doi: 10.1016/j.jep.2016.04.059

  • CrossRef
  • Google Scholar

• 10

  HussainWBadshahLUllahMAliMAliAHussainF. Quantitative Study of Medicinal Plants Used by the Communities Residing in Koh-E-Safaid Range, Northern Pakistani-Afghan Borders. J Ethnobiol Ethnomed (2018) 14:30. doi: 10.1186/s13002-018-0229-4

  • CrossRef
  • Google Scholar

• 11

  BhatJAKumarMBussmannRW. Ecological Status and Traditional Knowledge of Medicinal Plants in Kedarnath Wildlife Sanctuary of Garhwal Himalaya, India. J Ethnobiol Ethnomed (2013) 9:1–18. doi: 10.1186/1746-4269-9-1

  • CrossRef
  • Google Scholar

• 12

  BarkatullahIbrarMRaufABen HaddaTMubarakMSPatelS. Quantitative Ethnobotanical Survey of Medicinal Flora Thriving in Malakand Pass Hills, Khyber Pakhtunkhwa, Pakistan. J Ethnopharmacol (2015) 169:335–46. doi: 10.1016/j.jep.2015.04.052

  • CrossRef
  • Google Scholar

• 13

  MahmoodAMahmoodANaseem MalikRKhan ShinwariZ. Indigenous Knowledge of Medicinal Plants From Gujranwala District, Pakistan. J Ethnopharmacol (2013) 148:714–23. doi: 10.1016/j.jep.2013.05.035

  • CrossRef
  • Google Scholar

• 14

  KhanMKumarSHamalIA. Medicinal Plants of Sewa River Catchment Area in the Northwest Himalaya and Its Implication for Conservation. Ethnobot Leafl (2009) 13:1113–52.

  • Google Scholar

• 15

  AuDTWuJJiangZChenHLuGZhaoZ. Ethnobotanical Study of Medicinal Plants Used by Hakka in Guangdong, China. J Ethnopharmacol (2008) 117:41–50. doi: 10.1016/j.jep.2008.01.016

  • CrossRef
  • Google Scholar

• 16

  Ghasemi PirbaloutiAMomeniMBahmaniM. Ethnobotanical Study of Medicinal Plants Used by Kurd Tribe in Dehloran and Abdanan Districts, Ilam Province, Iran. Afr J Tradit Complement Altern Med (2013) 10:368–85. doi: 10.4314/ajtcam.v10i2.24

  • CrossRef
  • Google Scholar

• 17

  HamayunMAfzalSKhanMA. Ethnopharmacology, Indigenous Collection and Preservation Techniques of Some Frequently Used Medicinal Plants of Utror and Gabral, District Swat, Pakistan. Afr J Trad CAM (2006) 3:57–63. doi: 10.4314/ajtcam.v3i2.31158

  • CrossRef
  • Google Scholar

• 18

  JabeenNAjaibMSiddiquiMFUlfatMKhanB. A Survey of Ethnobotanically Important Plants of District Ghizer, Gilgit-Baltistan. FUUAST J Biol (2015) 5:153–60.

  • Google Scholar

• 19

  AhmadIIbrarMBarkatullahAliN. Ethnobotanical Study of Tehsil Kabal, Swat District, KPK, Pakistan. J Bot (2011) 2011:1–9. doi: 10.1155/2011/368572

  • CrossRef
  • Google Scholar

• 20

  SinghKNLalBTodariaNP. Ethnobotany of Higher Plants in Spiti Cold Desert of Western Himalaya. Nat Sci (2012) 10(5):7–14.

  • Google Scholar

• 21

  AhmadKSHamidANawazFHameedMAhmadFDengJet al. Ethnopharmacological Studies of Indigenous Plants in Kel Village, Neelum Valley, Azad Kashmir, Pakistan. J Ethnobiol Ethnomed (2017) 13:68. doi: 10.1186/s13002-017-0196-1

  • CrossRef
  • Google Scholar

• 22

  Al-AsmariAKAl-ElaiwiAMAtharMTTariqMAl EidA. Al-Asmary SM. A Review of Hepatoprotective Plants Used in Saudi Traditional Medicine. Evidence-Based Complement Altern Med (2014) 2014:890842. doi: 10.1155/2014/890842

  • CrossRef
  • Google Scholar

• 23

  ChaudharyMIHeQChengYYXiaoPG. Ethnobotany of Medicinal Plants From Tian Mu Shan Biosphere Reserve, Zhejiang-Province, China. Asian J Plant Sci (2006) 5:646–53. doi: 10.3923/ajps.2006.646.653

  • CrossRef
  • Google Scholar

• 24

  WrightMWatsonMF. Tibetan Medicinal Plants. In: KletterCKriechbaumM, editors, vol. 383. Stuttgar: Medpharm Scientific Publishers (2001) p. 77. Edinburgh J Bot (2002). doi: 10.1017/s0960428602260291

  • CrossRef
  • Google Scholar

• 25

  SafaOSoltanipoorMARastegarSKazemiMNourbakhsh DehkordiKGhannadiA. An Ethnobotanical Survey on Hormozgan Province, Iran. Avicenna J Phytomed (2013) 3:64–81. doi: 10.22038/ajp.2012.12

  • CrossRef
  • Google Scholar

• 26

  HayatMHayatMQKhanMAAshrafMJabeenS. Ethnobotany of the Genus Artemisia L. (Asteraceae) in Pakistan. Ethnobot Res Appl (2009) 7:147–62. doi: 10.17348/era.7.0.147-162

  • CrossRef
  • Google Scholar

• 27

  IshtiaqMMaqboolMAjaibMAhmedMHussainIKhanamHet al. Ethnomedicinal and Folklore Inventory of Wild Plants Used by Rural Communities of Valley Samahni, District Bhimber Azad Jammu and Kashmir, Pakistan. PloS One (2021) 16(1):e0243151. doi: 10.1371/journal.pone.0243151

  • CrossRef
  • Google Scholar

• 28

  HussainWUllahMDastagirGBadshahL. Quantitative Ethnobotanical Appraisal of Medicinal Plants Used by Inhabitants of Lower Kurram, Kurram Agency, Pakistan. Avicenna J Phytomed (2018) 8:313–29.

  • Google Scholar

• 29

  NaveedMHejaziVAbbasMKambohAAKhanGJShumzaidMet al. Chlorogenic Acid (CGA): A Pharmacological Review and Call for Further Research. BioMed Pharmacother (2018) 97:67–74. doi: 10.1016/j.biopha.2017.10.064

  • CrossRef
  • Google Scholar

• 30

  KhanSWBotPJWali Khan AndSKhatoonS. Ethnobotanical Studies on Some Useful Herbs of Haramosh and Burgote Valleys in Gilgit, Northern Areas of Pakistan. Pakistan J Bot (2008) 40:43–58.

  • Google Scholar

• 31

  JoshiRSatyalPSetzerW. Himalayan Aromatic Medicinal Plants: A Review of Their Ethnopharmacology, Volatile Phytochemistry, and Biological Activities. Medicines (2016) 3:6. doi: 10.3390/medicines3010006

  • CrossRef
  • Google Scholar

• 32

  AbbasZKhanSMAlamJKhanSWAbbasiAM. Medicinal Plants Used by Inhabitants of the Shigar Valley, Baltistan Region of Karakorum Range-Pakistan. J Ethnobiol Ethnomed (2017) 13:53. doi: 10.1186/s13002-017-0172-9

  • CrossRef
  • Google Scholar

• 33

  GanieAHTaliBAShapooGANawchooIAKhurooAA. Ethno-Survey of Traditional Use of Plants as Aphrodisiacs in Kashmir Himalaya, India. J Herb Med (2019) 17–18:100256. doi: 10.1016/j.hermed.2019.100256

  • CrossRef
  • Google Scholar

• 34

  RanaCSSharmaAKumarNDangwalLRTiwariJK. Ethnopharmacology of Some Important Medicinal Plants of Nanda Devi National Park (NDNP) Uttarakhand, India. Nat Sci (2010) 8:9–14.

  • Google Scholar

• 35

  China Medical Science Press. Pharmacopoeia of the People’s Republic of China: 2015. 10th Ed. Beijing, China: China Medical Science Press (2017).

  • Google Scholar

• 36

  CaiYZhengQSunRWuJLiXLiuR. Recent Progress in the Study of Artemisiae Scopariae Herba (Yin Chen), a Promising Medicinal Herb for Liver Diseases. BioMed Pharmacother (2020) 130:110513. doi: 10.1016/j.biopha.2020.110513

  • CrossRef
  • Google Scholar

• 37

  YoussefA. Medicinal and Non-Medicinal Uses of Some Plants Found in the Middle Region of Saudi Arabia. J Med Plant Res (2013) 7:2501–17. doi: 10.5897/JMPR12.798

  • CrossRef
  • Google Scholar

• 38

  YeungH. Handbook of Chinese Herbal Formulas. 2nd Ed. Rosemead, CA: Institute of Chinese Medicine (1995).

  • Google Scholar

• 39

  NadeemMKhan ShinwariZQaiserM. Screening of Folk Remedies by Genus Artemisia Based on Ethnomedicinal Surveys and Traditional Knowledge of Native Communities of Pakistan. Pak J Bot (2013) 45:111–7.

  • Google Scholar

• 40

  KhanSWBotPJWali Khan AndSKhatoonS. Ethnobotanical Studies on Some Useful Herbs of Haramosh and Bugrote Valleys in Gilgit. Northern Areas Pakistan (2008) 40:43–58.

  • Google Scholar

• 41

  DingJWangLHeCZhaoJSiLHuangH. Artemisia Scoparia: Traditional Uses, Active Constituents and Pharmacological Effects. J Ethnopharmacol (2021) 273:113960. doi: 10.1016/j.jep.2021.113960

  • CrossRef
  • Google Scholar

• 42

  Duah BoakyeYShaheenSNawazHNisarSAzeemMW. Artemisia Scoparia: A Review on Traditional Uses, Phytochemistry and Pharmacological Properties. IJCBS (2017) 12:92–7.

  • Google Scholar

• 43

  BenskyDClaveySStogerE. Chinese Herbal Medicine: Materia Medica (Portable 3rd Ed.) — Eastland Press. 3rd Ed. Seattle, WA: Eastland Press (2015).

  • Google Scholar

• 44

  HempenC-H. A Materia Medica for Chinese Medicine - 1st Edition. 1st Ed. London, UK: Churchill Livingstone (2009).

  • Google Scholar

• 45

  HungHYKuoSC. Recent Studies and Progression of Yin Chen Hao (Yīn Chén Hāo), A Long-Term Used Traditional Chinese Medicine. J Tradit Complement Med (2013) 3:2–6. doi: 10.4103/2225-4110.106533

  • CrossRef
  • Google Scholar

• 46

  TanXJLiQChenXHWangZWShiZYBiKSet al. Simultaneous Determination of 13 Bioactive Compounds in Herba Artemisiae Scopariae (Yin Chen) From Different Harvest Seasons by HPLC-DAD. J Pharm BioMed Anal (2008) 47:847–53. doi: 10.1016/j.jpba.2008.04.010

  • CrossRef
  • Google Scholar

• 47

  SunXSunHZhangJJiX. Artemisia Extract Improves Insulin Sensitivity in Women With Gestational Diabetes Mellitus by Up-Regulating Adiponectin. J Clin Pharmacol (2016) 56:1550–4. doi: 10.1002/jcph.755

  • CrossRef
  • Google Scholar

• 48

  RichardAJFullerSFedorcencoVBeylRBurrisTPMynattRet al. Artemisia Scoparia Enhances Adipocyte Development and Endocrine Function In Vitro and Enhances Insulin Action In Vivo. PloS One (2014) 9:e98897. doi: 10.1371/journal.pone.0098897

  • CrossRef
  • Google Scholar

• 49

  RichardAJBurrisTPSanchez-InfantesDWangYRibnickyDMStephensJM. Artemisia Extracts Activate Pparγ, Promote Adipogenesis, and Enhance Insulin Sensitivity in Adipose Tissue of Obese Mice. Nutrition (2014) 30:S31–536. doi: 10.1016/j.nut.2014.02.013

  • CrossRef
  • Google Scholar

• 50

  WangZQZhangXHYuYTiptonRCRaskinIRibnickyDet al. Artemisia Scoparia Extract Attenuates Non-Alcoholic Fatty Liver Disease in Diet-Induced Obesity Mice by Enhancing Hepatic Insulin and AMPK Signaling Independently of FGF21 Pathway. Metabolism (2013) 62:1239–49. doi: 10.1016/j.metabol.2013.03.004

  • CrossRef
  • Google Scholar

• 51

  RoodJCSchwarzJ-MGettysTMynattRLMendozaTJohnsonWDet al. Effects of Artemisia Species on De Novo Lipogenesis In Vivo. Nutrients (2014) 30:S17–20. doi: 10.1016/j.nut.2014.03.029

  • CrossRef
  • Google Scholar

• 52

  HarveyIStephensJM. Artemisia Scoparia Promotes Adipogenesis in the Absence of Adipogenic Effectors. Obesity (Silver Spring) (2021) 29(8):1309–19. doi: 10.1002/oby.23199

  • CrossRef
  • Google Scholar

• 53

  YahagiTYakuraNMatsuzakiKKitanakaS. Inhibitory Effect of Chemical Constituents From Artemisia Scoparia Waldst. Et Kit. On Triglyceride Accumulation in 3T3-L1 Cells and Nitric Oxide Production in RAW 264.7 Cells. J Nat Med (2014) 68:414–20. doi: 10.1007/s11418-013-0799-3

  • CrossRef
  • Google Scholar

• 54

  OhJHKaradenizFSeoYKongC-S. Artemisia Scoparia Inhibits Adipogenesis in 3T3-L1 Pre-Adipocytes by Downregulating the MAPK Pathway. J Life Sci (2018) 28:999–1006. doi: 10.5352/JLS.2018.28.9.999

  • CrossRef
  • Google Scholar

• 55

  DanforthE. Failure of Adipocyte Differentiation Causes Type II Diabetes Mellitus? Nat Genet (2000) 26:13–3. doi: 10.1038/79111

  • CrossRef
  • Google Scholar

• 56

  HammarstedtAAnderssonCXRotter SopasakisVSmithU. The Effect of Pparγ Ligands on the Adipose Tissue in Insulin Resistance. Prostaglandins Leukot Essent Fat Acids (2005) 73:65–75. doi: 10.1016/j.plefa.2005.04.008

  • CrossRef
  • Google Scholar

• 57

  Villarroel-VicenteCGutiérrez-PalomoSFerriJCortesDCabedoN. Natural Products and Analogs as Preventive Agents for Metabolic Syndrome via Peroxisome Proliferator-Activated Receptors: An Overview. Eur J Med Chem (2021) 221:113535. doi: 10.1016/j.ejmech.2021.113535

  • CrossRef
  • Google Scholar

• 58

  DukeCCTranVHDukeRKAbu-MellalAPlunkettGTKingDIet al. A Sedge Plant as the Source of Kangaroo Island Propolis Rich in Prenylated P-Coumarate Ester and Stilbenes. Phytochemistry (2017) 134:87–97. doi: 10.1016/j.phytochem.2016.11.005

  • CrossRef
  • Google Scholar

• 59

  ShafiSGuptaPKhatikGLGuptaJ. Pparγ: Potential Therapeutic Target for Ailments Beyond Diabetes and Its Natural Agonism. Curr Drug Targets (2019) 20:1281–94. doi: 10.2174/1389450120666190527115538

  • CrossRef
  • Google Scholar

• 60

  AbdallahHMDineRSEMohamedGAIbrahimSRMShehataIAEl-HalawanyAM. Natural Peroxisome Proliferator-Activated Receptor γ (Pparγ) Activators for Diabetes. Altern Ther Health Med (2020) 26:28–44.

  • Google Scholar

• 61

  MorignyPHoussierMMouiselELanginD. Adipocyte Lipolysis and Insulin Resistance. Biochimie (2016) 125:259–66. doi: 10.1016/j.biochi.2015.10.024

  • CrossRef
  • Google Scholar

• 62

  BoudreauARichardAJBurrellJAKingWTDunnRSchwarzJ-Met al. An Ethanolic Extract of Artemisia Scoparia (SCO) Inhibits Lipolysis In Vivo and has Anti-Lipolytic Effects on Murine Adipocytes In Vitro. Am J Physiol Metab (2018) 315(5):E1053–61. doi: 10.1152/ajpendo.00177.2018

  • CrossRef
  • Google Scholar

• 63

  ChoiEParkHLeeJKimG. Anticancer, Antiobesity, and Anti-Inflammatory Activity of Artemisia Species In Vitro. J Tradit Chin Med (2013) 33:92–7. doi: 10.1016/s0254-6272(13)60107-7

  • CrossRef
  • Google Scholar

• 64

  Gilani A ulHJanbazKH. Protective Effect of Artemisia Scoparia Extract Against Acetaminophen-Induced Hepatotoxicity. Gen Pharmacol (1993) 24:1455–8. doi: 10.1016/0306-3623(93)90434-Y

  • CrossRef
  • Google Scholar

• 65

  GilaniAHJanbazKH. Hepatoprotective Effects of Artemisia Scoparia Against Carbon Tetrachloride: An Environmental Contaminant. J Pak Med Assoc (1994) 44:65–8.

  • Google Scholar

• 66

  EnginA. The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation. Adv Exp Med Biol (2017) 960:221–45. doi: 10.1007/978-3-319-48382-5_9

  • CrossRef
  • Google Scholar

• 67

  GustafsonBHammarstedtAAnderssonCXSmithU. Inflamed Adipose Tissue: A Culprit Underlying the Metabolic Syndrome and Atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 27:2276–83. doi: 10.1161/ATVBAHA.107.147835

  • CrossRef
  • Google Scholar

• 68

  KhanMAKhanHTariqSAPervezS. In Vitro Attenuation of Thermal-Induced Protein Denaturation by Aerial Parts of Artemisia Scoparia. J Evid Based Complement Altern Med (2015) 20:9–12. doi: 10.1177/2156587214548458

  • CrossRef
  • Google Scholar

• 69

  AhnJHParkYLSongAYKimWGJeCYJungDHet al. Water Extract of Artemisia Scoparia Waldst. & Kitam Suppresses LPS-Induced Cytokine Production and NLRP3 Inflammasome Activation in Macrophages and Alleviates Carrageenan-Induced Acute Inflammation in Mice. J Ethnopharmacol (2021) 268:113606. doi: 10.1016/j.jep.2020.113606

  • CrossRef
  • Google Scholar

• 70

  HabibMWaheedI. Evaluation of Anti-Nociceptive, Anti-Inflammatory and Antipyretic Activities of Artemisia Scoparia Hydromethanolic Extract. J Ethnopharmacol (2013) 145:18–24. doi: 10.1016/J.JEP.2012.10.022

  • CrossRef
  • Google Scholar

• 71

  RyuKJYoouMSSeoYYoonKWKimHMJeongHJ. Therapeutic Effects of Artemisia Scoparia Waldst. Et Kitaib in a Murine Model of Atopic Dermatitis. Clin Exp Dermatol (2018) 43:798–805. doi: 10.1111/ced.13565

  • CrossRef
  • Google Scholar

• 72

  BoudreauABurkeSJCollierJJRichardAJRibnickyDMStephensJM. Mechanisms of Artemisia Scoparia ‘S Anti-Inflammatory Activity in Cultured Adipocytes, Macrophages, and Pancreatic β-Cells. Obesity (2020) 28(9):1726–35. doi: 10.1002/oby.22912

  • CrossRef
  • Google Scholar

• 73

  NamS-YHanN-RRahS-YSeoYKimH-MJeongH-J. Anti-Inflammatory Effects of Artemisia Scoparia and Its Active Constituent, 3,5-Dicaffeoyl-Epi-Quinic Acid Against Activated Mast Cells. Immunopharmacol Immunotoxicol (2018) 40:52–8. doi: 10.1080/08923973.2017.1405438

  • CrossRef
  • Google Scholar

• 74

  RudichATlroshAPotashnikRHemiRKanetyHBashanN. Prolonged Oxidative Stress Impairs Insulin-Induced GLUT4 Translocation in 3T3-L1 Adipocytes. Diabetes (1998) 47:1562–9. doi: 10.2337/diabetes.47.10.1562

  • CrossRef
  • Google Scholar

• 75

  BlairASHajduchELitherlandGJHundalHS. Regulation of Glucose Transport and Glycogen Synthesis in L6 Muscle Cells During Oxidative Stress. Evidence for Cross-Talk Between the Insulin and SAPK2/p38 Mitogen-Activated Protein Kinase Signaling Pathways. J Biol Chem (1999) 274:36293–9. doi: 10.1074/jbc.274.51.36293

  • CrossRef
  • Google Scholar

• 76

  FrankGDEguchiSMotleyED. The Role of Reactive Oxygen Species in Insulin Signaling in the Vasculature. Antioxid Redox Signal (2005) 7:1053–61. doi: 10.1089/ars.2005.7.1053

  • CrossRef
  • Google Scholar

• 77

  KimJSSaengsirisuwanVSlonigerJATeacheyMKHenriksenEJ. Oxidant Stress and Skeletal Muscle Glucose Transport: Roles of Insulin Signaling and P38 MAPK. Free Radic Biol Med (2006) 41:818–24. doi: 10.1016/j.freeradbiomed.2006.05.031

  • CrossRef
  • Google Scholar

• 78

  RainsJLJainSK. Oxidative Stress, Insulin Signaling, and Diabetes. Free Radic Biol Med (2011) 50:567–75. doi: 10.1016/j.freeradbiomed.2010.12.006

  • CrossRef
  • Google Scholar

• 79

  MadduxBASeeWLawrenceJCGoldfineALGoldfineIDEvansJL. Protection Against Oxidative Stress-Induced Insulin Resistance in Rat L6 Muscle Cells by Micromolar Concentrations of α-Lipoic Acid. Diabetes (2001) 50:404–10. doi: 10.2337/diabetes.50.2.404

  • CrossRef
  • Google Scholar

• 80

  YaribeygiHSathyapalanTAtkinSLSahebkarA. Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus. Oxid Med Cell Longev (2020) 2020:8609213. doi: 10.1155/2020/8609213

  • CrossRef
  • Google Scholar

• 81

  GerberPARutterGA. The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus. Antioxid Redox Signal (2017) 26:501–18. doi: 10.1089/ars.2016.6755

  • CrossRef
  • Google Scholar

• 82

  SinghHPMittalSKaurSBatishDRKohliRK. Chemical Composition and Antioxidant Activity of Essential Oil From Residues of Artemisia Scoparia. Food Chem (2009) 114:642–5. doi: 10.1016/j.foodchem.2008.09.101

  • CrossRef
  • Google Scholar

• 83

  AfsharFHDelazarAJannehONazemiyehHPasdaranANaharLet al. Evaluation of Antimalarial, Free-Radicalscavenging and Insecticidal Activities of Artemisia Scoparia and A. Spicigera, Asteraceae. Rev Bras Farmacogn (2011) 21:986–90. doi: 10.1590/S0102-695X2011005000144

  • CrossRef
  • Google Scholar

• 84

  SajidMKhanMRShahNAUllahSYounisTMajidMet al. Proficiencies of Artemisia Scoparia Against CCl4 Induced DNA Damages and Renal Toxicity in Rat. BMC Complement Altern Med (2016) 16:149. doi: 10.1186/s12906-016-1137-6

  • CrossRef
  • Google Scholar

• 85

  KhanKFatimaHTaqiMMZiaMur-RehmanTMirzaBet al. Phytochemical and In Vitro Biological Evaluation of Artemisia Scoparia Waldst. & Kit for Enhanced Extraction of Commercially Significant Bioactive Compounds. J Appl Res Med Aromat Plants (2015) 2:77–86. doi: 10.1016/j.jarmap.2015.04.002

  • CrossRef
  • Google Scholar

• 86

  WicksSTaylorCMLuoMBlanchardERibnickyDMCefaluWTet al. Artemisia Supplementation Differentially Affects the Mucosal and Luminal Ileal Microbiota of Diet-Induced Obese Mice. Nutrition (2014) 30:S26–30. doi: 10.1016/J.NUT.2014.02.007

  • CrossRef
  • Google Scholar

• 87

  ChoiEKimG. Effect of Artemisia Species on Cellular Proliferation and Apoptosis in Human Breast Cancer Cells via Estrogen Receptor-Related Pathway. J Tradit Chin Med (2013) 33:658–63. doi: 10.1016/S0254-6272(14)60038-8

  • CrossRef
  • Google Scholar

• 88

  ChoJ-YParkK-HHwangDChanmuangSJaiswalLParkY-Ket al. Antihypertensive Effects of Artemisia Scoparia Waldst in Spontaneously Hypertensive Rats and Identification of Angiotensin I Converting Enzyme Inhibitors. Molecules (2015) 20:19789–804. doi: 10.3390/molecules201119657

  • CrossRef
  • Google Scholar

• 89

  PromyoKChoJYParkKHJaiswalLParkSYHamKS. Artemisia Scoparia Attenuates Amyloid β Accumulation and Tau Hyperphosphorylation in Spontaneously Hypertensive Rats. Food Sci Biotechnol (2017) 26:775–82. doi: 10.1007/s10068-017-0077-3

  • CrossRef
  • Google Scholar

• 90

  WangXHuangHMaXWangLLiuCHouBet al. Anti-Inflammatory Effects and Mechanism of the Total Flavonoids From Artemisia Scoparia Waldst. Et Kit. In Vitro and In Vivo. BioMed Pharmacother (2018) 104:390–403. doi: 10.1016/J.BIOPHA.2018.05.054

  • CrossRef
  • Google Scholar

• 91

  SinghHPKaurSMittalSBatishDRKohliRK. In Vitro Screening of Essential Oil From Young and Mature Leaves of Artemisia Scoparia Compared to Its Major Constituents for Free Radical Scavenging Activity. Food Chem Toxicol (2010) 48:1040–4. doi: 10.1016/j.fct.2010.01.017

  • CrossRef
  • Google Scholar

• 92

  ChaJ-DJeongM-RJeongS-IMoonS-EKimJ-YKilB-Set al. Chemical Composition and Antimicrobial Activity of the Essential Oils of Artemisia Scoparia and A. Capillaris. Planta Med (2005) 71:186–90. doi: 10.1055/s-2005-837790

  • CrossRef
  • Google Scholar

• 93

  YarnellEAbascalK. Plant Coumarins: Myths and Realities. Altern Complement Ther (2009) 15:24–30. doi: 10.1089/act.2009.15104

  • CrossRef
  • Google Scholar

• 94

  HassaneinEHMSayedAMHusseinOEMahmoudAM. Coumarins as Modulators of the Keap1/Nrf2/ARE Signaling Pathway. Oxid Med Cell Longev (2020) 2020:1675957. doi: 10.1155/2020/1675957

  • CrossRef
  • Google Scholar

• 95

  GargSSGuptaJSharmaSSahuD. An Insight Into the Therapeutic Applications of Coumarin Compounds and Their Mechanisms of Action. Eur J Pharm Sci (2020) 152:105424. doi: 10.1016/j.ejps.2020.105424

  • CrossRef
  • Google Scholar

• 96

  Küpeli AkkolEGençYKarpuzBSobarzo-SánchezECapassoR. Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer. Cancers (Basel) (2020) 12:1–25. doi: 10.3390/cancers12071959

  • CrossRef
  • Google Scholar

• 97

  PintoDCGASilvaAMS. Anticancer Natural Coumarins as Lead Compounds for the Discovery of New Drugs. Curr Top Med Chem (2017) 17(29):3190–8. doi: 10.2174/1568026618666171215095750

  • CrossRef
  • Google Scholar

• 98

  YererMBDayanSHanMISharmaATuliHSSakK. Nanoformulations of Coumarins and the Hybrid Molecules of Coumarins With Potential Anticancer Effects. Anticancer Agents Med Chem (2020) 20:1797–816. doi: 10.2174/1871520620666200310094646

  • CrossRef
  • Google Scholar

• 99

  MenezesJCJMDSDiederichM. Translational Role of Natural Coumarins and Their Derivatives as Anticancer Agents. Future Med Chem (2019) 11:1057–82. doi: 10.4155/fmc-2018-0375

  • CrossRef
  • Google Scholar

• 100

  ShiWZhangJBaoNGuanFChenLSunJ. Design, Synthesis, and Cytotoxic Evaluation of Novel Scopoletin Derivatives. Chem Biol Drug Des (2018) 91:641–6. doi: 10.1111/cbdd.13120

  • CrossRef
  • Google Scholar

• 101

  KhunnawutmanothamNChimnoiNSaparpakornPTechasakulS. Synthesis and Anti-Acetylcholinesterase Activity of Scopoletin Derivatives. Bioorg Chem (2016) 65:137–45. doi: 10.1016/j.bioorg.2015.12.002

  • CrossRef
  • Google Scholar

• 102

  NamSOParkDHLeeYHRyuJHLeeYS. Synthesis of Aminoalkyl-Substituted Coumarin Derivatives as Acetylcholinesterase Inhibitors. Bioorg Med Chem (2014) 22:1262–7. doi: 10.1016/j.bmc.2014.01.010

  • CrossRef
  • Google Scholar

• 103

  WangZLingBZhangRLiuY. Docking and Molecular Dynamics Study on the Inhibitory Activity of Coumarins on Aldose Reductase. J Phys Chem B (2008) 112:10033–40. doi: 10.1021/jp8033227

  • CrossRef
  • Google Scholar

• 104

  YuanCWangMHWangFChenPYKeXGYuBet al. Network Pharmacology and Molecular Docking Reveal the Mechanism of Scopoletin Against Non-Small Cell Lung Cancer. Life Sci (2021) 270:119105. doi: 10.1016/j.lfs.2021.119105

  • CrossRef
  • Google Scholar

• 105

  KimJKKimJYKimHJParkKGHarrisRAChoWJet al. Scoparone Exerts Anti-Tumor Activity Against DU145 Prostate Cancer Cells via Inhibition of STAT3 Activity. PloS One (2013) 8(11):e80391. doi: 10.1371/journal.pone.0080391

  • CrossRef
  • Google Scholar

• 106

  BasuMMayanaKXavierSBalachandranSMishraN. Effect of Scopoletin on Monoamine Oxidases and Brain Amines. Neurochem Int (2016) 93:113–7. doi: 10.1016/j.neuint.2016.01.001

  • CrossRef
  • Google Scholar

• 107

  PrajapatiSTomarBSrivastavaANarkhedeYBGaikwadANLahiriAet al. 6,7-Dihydroxycoumarin Ameliorates Crystal-Induced Necroptosis During Crystal Nephropathies by Inhibiting MLKL Phosphorylation. Life Sci (2021) 271:119193. doi: 10.1016/j.lfs.2021.119193

  • CrossRef
  • Google Scholar

• 108

  TanDCIdrisKIKassimNKLimPCSafinar IsmailIHamidMet al. Comparative Study of the Antidiabetic Potential of Paederia Foetida Twig Extracts and Compounds From Two Different Locations in Malaysia. Pharm Biol (2019) 57:345–54. doi: 10.1080/13880209.2019.1610462

  • CrossRef
  • Google Scholar

• 109

  RaneARPaithankarHHosurRVChoudharyS. Modulation of α-Synuclein Fibrillation by Plant Metabolites, Daidzein, Fisetin and Scopoletin Under Physiological Conditions. Int J Biol Macromol (2021) 182:1278–91. doi: 10.1016/j.ijbiomac.2021.05.071

  • CrossRef
  • Google Scholar

• 110

  KashyapPRamHShuklaSDKumarS. Scopoletin: Antiamyloidogenic, Anticholinesterase, and Neuroprotective Potential of a Natural Compound Present in Argyreia Speciosa Roots by In Vitro and In Silico Study. Neurosci Insights (2020) 15:2633105520937693. doi: 10.1177/2633105520937693

  • CrossRef
  • Google Scholar

• 111

  AliMYJannatSJungHAChoiRJRoyAChoiJS. Anti-Alzheimer’s Disease Potential of Coumarins From Angelica Decursiva and Artemisia Capillaris and Structure-Activity Analysis. Asian Pac J Trop Med (2016) 9:103–11. doi: 10.1016/j.apjtm.2016.01.014

  • CrossRef
  • Google Scholar

• 112

  YusufzaiSKKhanMSSulaimanOOsmanHLamjinDN. Molecular Docking Studies of Coumarin Hybrids as Potential Acetylcholinesterase, Butyrylcholinesterase, Monoamine Oxidase a/B and β-Amyloid Inhibitors for Alzheimer’s Disease. Chem Cent J (2018) 12:1–57. doi: 10.1186/s13065-018-0497-z

  • CrossRef
  • Google Scholar

• 113

  LinHCTsaiSHChenCSChangYCLeeCMLaiZYet al. Structure-Activity Relationship of Coumarin Derivatives on Xanthine Oxidase-Inhibiting and Free Radical-Scavenging Activities. Biochem Pharmacol (2008) 75:1416–25. doi: 10.1016/j.bcp.2007.11.023

  • CrossRef
  • Google Scholar

• 114

  ThuongPTHungTMNgocTMHaDTMinBSKwackSJet al. Antioxidant Activities of Coumarins From Korean Medicinal Plants and Their Structure-Activity Relationships. Phyther Res (2010) 24:101–6. doi: 10.1002/ptr.2890

  • CrossRef
  • Google Scholar

• 115

  KolodziejHKayserOWoerdenbagHJvan UdenWPrasN. Structure - Cytotoxicity Relationships of a Series of Natural and Semi-Synthetic Simple Coumarins as Assessed in Two Human Tumour Cell Lines. Z Fur Naturforsch - Sect C J Biosci (1997) 52:240–4. doi: 10.1515/znc-1997-3-416

  • CrossRef
  • Google Scholar

• 116

  Nurul IslamMJungHASohnHSKimHMChoiJS. Potent α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitors From Artemisia Capillaris. Arch Pharm Res (2013) 36:542–52. doi: 10.1007/s12272-013-0069-7

  • CrossRef
  • Google Scholar

• 117

  Al-WarhiTSabtAElkaeedEBEldehnaWM. Recent Advancements of Coumarin-Based Anticancer Agents: An Up-to-Date Review. Bioorg Chem (2020) 103:104163. doi: 10.1016/j.bioorg.2020.104163

  • CrossRef
  • Google Scholar

• 118

  SharmaML. Mechanism of Hypotensive Action of Scoparone. Indian J Med Res (1988) 87:387–94.

  • Google Scholar

• 119

  ThakurRSBagadiaSCSharmaML. Hypotensive Activity of Some Dihydroxycoumarins and Their Congeners. Experientia (1978) 34:158–9. doi: 10.1007/BF01944649

  • CrossRef
  • Google Scholar

• 120

  ZutshiURaoPGSoniAAtalCK. Absorption, Distribution and Excretion of Scoparone: A Potent Hypotensive Agent. Indian J Exp Biol (1978) 16:836–8.

  • Google Scholar

• 121

  HoultJRSPayáM. Pharmacological and Biochemical Actions of Simple Coumarins: Natural Products With Therapeutic Potential. Gen Pharmacol (1996) 27:713–22. doi: 10.1016/0306-3623(95)02112-4

  • CrossRef
  • Google Scholar

• 122

  HuangHCLeeCRWengYILeeMCLeeYT. Vasodilator Effect of Scoparone (6,7-Dimethoxycoumarin) From a Chinese Herb. Eur J Pharmacol (1992) 218:123–8. doi: 10.1016/0014-2999(92)90155-W

  • CrossRef
  • Google Scholar

• 123

  YamaharaJKobayashiGMatsudaHKatayamaTFujimuraH. Vascular Dilatory Action of Artemisia Capillaris Bud Extracts and Their Active Constituent. J Ethnopharmacol (1989) 26:129–36. doi: 10.1016/0378-8741(89)90060-3

  • CrossRef
  • Google Scholar

• 124

  YamaharaJKobayashiGMatsudaHIwamotoMFujimuraH. Vascular Dilatory Action of the Chinese Crude Drug. II. Effects of Scoparone on Calcium Mobilization. Chem Pharm Bull (1989) 37:485–9. doi: 10.1248/cpb.37.485

  • CrossRef
  • Google Scholar

• 125

  YamaharaJKobayashiGMatsudaHKatayamaTFujimuraH. The Effect of Scoparone, a Coumarin Derivative Isolated From the Chinese Crude Drug Artemisiae Capillaris Flos, on the Heart. Chem Pharm Bull (1989) 37:1297–9. doi: 10.1248/cpb.37.1297

  • CrossRef
  • Google Scholar

• 126

  ChoDYKoHMKimJKimBWYunYSParkJIet al. Scoparone Inhibits LPS-Simulated Inflammatory Response by Suppressing IRF3 and ERK in BV-2 Microglial Cells. Molecules (2016) 21(12):1718. doi: 10.3390/molecules21121718

  • CrossRef
  • Google Scholar

• 127

  FuBSuYMaXMuCYuF. Scoparone Attenuates Angiotensin II-Induced Extracellular Matrix Remodeling in Cardiac Fibroblasts. J Pharmacol Sci (2018) 137:110–5. doi: 10.1016/j.jphs.2018.05.006

  • CrossRef
  • Google Scholar

• 128

  LyuLChenJWangWYanTLinJGaoHet al. Scoparone Alleviates Ang II-Induced Pathological Myocardial Hypertrophy in Mice by Inhibiting Oxidative Stress. J Cell Mol Med (2021) 25:3136–48. doi: 10.1111/jcmm.16304

  • CrossRef
  • Google Scholar

• 129

  WanCWeiYMaJGengX. Protective Effects of Scoparone Against Ischemia−Reperfusion−Induced Myocardial Injury. Mol Med Rep (2018) 18:1752–60. doi: 10.3892/mmr.2018.9123

  • CrossRef
  • Google Scholar

• 130

  ParkSKimJKOhCJChoiSHJeonJHLeeIK. Scoparone Interferes With STAT3-Induced Proliferation of Vascular Smooth Muscle Cells. Exp Mol Med (2015) 47(3):e145. doi: 10.1038/emm.2014.113

  • CrossRef
  • Google Scholar

• 131

  JungSHLeeGBRyuYCuiLLeeHMKimJet al. Inhibitory Effects of Scoparone From Chestnut Inner Shell on Platelet-Derived Growth Factor-BB-Induced Vascular Smooth Muscle Cell Migration and Vascular Neointima Hyperplasia. J Sci Food Agric (2019) 99:4397–406. doi: 10.1002/jsfa.9674

  • CrossRef
  • Google Scholar

• 132

  OkadaYMiyauchiNOkuyamaTSuzukiKKobayashiTTsutsuiCet al. Search for Naturally Occurring Substances to Prevent the Complications of Diabetes. II. Inhibitory Effect of Coumarin and Flavonoid Derivatives on Bovine Lens Aldose Reductase and Rabbit Platelet Aggregation. Chem Pharm Bull (1995) 43:1385–7. doi: 10.1248/cpb.43.1385

  • CrossRef
  • Google Scholar

• 133

  ChenYLHuangHCWengYIYuYJLeeYT. Morphological Evidence for the Antiatherogenic Effect of Scoparone in Hyperlipidaemic Diabetic Rabbits. Cardiovasc Res (1994) 28:1679–85. doi: 10.1093/cvr/28.11.1679

  • CrossRef
  • Google Scholar

• 134

  HuangH-CWengY-ILeeC-RJanT-RChenY-LLeeY-T. Protection by Scoparone Against the Alterations of Plasma Lipoproteins, Vascular Morphology and Vascular Reactivity in Hyperlipidaemic Diabetic Rabbit. Br J Pharmacol (1993) 110:1508–14. doi: 10.1111/j.1476-5381.1993.tb13993.x

  • CrossRef
  • Google Scholar

• 135

  NohJRKimYHHwangJHGangGTYeoSHKimKSet al. Scoparone Inhibits Adipocyte Differentiation Through Down-Regulation of Peroxisome Proliferators-Activated Receptor γ in 3T3-L1 Preadipocytes. Food Chem (2013) 141:723–30. doi: 10.1016/j.foodchem.2013.04.036

  • CrossRef
  • Google Scholar

• 136

  WangYWangMChenBShiJ. Scoparone Attenuates High Glucose-Induced Extracellular Matrix Accumulation in Rat Mesangial Cells. Eur J Pharmacol (2017) 815:376–80. doi: 10.1016/j.ejphar.2017.09.039

  • CrossRef
  • Google Scholar

• 137

  LiuBDengXJiangQLiGZhangJZhangNet al. Scoparone Alleviates Inflammation, Apoptosis and Fibrosis of Non-Alcoholic Steatohepatitis by Suppressing the TLR4/NF-κb Signaling Pathway in Mice. Int Immunopharmacol (2019) 75:105797. doi: 10.1016/j.intimp.2019.105797

  • CrossRef
  • Google Scholar

• 138

  LiuBDengXJiangQLiGZhangJZhangNet al. Scoparone Improves Hepatic Inflammation and Autophagy in Mice With Nonalcoholic Steatohepatitis by Regulating the ROS/P38/Nrf2 Axis and PI3K/AKT/mTOR Pathway in Macrophages. BioMed Pharmacother (2020) 125:109895. doi: 10.1016/j.biopha.2020.109895

  • CrossRef
  • Google Scholar

• 139

  Murat BilginHAtmacaMDeniz ObayBÖzekinciSTaşdemirEKetaniA. Protective Effects of Coumarin and Coumarin Derivatives Against Carbon Tetrachloride-Induced Acute Hepatotoxicity in Rats. Exp Toxicol Pathol (2011) 63:325–30. doi: 10.1016/j.etp.2010.02.006

  • CrossRef
  • Google Scholar

• 140

  AtmacaMBilginHMObayBDDikenHKelleMKaleE. The Hepatoprotective Effect of Coumarin and Coumarin Derivates on Carbon Tetrachloride-Induced Hepatic Injury by Antioxidative Activities in Rats. J Physiol Biochem (2011) 67:569–76. doi: 10.1007/s13105-011-0103-5

  • CrossRef
  • Google Scholar

• 141

  ZhangASunHWangX. Urinary Metabolic Profiling of Rat Models Revealed Protective Function of Scoparone Against Alcohol Induced Hepatotoxicity. Sci Rep (2014) 4:6768. doi: 10.1038/srep06768

  • CrossRef
  • Google Scholar

• 142

  HuangWZhangJMooreDD. A Traditional Herbal Medicine Enhances Bilirubin Clearance by Activating the Nuclear Receptor CAR. J Clin Invest (2004) 113:137–43. doi: 10.1172/jci18385

  • CrossRef
  • Google Scholar

• 143

  DongBSahaPKHuangWChenWAbu-ElheigaLAWakilSJet al. Activation of Nuclear Receptor CAR Ameliorates Diabetes and Fatty Liver Disease. Proc Natl Acad Sci USA (2009) 106:18831–6. doi: 10.1073/pnas.0909731106

  • CrossRef
  • Google Scholar

• 144

  GaoJHeJZhaiYWadaTXieW. The Constitutive Androstane Receptor Is an Anti-Obesity Nuclear Receptor That Improves in Sulin Sensitivity. J Biol Chem (2009) 284:25984–92. doi: 10.1074/jbc.M109.016808

  • CrossRef
  • Google Scholar

• 145

  JiangMXieW. Role of the Constitutive Androstane Receptor in Obesity and Type 2 Diabetes: A Case Study of the Endobiotic Function of a Xenobiotic Receptor. Drug Metab Rev (2013) 45:156–63. doi: 10.3109/03602532.2012.743561

  • CrossRef
  • Google Scholar

• 146

  LiXWangZKlaunigJE. Modulation of Xenobiotic Nuclear Receptors in High-Fat Diet Induced Non-Alcoholic Fatty Liver Disease. Toxicology (2018) 410:199–213. doi: 10.1016/J.TOX.2018.08.007

  • CrossRef
  • Google Scholar

• 147

  JuangSHHsiehMTHsuPLChenJLLiuHKLiangFPet al. Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation. Molecules (2020) 26(1):164. doi: 10.3390/molecules26010164

  • CrossRef
  • Google Scholar

• 148

  JangSIKimY-JLeeW-YKwakKCBaekHBeum KwakGet al. Scoparone From Artemisia Capillaris Inhibits the Release of Inflammatory Mediators in RAW 264,7 Cells Upon Stimulation Cells by Interferon-Y Plus LPS. Arch Pharm Res (2005) 28:203–8. doi: 10.1007/BF02977716

  • CrossRef
  • Google Scholar

• 149

  JangSKimYJKimHJLeeJCKimHYKimYCet al. Scoparone Inhibits PMA-Induced IL-8 and MCP-1 Production Through Suppression of NF-κb Activation in U937 Cells. Life Sci (2006) 78:2937–43. doi: 10.1016/j.lfs.2005.11.020

  • CrossRef
  • Google Scholar

• 150

  NiuNLiBHuYLiXLiJZhangH. Protective Effects of Scoparone Against Lipopolysaccharide-Induced Acute Lung Injury. Int Immunopharmacol (2014) 23:127–33. doi: 10.1016/j.intimp.2014.08.014

  • CrossRef
  • Google Scholar

• 151

  WitaicenisASeitoLNDa Silveira ChagasADe AlmeidaLDLuchiniACRodrigues-OrsiPet al. Antioxidant and Intestinal Anti-Inflammatory Effects of Plant-Derived Coumarin Derivatives. Phytomedicine (2014) 21:240–6. doi: 10.1016/j.phymed.2013.09.001

  • CrossRef
  • Google Scholar

• 152

  XiaJLiCYWangHZhangQMHanZM. Therapeutic Effects of Scoparone on Pilocarpine (Pilo)-Induced Seizures in Mice. BioMed Pharmacother (2018) 97:1501–13. doi: 10.1016/j.biopha.2017.09.127

  • CrossRef
  • Google Scholar

• 153

  SourivongPSchronerováKBabincováM. Scoparone Inhibits Ultraviolet Radiation-Induced Lipid Peroxidation. Z Fur Naturforsch - Sect C J Biosci (2007) 62:61–4. doi: 10.1515/znc-2007-1-211

  • CrossRef
  • Google Scholar

• 154

  NohJRGangGTKimYHYangKJHwangJHLeeHSet al. Antioxidant Effects of the Chestnut (Castanea Crenata) Inner Shell Extract in T-BHP-Treated HepG2 Cells, and CCl4- and High-Fat Diet-Treated Mice. Food Chem Toxicol (2010) 48:3177–83. doi: 10.1016/j.fct.2010.08.018

  • CrossRef
  • Google Scholar

• 155

  NohJRKimYHGangGTHwangJHLeeHSLySYet al. Hepatoprotective Effects of Chestnut (Castanea Crenata) Inner Shell Extract Against Chronic Ethanol-Induced Oxidative Stress in C57BL/6 Mice. Food Chem Toxicol (2011) 49:1537–43. doi: 10.1016/j.fct.2011.03.045

  • CrossRef
  • Google Scholar

• 156

  LiuSJZhouSW. 6,7-Dimethoxycoumarin Attenuated Cisplatin-Induced DNA Interstrand Crosslink and DNA-Protein Crosslink in Primary Cultured Rabbit Kidney Proximal Tubular Cells. Acta Pharmacol Sin (1999) 20:391–4.

  • Google Scholar

• 157

  XuMCaiJWeiHZhouMXuPHuangHet al. Scoparone Protects Against Pancreatic Fibrosis via TGF-β/Smad Signaling in Rats. Cell Physiol Biochem (2016) 40:277–86. doi: 10.1159/000452544

  • CrossRef
  • Google Scholar

• 158

  LeeSHJangHD. Scoparone Attenuates RANKL-Induced Osteoclastic Differentiation Through Controlling Reactive Oxygen Species Production and Scavenging. Exp Cell Res (2015) 331:267–77. doi: 10.1016/j.yexcr.2014.12.018

  • CrossRef
  • Google Scholar

• 159

  Huei-ChenHShu-HsunCLee ChaoP-D. Vasorelaxants From Chinese Herbs, Emodin and Scoparone, Possess Immunosuppressive Properties. Eur J Pharmacol (1991) 198:211–3. doi: 10.1016/0014-2999(91)90624-Y

  • CrossRef
  • Google Scholar

• 160

  ChoiYHYanGH. Anti-Allergic Effects of Scoparone on Mast Cell-Mediated Allergy Model. Phytomedicine (2009) 16:1089–94. doi: 10.1016/j.phymed.2009.05.003

  • CrossRef
  • Google Scholar

• 161

  YangYJLeeHJChoiDHHuangHSLimSCLeeMK. Effect of Scoparone on Neurite Outgrowth in PC12 Cells. Neurosci Lett (2008) 440:14–8. doi: 10.1016/j.neulet.2008.05.051

  • CrossRef
  • Google Scholar

• 162

  YangYJLeeHJLeeBKLimSCLeeCKLeeMK. Effects of Scoparone on Dopamine Release in PC12 Cells. Fitoterapia (2010) 81:497–502. doi: 10.1016/j.fitote.2010.01.003

  • CrossRef
  • Google Scholar

• 163

  YangYJLeeHJHuangHSLeeBKChoiHSLimSCet al. Effects of Scoparone on Dopamine Biosynthesis and L-DOPA-Induced Cytotoxicity in PC12 Cells. J Neurosci Res (2009) 87:1929–37. doi: 10.1002/jnr.22009

  • CrossRef
  • Google Scholar

• 164

  KiełbusMSkalicka-WoźniakKGrabarskaAJeleniewiczWDmoszyńska-GraniczkaMMarstonAet al. 7-Substituted Coumarins Inhibit Proliferation and Migration of Laryngeal Cancer Cells In Vitro. Anticancer Res (2013) 33:4347–56.

  • Google Scholar

• 165

  CéspedesCLAvilaJGMartínezASerratoBCalderón-MugicaJCSalgado-GarcigliaR. Antifungal and Antibacterial Activities of Mexican Tarragon (Tagetes Lucida). J Agric Food Chem (2006) 54:3521–7. doi: 10.1021/jf053071w

  • CrossRef
  • Google Scholar

• 166

  YangBChenGSongXChenZSongXWangJ. Chemical Constituents and Antimicrobial Activities of Canthium Horridum. Nat Prod Commun (2010) 5:913–4. doi: 10.1177/1934578x1000500620

  • CrossRef
  • Google Scholar

• 167

  Vila-NovaNSde MoraisSMFalcãoMJCAlcantaraTTNFerreiraPATCavalcantiESBet al. Different Susceptibilities of Leishmania Spp. Promastigotes to the Annona Muricata Acetogenins Annonacinone and Corossolone, and the Platymiscium Floribundum Coumarin Scoparone. Exp Parasitol (2013) 133:334–8. doi: 10.1016/j.exppara.2012.11.025

  • CrossRef
  • Google Scholar

• 168

  XuLNNaWLLiuXHouSGLinSYangHet al. Identification of Natural Coumarin Compounds That Rescue Defective Δf508-CFTR Chloride Channel Gating. Clin Exp Pharmacol Physiol (2008) 35:878–83. doi: 10.1111/j.1440-1681.2008.04943.x

  • CrossRef
  • Google Scholar

• 169

  YangHXuLNLiuXHeCYFangRYLiuJet al. Stimulation of Airway and Intestinal Mucosal Secretion by Natural Coumarin CFTR Activators. Front Pharmacol (2011) 52:52. doi: 10.3389/fphar.2011.00052

  • CrossRef
  • Google Scholar

• 170

  YangDYangJShiDDengRYanB. Scoparone Potentiates Transactivation of the Bile Salt Export Pump Gene and This Effect Is Enhanced by Cytochrome P450 Metabolism But Abolished by a PKC Inhibitor. Br J Pharmacol (2011) 164:1547–57. doi: 10.1111/j.1476-5381.2011.01522.x

  • CrossRef
  • Google Scholar

• 171

  TaşdemirEAtmacaMYlldlrlmYBilginHMDemirtaşBObayBDet al. Influence of Coumarin and Some Coumarin Derivatives on Serum Lipid Profiles in Carbontetrachloride-Exposed Rats. Hum Exp Toxicol (2017) 36:295–301. doi: 10.1177/0960327116649675

  • CrossRef
  • Google Scholar

• 172

  LiuXZhaoX. Scoparone Attenuates Hepatic Stellate Cell Activation Through Inhibiting TGF-β/Smad Signaling Pathway. BioMed Pharmacother (2017) 93:57–61. doi: 10.1016/j.biopha.2017.06.006

  • CrossRef
  • Google Scholar

• 173

  HuiYWangXYuZFanXCuiBZhaoTet al. Scoparone as a Therapeutic Drug in Liver Diseases: Pharmacology, Pharmacokinetics and Molecular Mechanisms of Action. Pharmacol Res (2020) 160:105170. doi: 10.1016/j.phrs.2020.105170

  • CrossRef
  • Google Scholar

• 174

  GaoYXiBLiJLiZXuJZhongMet al. Scoparone Alleviates Hepatic Fibrosis by Inhibiting the TLR-4/NF-κb Pathway. J Cell Physiol (2021) 236:3044–58. doi: 10.1002/jcp.30083

  • CrossRef
  • Google Scholar

• 175

  IvanovskaNYossifovaTVassilevaEKostovaI. Effect of Some Hydroxycoumarins on Complement-Mediated Hemolysis in Human Serum. Methods Find Exp Clin Pharmacol (1994) 16:557–62.

  • Google Scholar

• 176

  LuCLiYHuSCaiYYangZPengK. Scoparone Prevents IL-1β-Induced Inflammatory Response in Human Osteoarthritis Chondrocytes Through the PI3K/Akt/NF-κb Pathway. BioMed Pharmacother (2018) 106:1169–74. doi: 10.1016/j.biopha.2018.07.062

  • CrossRef
  • Google Scholar

• 177

  ChoiBRKimHKParkJK. Penile Erection Induced by Scoparone From Artemisia Capillaris Through the Nitric Oxide-Cyclic Guanosine Monophosphate Signaling Pathway. World J Mens Health (2017) 35:196. doi: 10.5534/wjmh.17023

  • CrossRef
  • Google Scholar

• 178

  YangJYKooJHSongYGKwonKBLeeJHSohnHSet al. Stimulation of Melanogenesis by Scoparone in B16 Melanoma Cells. Acta Pharmacol Sin (2006) 27:1467–73. doi: 10.1111/j.1745-7254.2006.00435.x

  • CrossRef
  • Google Scholar

• 179

  LeeSHLeeJYKwonYIJangHD. Anti-Osteoclastic Activity of Artemisia Capillaris Thunb. Extract Depends Upon Attenuation of Osteoclast Differentiation and Bone Resorption-Associated Acidification Due to Chlorogenic Acid, Hyperoside, and Scoparone. Int J Mol Sci (2017) 18(2):322. doi: 10.3390/ijms18020322

  • CrossRef
  • Google Scholar

• 180

  JungHAParkJJIslamMNJinSEMinB-SLeeJ-Het al. Inhibitory Activity of Coumarins From Artemisia Capillaris Against Advanced Glycation Endproduct Formation. Arch Pharm Res (2012) 35:1021–35. doi: 10.1007/s12272-012-0610-0

  • CrossRef
  • Google Scholar

• 181

  LeeHILeeMK. Coordinated Regulation of Scopoletin at Adipose Tissue-Liver Axis Improved Alcohol-Induced Lipid Dysmetabolism and Inflammation in Rats. Toxicol Lett (2015) 237:210–8. doi: 10.1016/j.toxlet.2015.06.016

  • CrossRef
  • Google Scholar

• 182

  LeeHIYunKWSeoKKimMJLeeMK. Scopoletin Prevents Alcohol-Induced Hepatic Lipid Accumulation by Modulating the AMPK-SREBP Pathway in Diet-Induced Obese Mice. Metabolism (2014) 63:593–601. doi: 10.1016/j.metabol.2014.01.003

  • CrossRef
  • Google Scholar

• 183

  ChoiRYHamJRLeeHIChoHWChoiMSParkSKet al. Scopoletin Supplementation Ameliorates Steatosis and Inflammation in Diabetic Mice. Phyther Res (2017) 31:1795–804. doi: 10.1002/ptr.5925

  • CrossRef
  • Google Scholar

• 184

  ChangWCWuSCXuKDLiaoBCWuJFChengAS. Scopoletin Protects Against Methylglyoxal-Induced Hyperglycemia and Insulin Resistance Mediated by Suppression of Advanced Glycation Endproducts (AGEs) Generation and Anti-Glycation. Molecules (2015) 20:2786–801. doi: 10.3390/molecules20022786

  • CrossRef
  • Google Scholar

• 185

  KalpanaKPriyadarshiniESreejaSJaganKAnuradhaCV. Scopoletin Intervention in Pancreatic Endoplasmic Reticulum Stress Induced by Lipotoxicity. Cell Stress Chaperones (2018) 23:857–69. doi: 10.1007/s12192-018-0893-2

  • CrossRef
  • Google Scholar

• 186

  KalpanaKSathiya PriyaCDiptiNVidhyaRAnuradhaCV. Supplementation of Scopoletin Improves Insulin Sensitivity by Attenuating the Derangements of Insulin Signaling Through AMPK. Mol Cell Biochem (2019) 453:65–78. doi: 10.1007/s11010-018-3432-7

  • CrossRef
  • Google Scholar

• 187

  JangJHParkJEHanJS. Scopoletin Inhibits α-Glucosidase In Vitro and Alleviates Postprandial Hyperglycemia in Mice With Diabetes. Eur J Pharmacol (2018) 834:152–6. doi: 10.1016/j.ejphar.2018.07.032

  • CrossRef
  • Google Scholar

• 188

  ZhangWYLeeJJKimYKimISParkJSMyungCS. Amelioration of Insulin Resistance by Scopoletin in High-Glucose-Induced, Insulin-Resistant HepG2 Cells. Horm Metab Res (2010) 42:930–5. doi: 10.1055/s-0030-1265219

  • CrossRef
  • Google Scholar

• 189

  KimJKimCSLeeYMSohnEJoKShinSDet al. Scopoletin Inhibits Rat Aldose Reductase Activity and Cataractogenesis in Galactose-Fed Rats. Evidence-Based Complement Altern Med (2013) 2013:787138. doi: 10.1155/2013/787138

  • CrossRef
  • Google Scholar

• 190

  LeeJKimNHNamJWLeeYMJangDSKimYSet al. Scopoletin From the Flower Buds of Magnolia Fargesii Inhibits Protein Glycation, Aldose Reductase, and Cataractogenesis Ex Vivo. Arch Pharm Res (2010) 33:1317–23. doi: 10.1007/s12272-010-0904-z

  • CrossRef
  • Google Scholar

• 191

  OjewoleJAOAdesinaSK. Cardiovascular and Neuromuscular Actions of Scopoletin From Fruit of Tetrapleura Tetrapetra. Planta Med (1983) 49:99–102. doi: 10.1055/s-2007-969824

  • CrossRef
  • Google Scholar

• 192

  Lagunas-HerreraHTortorielloJHerrera-RuizMMartínez-HenándezGBZamilpaASantamaríaLAet al. Acute and Chronic Antihypertensive Effect of Fractions, Tiliroside and Scopoletin From Malva Parviflora. Biol Pharm Bull (2019) 42:18–25. doi: 10.1248/bpb.b18-00355

  • CrossRef
  • Google Scholar

• 193

  OjewoleJAOAdesinaSK. Mechanism of the Hypotensive Effect of Scopoletin Isolated From the Fruit of Tetrapleura Tetraptera. Planta Med (1983) 49:46–50. doi: 10.1055/s-2007-969809

  • CrossRef
  • Google Scholar

• 194

  ThuongPTNaMSuNDSeongRSLeeYMSokDEet al. Inhibitory Effect of Coumarins From Weigela Subsessilis on Low Density Lipoprotein Oxidation. Biol Pharm Bull (2005) 28:1095–7. doi: 10.1248/bpb.28.1095

  • CrossRef
  • Google Scholar

• 195

  YangJYKooJHYoonHYLeeJHParkBHKimJSet al. Effect of Scopoletin on Lipoprotein Lipase Activity in 3T3-L1 Adipocytes. Int J Mol Med (2007) 20:527–31. doi: 10.3892/ijmm.20.4.527

  • CrossRef
  • Google Scholar

• 196

  ParkSHSungYYNhoKJKimDSKimHK. E Effects of Viola Mandshurica on Atherosclerosis and Hepatic Steatosis in ApoE-/- via the AMPK Pathway. Am J Chin Med (2017) 45:757–72. doi: 10.1142/S0192415X17500409

  • CrossRef
  • Google Scholar

• 197

  OliveiraEJRomeroMASilvaMSSilvaBAMedeirosIA. Intracellular Calcium Mobilization as a Target for the Spasmolytic Action of Scopoletin. Planta Med (2001) 67:605–8. doi: 10.1055/s-2001-17355

  • CrossRef
  • Google Scholar

• 198

  IizukaTNagumoSYotsumotoHMoriyamaHNagaiM. Vasorelaxant Effects of Acer Nikoense Extract and Isolated Coumarinolignans on Rat Aortic Rings. Biol Pharm Bull (2007) 30:1164–6. doi: 10.1248/bpb.30.1164

  • CrossRef
  • Google Scholar

• 199

  PanRDaiYGaoXHLuDXiaYF. Inhibition of Vascular Endothelial Growth Factor-Induced Angiogenesis by Scopoletin Through Interrupting the Autophosphorylation of VEGF Receptor 2 and Its Downstream Signaling Pathways. Vascul Pharmacol (2011) 54:18–28. doi: 10.1016/j.vph.2010.11.001

  • CrossRef
  • Google Scholar

• 200

  KangSYSungSHParkJHKimYC. Hepatoprotective Activity of Scopoletin, a Constituent of Solanum Lyratum. Arch Pharm Res (1998) 21:718–22. doi: 10.1007/BF02976764

  • CrossRef
  • Google Scholar

• 201

  ZengYMaYYangZMaoJZhengY. Antihyperuricemic Efficacy of Scopoletin-Loaded Soluplus Micelles in Yeast Extract/Potassium Oxonate-Induced Hyperuricemic Mice. Drug Dev Ind Pharm (2020) 46:1550–7. doi: 10.1080/03639045.2020.1811302

  • CrossRef
  • Google Scholar

• 202

  DingZDaiYWangZ. Hypouricemic Action of Scopoletin Arising From Xanthine Oxidase Inhibition and Uricosuric Activity. Planta Med (2005) 71:183–5. doi: 10.1055/s-2005-837789

  • CrossRef
  • Google Scholar

• 203

  TangWMChanEKwokCYLeeYKWuJHWanCWet al. A Review of the Anticancer and Immunomodulatory Effects of Lycium Barbarum Fruit. Inflammopharmacology (2012) 20:307–14. doi: 10.1007/s10787-011-0107-3

  • CrossRef
  • Google Scholar

• 204

  XueMTianQWangLSunXZengFPanQ. Scopoletin Exerts Anticancer Effects on Human Cervical Cancer Cell Lines by Triggering Apoptosis, Cell Cycle Arrest, Inhibition of Cell Invasion and PI3K/AKT Signalling Pathway. JBUON (2019) 24:997–1002.

  • Google Scholar

• 205

  AdamsMEfferthTBauerR. Activity-Guided Isolation of Scopoletin and Isoscopoletin, the Inhibitory Active Principles Towards CCRF-CEM Leukaemia Cells and Multi-Drug Resistant CEM/ADR5000 Cells, From Artemisia Argyi. Planta Med (2006) 72:862–4. doi: 10.1055/s-2006-947165

  • CrossRef
  • Google Scholar

• 206

  CassadyJMOjimaNChangCJMcLaughlinJL. An Investigation of the Antitumor Activity of Micromelum Integerrimum (Rutaceae). J Nat Prod (1979) 42:274–8. doi: 10.1021/np50003a005

  • CrossRef
  • Google Scholar

• 207

  Barreiro ArcosMLCremaschiGWernerSCoussioJFerraroGAnesiniC. Tilia Cordata Mill. Extracts and Scopoletin (Isolated Compound): Differential Cell Growth Effects on Lymphocytes. Phyther Res (2006) 20:34–40. doi: 10.1002/ptr.1798

  • CrossRef
  • Google Scholar

• 208

  ManueleMGFerraroGBarreiro ArcosMLLópezPCremaschiGAnesiniC. Comparative Immunomodulatory Effect of Scopoletin on Tumoral and Normal Lymphocytes. Life Sci (2006) 79:2043–8. doi: 10.1016/j.lfs.2006.06.045

  • CrossRef
  • Google Scholar

• 209

  BhattacharyyaSSPaulSDuttaSBoujedainiNKhuda-BukhshAR. Anti-Oncogenic Potentials of a Plant Coumarin (7-Hydroxy-6-Methoxy Coumarin) Against 7,12-Dimethylbenz[a]Anthracene-Induced Skin Papilloma in Mice: The Possible Role of Several Key Signal Proteins. J Chin Integr Med (2010) 8:645–54. doi: 10.3736/jcim20100708

  • CrossRef
  • Google Scholar

• 210

  Khuda-BukhshARBhattacharyyaSSPaulSBoujedainiN. Polymeric Nanoparticle Encapsulation of a Naturally Occurring Plant Scopoletin and Its Effects on Human Melanoma Cell A375. J Chin Integr Med (2010) 8:853–62. doi: 10.3736/jcim20100909

  • CrossRef
  • Google Scholar

• 211

  TabanaYMHassanLEAAhamedMBKDahhamSSIqbalMASaeedMAAet al. Scopoletin, an Active Principle of Tree Tobacco (Nicotiana Glauca) Inhibits Human Tumor Vascularization in Xenograft Models and Modulates ERK1, VEGF-A, and FGF-2 in Computer Model. Microvasc Res (2016) 107:17–33. doi: 10.1016/j.mvr.2016.04.009

  • CrossRef
  • Google Scholar

• 212

  ShengLYangYZhangYLiN. Chemical Constituents of Patrinia Heterophylla Bunge and Selective Cytotoxicity Against Six Human Tumor Cells. J Ethnopharmacol (2019) 236:129–35. doi: 10.1016/j.jep.2019.03.005

  • CrossRef
  • Google Scholar

• 213

  KhunluckTKukongviriyapanVSenggunpraiLDuangarsongWPrawanA. The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells. Integr Cancer Ther (2019) 18:1534735418820444. doi: 10.1177/1534735418820444

  • CrossRef
  • Google Scholar

• 214

  DengSPaluAKWestBJSuCXZhouBNJensenJC. Lipoxygenase Inhibitory Constituents of the Fruits of Noni (Morinda Citrifolia) Collected in Tahiti. J Nat Prod (2007) 70:859–62. doi: 10.1021/np0605539

  • CrossRef
  • Google Scholar

• 215

  PanRGaoXHLiYXiaYFDaiY. Anti-Arthritic Effect of Scopoletin, a Coumarin Compound Occurring in Erycibe Obtusifolia Benth Stems, Is Associated With Decreased Angiogenesis in Synovium. Fundam Clin Pharmacol (2010) 24:477–90. doi: 10.1111/j.1472-8206.2009.00784.x

  • CrossRef
  • Google Scholar

• 216

  ShawCYChenCHHsuCCChenCCTsaiYC. Antioxidant Properties of Scopoletin Isolated From Sinomonium Acutum. Phyther Res (2003) 17:823–5. doi: 10.1002/ptr.1170

  • CrossRef
  • Google Scholar

• 217

  KimARZouYNParkTHShimKHKimMSKimNDet al. Active Components From Artemisia Iwayomogi Displaying ONOO- Scavenging Activity. Phyther Res (2004) 18:1–7. doi: 10.1002/ptr.1358

  • CrossRef
  • Google Scholar

• 218

  AbreuPMMatthewSGonzálezTVanickovaLCostaDGomesAet al. Isolation and Identification of Antioxidants From Pedilanthus Tithymaloides. J Nat Med (2008) 62:67–70. doi: 10.1007/s11418-007-0186-z

  • CrossRef
  • Google Scholar

• 219

  KhanSRiazNAfzaNMalikAAziz-Ur-RehmanaIqbalLet al. Antioxidant Constituents From Cotoneaster Racemiflora. J Asian Nat Prod Res (2009) 11:44–8. doi: 10.1080/10286020802435745

  • CrossRef
  • Google Scholar

• 220

  DellaGrecaMCutilloFD’AbroscaBFiorentinoAPacificoSZarrelliA. Antioxidant and Radical Scavenging Properties of Malva Sylvestris. Nat Prod Commun (2009) 4:893–6. doi: 10.1177/1934578x0900400702

  • CrossRef
  • Google Scholar

• 221

  KassimNKRahmaniMIsmailASukariMAEeGCLNasirNMet al. Antioxidant Activity-Guided Separation of Coumarins and Lignan From Melicope Glabra (Rutaceae). Food Chem (2013) 139:87–92. doi: 10.1016/j.foodchem.2013.01.108

  • CrossRef
  • Google Scholar

• 222

  NugrohoALimSCKarkiSChoiJSParkHJ. Simultaneous Quantification and Validation of New Peroxynitrite Scavengers From Artemisia Iwayomogi. Pharm Biol (2015) 53:653–61. doi: 10.3109/13880209.2014.936022

  • CrossRef
  • Google Scholar

• 223

  ParraCSotoELeónGSalasCOHeinrichMEchiburú-ChauC. Nutritional Composition, Antioxidant Activity and Isolation of Scopoletin From Senecio Nutans: Support of Ancestral and New Uses. Nat Prod Res (2018) 32:719–22. doi: 10.1080/14786419.2017.1335726

  • CrossRef
  • Google Scholar

• 224

  PandaSKarA. Evaluation of the Antithyroid, Antioxidative and Antihyperglycemic Activity of Scopoletin From Aegle Marmelos Leaves in Hyperthyroid Rats. Phyther Res (2006) 20:1103–5. doi: 10.1002/ptr.2014

  • CrossRef
  • Google Scholar

• 225

  NgTBLiuFLuYChengCHKWangZ. Antioxidant Activity of Compounds From the Medicinal Herb Aster Tataricus. Comp Biochem Physiol - C Toxicol Pharmacol (2003) 136:109–15. doi: 10.1016/S1532-0456(03)00170-4

  • CrossRef
  • Google Scholar

• 226

  TodaS. Inhibitory Effects of Phenylpropanoid Metabolites on Copper-Induced Protein Oxidative Modification of Mice Brain Homogenate In Vitro. Biol Trace Elem Res (2002) 85:183–8. doi: 10.1385/BTER:85:2:183

  • CrossRef
  • Google Scholar

• 227

  PradhanPMajhiOBiswasAJoshiVKSinhaD. Enhanced Accumulation of Reduced Glutathione by Scopoletin Improves Survivability of Dopaminergic Neurons in Parkinson’s Model. Cell Death Dis (2020) 11:1–11. doi: 10.1038/s41419-020-02942-8

  • CrossRef
  • Google Scholar

• 228

  SilvánAMAbadMJBermejoPSollhuberMVillarA. Antiinflammatory Activity of Coumarins From Santolina Oblongifolia. J Nat Prod (1996) 59:1183–5. doi: 10.1021/np960422f

  • CrossRef
  • Google Scholar

• 229

  SilvanAMAbadMJBermejoPVillarA. Effects of Compounds Extracted From Santolina Oblongifolia on TXB2 Release in Human Platelets. Inflammopharmacology (1998) 6:255–63. doi: 10.1007/s10787-998-0024-2

  • CrossRef
  • Google Scholar

• 230

  KangTHPaeHOJeongSJYooJCChoiBMJunCDet al. Scopoletin: An Inducible Nitric Oxide Synthesis Inhibitory Active Constituent From Artemisia Feddei. Planta Med (1999) 65:400–3. doi: 10.1055/s-1999-14014

  • CrossRef
  • Google Scholar

• 231

  KimHJJangSKimYJChungHTYunYGKangTHet al. Scopoletin Suppresses Pro-Inflammatory Cytokines and PGE2 From LPS-Stimulated Cell Line, RAW 264.7 Cells. Fitoterapia (2004) 75:261–6. doi: 10.1016/j.fitote.2003.12.021

  • CrossRef
  • Google Scholar

• 232

  KimJSJinCKSangHSEunJLJinWYBaeKHet al. Chemical Constituents of the Root of Dystaenia Takeshimana and Their Anti-Inflammatory Activity. Arch Pharm Res (2006) 29:617–23. doi: 10.1007/BF02968244

  • CrossRef
  • Google Scholar

• 233

  MoonPDLeeBHJeongHJAnHJParkSJKimHRet al. Use of Scopoletin to Inhibit the Production of Inflammatory Cytokines Through Inhibition of the Iκb/NF-κb Signal Cascade in the Human Mast Cell Line HMC-1. Eur J Pharmacol (2007) 555:218–25. doi: 10.1016/j.ejphar.2006.10.021

  • CrossRef
  • Google Scholar

• 234

  ChoiYGYeoSKimSHLimS. Anti-Inflammatory Changes of Gene Expression by Artemisia Iwayomogi in the LPS-Stimulated Human Gingival Fibroblast: Microarray Analysis. Arch Pharm Res (2012) 35:549–63. doi: 10.1007/s12272-012-0319-0

  • CrossRef
  • Google Scholar

• 235

  DouYTongBWeiZLiYXiaYDaiY. Scopoletin Suppresses IL-6 Production From Fibroblast-Like Synoviocytes of Adjuvant Arthritis Rats Induced by IL-1β Stimulation. Int Immunopharmacol (2013) 17:1037–43. doi: 10.1016/j.intimp.2013.10.011

  • CrossRef
  • Google Scholar

• 236

  KaminoTShimokuraTMoritaYTezukaYNishizawaMTanakaK. Comparative Analysis of the Constituents in Saposhnikoviae Radix and Glehniae Radix Cum Rhizoma by Monitoring Inhibitory Activity of Nitric Oxide Production. J Nat Med (2016) 70:253–9. doi: 10.1007/s11418-016-0969-1

  • CrossRef
  • Google Scholar

• 237

  YaoXDingZXiaYWeiZLuoYFelederCet al. Inhibition of Monosodium Urate Crystal-Induced Inflammation by Scopoletin and Underlying Mechanisms. Int Immunopharmacol (2012) 14:454–62. doi: 10.1016/j.intimp.2012.07.024

  • CrossRef
  • Google Scholar

• 238

  MuschiettiLGorzalczanySFerraroGAcevedoCMartinoV. Phenolic Compounds With Anti-Inflammatory Activity From Eupatorium Buniifolium. Planta Med (2001) 67:743–4. doi: 10.1055/s-2001-18355

  • CrossRef
  • Google Scholar

• 239

  FarahMHSamuelssonG. Pharmacologically Active Phenylpropanoids From Senra Incana. Planta Med (1992) 58:14–8. doi: 10.1055/s-2006-961380

  • CrossRef
  • Google Scholar

• 240

  ChangTNDengJSChangYCLeeCYJung-ChunLLeeMMet al. Ameliorative Effects of Scopoletin From Crossostephium Chinensis Against Inflammation Pain and Its Mechanisms in Mice. Evidence-Based Complement Altern Med (2012) 2012:595603. doi: 10.1155/2012/595603

  • CrossRef
  • Google Scholar

• 241

  Pereira dos Santos NascimentoMVArruda-SilvaFGobbo LuzABBarattoBVenzkeDMendesBGet al. Inhibition of the NF-κb and P38 MAPK Pathways by Scopoletin Reduce the Inflammation Caused by Carrageenan in the Mouse Model of Pleurisy. Immunopharmacol Immunotoxicol (2016) 38:344–52. doi: 10.1080/08923973.2016.1203929

  • CrossRef
  • Google Scholar

• 242

  RibasCMMeottiFCNascimentoFPJacquesAVDafreALRodriguesALSet al. Antinociceptive Effect of the Polygala Sabulosa Hydroalcoholic Extract in Mice: Evidence for the Involvement of Glutamatergic Receptors and Cytokine Pathways. Basic Clin Pharmacol Toxicol (2008) 103:43–7. doi: 10.1111/j.1742-7843.2008.00245.x

  • CrossRef
  • Google Scholar

• 243

  SakthivelKMVishnupriyaSPriya DharshiniLCRasmiRRRameshB. Modulation of Multiple Cellular Signalling Pathways as Targets for Anti-Inflammatory and Anti-Tumorigenesis Action of Scopoletin. J Pharm Pharmacol (2021) 13:rgab047. doi: 10.1093/jpp/rgab047

  • CrossRef
  • Google Scholar

• 244

  MahattanadulSRidtitidWNimaSPhdoongsombutNRatanasuwonPKasiwongS. Effects of Morinda Citrifolia Aqueous Fruit Extract and Its Biomarker Scopoletin on Reflux Esophagitis and Gastric Ulcer in Rats. J Ethnopharmacol (2011) 134:243–50. doi: 10.1016/j.jep.2010.12.004

  • CrossRef
  • Google Scholar

• 245

  DingZDaiYHaoHPanRYaoXWangZ. Anti-Inflammatory Effects of Scopoletin and Underlying Mechanisms. Pharm Biol (2008) 46:854–60. doi: 10.1080/13880200802367155

  • CrossRef
  • Google Scholar

• 246

  CapraJCCunhaMPMachadoDGZomkowskiADEMendesBGSantosARSet al. Antidepressant-Like Effect of Scopoletin, a Coumarin Isolated From Polygala Sabulosa (Polygalaceae) in Mice: Evidence for the Involvement of Monoaminergic Systems. Eur J Pharmacol (2010) 643:232–8. doi: 10.1016/j.ejphar.2010.06.043

  • CrossRef
  • Google Scholar

• 247

  MoganaRTeng-JinKWiartC. Anti-Inflammatory, Anticholinesterase, and Antioxidant Potential of Scopoletin Isolated From Canarium Patentinervium Miq. (Burseraceae Kunth). Evidence-Based Complement Altern Med (2013) 2013:734824. doi: 10.1155/2013/734824

  • CrossRef
  • Google Scholar

• 248

  NarasimhanKKSJayakumarDVelusamyPSrinivasanAMohanTRaviDBet al. Morinda Citrifolia and Its Active Principle Scopoletin Mitigate Protein Aggregation and Neuronal Apoptosis Through Augmenting the DJ-1/Nrf2/ARE Signaling Pathway. Oxid Med Cell Longev (2019) 2019:2761041. doi: 10.1155/2019/2761041

  • CrossRef
  • Google Scholar

• 249

  LeeBWeonJEomMJungYMaC. Neuroprotective Compounds of Tilia Amurensis. Pharmacogn Mag (2015) 11:303. doi: 10.4103/0973-1296.166065

  • CrossRef
  • Google Scholar

• 250

  YunBSLeeIKRyooIJYooID. Coumarins With Monoamine Oxidase Inhibitory Activity and Antioxidative Coumarino-Lignans From Hibiscus Syriacus. J Nat Prod (2001) 64:1238–40. doi: 10.1021/np0100946

  • CrossRef
  • Google Scholar

• 251

  ZhangFZhangYYangTYeZQTianJFangHRet al. Scopoletin Suppresses Activation of Dendritic Cells and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κb Signaling. Front Pharmacol (2019) 10:863. doi: 10.3389/fphar.2019.00863

  • CrossRef
  • Google Scholar

• 252

  LuoLSunTYangLLiuALiuQQTianQQet al. Scopoletin Ameliorates Anxiety-Like Behaviors in Complete Freund’s Adjuvant-Induced Mouse Model. Mol Brain (2020) 13:1–13. doi: 10.1186/s13041-020-0560-2

  • CrossRef
  • Google Scholar

• 253

  ZhangWZhaoWGeCLiXSunZ. Scopoletin Attenuates Intracerebral Hemorrhage-Induced Brain Injury and Improves Neurological Performance in Rats. Neuroimmunomodulation (2021) 28:74–81. doi: 10.1159/000505731

  • CrossRef
  • Google Scholar

• 254

  LeeJHKiTLJaeHYNamIBDaeKK. Acetylcholinesterase Inhibitors From the Twigs of Vaccinium Oldhami Miquel. Arch Pharm Res (2004) 27:53–6. doi: 10.1007/BF02980046

  • CrossRef
  • Google Scholar

• 255

  OrhanITosunFŞenerB. Coumarin, Anthroquinone and Stilbene Derivatives With Anticholinesterase Activity. Z Fur Naturforsch - Sect C J Biosci (2008) 63:366–70. doi: 10.1515/znc-2008-5-610

  • CrossRef
  • Google Scholar

• 256

  SuchaichitNKanokmedhakulSKanokmedhakulKMoosophonPBoonyaratCPlekratokeKet al. Phytochemical Investigation and Acetylcholinesterase Inhibitory Activity of Bark of Hymenodictyon Orixense. Nat Prod Res (2018) 32:2936–9. doi: 10.1080/14786419.2017.1389930

  • CrossRef
  • Google Scholar

• 257

  KuppusamyAArumugamMGeorgeS. Combining in Silico and In Vitro Approaches to Evaluate the Acetylcholinesterase Inhibitory Profile of Some Commercially Available Flavonoids in the Management of Alzheimer’s Disease. Int J Biol Macromol (2017) 95:199–203. doi: 10.1016/j.ijbiomac.2016.11.062

  • CrossRef
  • Google Scholar

• 258

  MalikJKaranMVasishtK. Attenuating Effect of Bioactive Coumarins From Convolvulus Pluricaulis on Scopolamine-Induced Amnesia in Mice. Nat Prod Res (2016) 30:578–82. doi: 10.1080/14786419.2015.1025398

  • CrossRef
  • Google Scholar

• 259

  HornickALiebAVoNPRollingerJMStuppnerHPrastH. The Coumarin Scopoletin Potentiates Acetylcholine Release From Synaptosomes, Amplifies Hippocampal Long-Term Potentiation and Ameliorates Anticholinergic- and Age-Impaired Memory. Neuroscience (2011) 197:280–92. doi: 10.1016/j.neuroscience.2011.09.006

  • CrossRef
  • Google Scholar

• 260

  Monsef-EsfahaniHRAminiMGoodarziNSaiedmohammadiFHajiaghaeeRFaramarziMAet al. Coumarin Compounds of Biebersteinia Multifida Roots Show Potential Anxiolytic Effects in Mice. DARU J Pharm Sci (2013) 21:51. doi: 10.1186/2008-2231-21-51

  • CrossRef
  • Google Scholar

• 261

  PandyVVijeepallamK. Antipsychotic-Like Activity of Scopoletin and Rutin Against the Positive Symptoms of Schizophrenia in Mouse Models. Exp Anim (2017) 66:417–23. doi: 10.1538/expanim.17-0050

  • CrossRef
  • Google Scholar

• 262

  MishraNOraonADevAJayaprakashVBasuAPattnaikAKet al. Anticonvulsant Activity of Benkara Malabarica (Linn.) Root Extract: In vitro and in vivo investigation. J Ethnopharmacol (2010) 128:533–6. doi: 10.1016/j.jep.2010.01.042

  • CrossRef
  • Google Scholar

• 263

  ZhouRKanSCaiSSunRYuanHYuB. Scopoletin Activates Adenosine Monophosphate-Activated Protein Kinase/Mammalian Target of Rapamycin Signaling Pathway and Improves Functional Recovery After Spinal Cord Injury in Rats. Pharmacology (2020) 105:349–59. doi: 10.1159/000503866

  • CrossRef
  • Google Scholar

• 264

  DasRSenguptaTRoySChattarjiSRayJ. Convolvulus Pluricaulis Extract Can Modulate Synaptic Plasticity in Rat Brain Hippocampus. Neuroreport (2020) 31(8):597–604. doi: 10.1097/WNR.0000000000001446

  • CrossRef
  • Google Scholar

• 265

  KayserOKolodziejH. Antibacterial Activity of Extracts and Constituents of Pelargonium Sidoides and Pelargonium Reniforme. Planta Med (1997) 63:508–10. doi: 10.1055/s-2006-957752

  • CrossRef
  • Google Scholar

• 266

  LemosASOFlorêncioJRPintoNCCCamposLMSilvaTPGrazulRMet al. Antifungal Activity of the Natural Coumarin Scopoletin Against Planktonic Cells and Biofilms From a Multidrug-Resistant Candida Tropicalis Strain. Front Microbiol (2020) 11:1525. doi: 10.3389/fmicb.2020.01525

  • CrossRef
  • Google Scholar

• 267

  MoreGLallNHusseinATshikalangeTE. Antimicrobial Constituents of Artemisia Afra Jacq. Ex Willd. Against Periodontal Pathogens. Evidence-Based Complement Altern Med (2012) 2012:252758. doi: 10.1155/2012/252758

  • CrossRef
  • Google Scholar

• 268

  Navarro-GarcíaVMRojasGAvilésMFuentesMZepedaG. In Vitro Antifungal Activity of Coumarin Extracted From Loeselia Mexicana Brand. Mycoses (2011) 54:e569–71. doi: 10.1111/j.1439-0507.2010.01993.x

  • CrossRef
  • Google Scholar

• 269

  MeerungrueangWPanichayupakaranantP. Antimicrobial Activities of Some Thai Traditional Medical Longevity Formulations From Plants and Antibacterial Compounds From Ficus Foveolata. Pharm Biol (2014) 52:1104–9. doi: 10.3109/13880209.2013.877493

  • CrossRef
  • Google Scholar

• 270

  Ramírez-ReyesTIAguilar-ColoradoÁSMurrieta-LeónDLLicona-VelázquezLSBonilla-LandaIDurán-EspinosaCet al. Identification of Antibacterial Phenolics in Selected Plant Species From Mexican Cloud Forest by Mass Spectrometry Dereplication. Chem Biodivers (2019) 16:e1800603. doi: 10.1002/cbdv.201800603

  • CrossRef
  • Google Scholar

• 271

  SokoudjouJBAtolaniONjatengGSSKhanATagousopCNBitomboANet al. Isolation, Characterization and In Vitro Anti-Salmonellal Activity of Compounds From Stem Bark Extract of Canarium Schweinfurthii. BMC Complement Med Ther (2020) 20(1):316. doi: 10.1186/s12906-020-03100-5

  • CrossRef
  • Google Scholar

• 272

  DuncanSHFlintHJStewartCS. Inhibitory Activity of Gut Bacteria Against Escherichia Coli O157 Mediated by Dietary Plant Metabolites. FEMS Microbiol Lett (1998) 164:283–8. doi: 10.1111/j.1574-6968.1998.tb13099.x

  • CrossRef
  • Google Scholar

• 273

  KuigouaGMKouamSFNgadjuiBTSchulzBGreenIRChoudharyMIet al. Minor Secondary Metabolic Products From the Stem Bark of Plumeria Rubra Linn. Displaying Antimicrobial Activities. Planta Med (2010) 76:620–5. doi: 10.1055/s-0029-1240611

  • CrossRef
  • Google Scholar

• 274

  ChiangCCChengMJPengCFHuangHYChenIS. A Novel Dimeric Coumarin Analog and Antimycobacterial Constituents From Fatoua Pilosa. Chem Biodivers (2010) 7:1728–36. doi: 10.1002/cbdv.200900326

  • CrossRef
  • Google Scholar

• 275

  DuggiralaSNankarRPRajendranSDobleM. Phytochemicals as Inhibitors of Bacterial Cell Division Protein FtsZ: Coumarins Are Promising Candidates. Appl Biochem Biotechnol (2014) 174:283–96. doi: 10.1007/s12010-014-1056-2

  • CrossRef
  • Google Scholar

• 276

  BuathongRChamchumroonVSchinnerlJBacherMSantimaleeworagunWKraichakEet al. Chemovariation and Antibacterial Activity of Extracts and Isolated Compounds From Species of Ixora and Greenea (Ixoroideae, Rubiaceae). PeerJ (2019) 2019:e6893. doi: 10.7717/peerj.6893

  • CrossRef
  • Google Scholar

• 277

  De La Cruz-SánchezNGGómez-RiveraAAlvarez-FitzPVentura-ZapataEPérez-GarcíaMDAvilés-FloresMet al. Antibacterial Activity of Morinda Citrifolia Linneo Seeds Against Methicillin-Resistant Staphylococcus Spp. Microb Pathog (2019) 128:347–53. doi: 10.1016/j.micpath.2019.01.030

  • CrossRef
  • Google Scholar

• 278

  DasSCzuniLBálóVPappGGazdagZPappNet al. Cytotoxic Action of Artemisinin and Scopoletin on Planktonic Forms and on Biofilms of Candida Species. Molecules (2020) 25(3):476. doi: 10.3390/molecules25030476

  • CrossRef
  • Google Scholar

• 279

  ChoiBRKumarSKZhaoCZhangLTKimCYLeeSWet al. Additive Effects of Artemisia Capillaris Extract and Scopoletin on the Relaxation of Penile Corpus Cavernosum Smooth Muscle. Int J Impot Res (2015) 27:225–32. doi: 10.1038/ijir.2015.23

  • CrossRef
  • Google Scholar

• 280

  LeeJHLeeDUKimYSKimHP. 5-Lipoxygenase Inhibition of the Fructus of Foeniculum Vulgare and Its Constituents. Biomol Ther (2012) 20:113–7. doi: 10.4062/biomolther.2012.20.1.113

  • CrossRef
  • Google Scholar

• 281

  YoshiyukiKHiromichiOShigeruAKimiyeBMitsugiK. Inhibition of the Formation of 5-Hydroxy-6,8,11,14-Eicosatetraenoic Acid From Arachidonic Acid in Polymorphonuclear Leukocytes by Various Coumarins. Biochim Biophys Acta (BBA)/Lipids Lipid Metab (1985) 834:224–9. doi: 10.1016/0005-2760(85)90159-6

  • CrossRef
  • Google Scholar

• 282

  OshimaNNarukawaYTakedaTKiuchiF. Collagenase Inhibitors From Viola Yedoensis. J Nat Med (2013) 67:240–5. doi: 10.1007/s11418-012-0665-8

  • CrossRef
  • Google Scholar

• 283

  PatelMRBhalodiaYSPathakNLPatelMSSutharKPatelNet al. Study on the Mechanism of the Bronchodilatory Effects of Cynodon Dactylon (Linn.) and Identification of the Active Ingredient. J Ethnopharmacol (2013) 150:946–52. doi: 10.1016/j.jep.2013.09.053

  • CrossRef
  • Google Scholar

• 284

  LeeHEYangGChoiJSLeeJY. Suppression of Primary Splenocyte Proliferation by Artemisia Capillaris and Its Components. Toxicol Res (2017) 33:283–90. doi: 10.5487/TR.2017.33.4.283

  • CrossRef
  • Google Scholar

• 285

  ThabetAAYoussefFSKorinekMChangFRWuYCChenBHet al. Study of the Anti-Allergic and Anti-Inflammatory Activity of Brachychiton Rupestris and Brachychiton Discolor Leaves (Malvaceae) Using In Vitro Models. BMC Complement Altern Med (2018) 18(1):299. doi: 10.1186/s12906-018-2359-6

  • CrossRef
  • Google Scholar

• 286

  RenWWangYHeQZhouYLiCWangWet al. Chemical Composition of Erycibe Schmidtii and Antiproliferative Activity of Scopoletin on Immature Dendritic Cells. Nat Prod Res (2020) 34:2581–8. doi: 10.1080/14786419.2018.1547292

  • CrossRef
  • Google Scholar

• 287

  AlkorashyAIDoghishASAbulsoudAIEweesMGAbdelghanyTMElshafeyMMet al. Effect of Scopoletin on Phagocytic Activity of U937-Derived Human Macrophages: Insights From Transcriptomic Analysis. Genomics (2020) 112:3518–24. doi: 10.1016/j.ygeno.2020.03.022

  • CrossRef
  • Google Scholar

• 288

  ChengASChengYHChangTL. Scopoletin Attenuates Allergy by Inhibiting Th2 Cytokines Production in EL-4 T Cells. Food Funct (2012) 3:886–90. doi: 10.1039/c2fo30054k

  • CrossRef
  • Google Scholar

• 289

  NamHKimMM. Scopoletin Has a Potential Activity for Anti-Aging via Autophagy in Human Lung Fibroblasts. Phytomedicine (2015) 22:362–8. doi: 10.1016/j.phymed.2015.01.004

  • CrossRef
  • Google Scholar

• 290

  KimHLMin WooSRin ChoiWKimHSChunsikYKimKHet al. Scopoletin Downregulates MMP-1 Expression in Human Fibroblasts via Inhibition of P38 Phosphorylation. Int J Mol Med (2018) 42:1917–24. doi: 10.3892/ijmm.2018.3757

  • CrossRef
  • Google Scholar

• 291

  Wan OsmanWNFChe Ahmad TantowiNALauSFMohamedS. Epicatechin and Scopoletin Rich Morinda Citrifolia (Noni) Leaf Extract Supplementation, Mitigated Osteoarthritis via Anti-Inflammatory, Anti-Oxidative, and Anti-Protease Pathways. J Food Biochem (2019) 43:e12755. doi: 10.1111/jfbc.12755

  • CrossRef
  • Google Scholar

• 292

  LeeSHDingYYanXTKimYHJangHD. Scopoletin and Scopolin Isolated From Artemisia Iwayomogi Suppress Differentiation of Osteoclastic Macrophage RAW 264.7 Cells by Scavenging Reactive Oxygen Species. J Nat Prod (2013) 76:615–20. doi: 10.1021/np300824h

  • CrossRef
  • Google Scholar

• 293

  WuYBZhengCJQinLPSunLNHanTJiaoLet al. Antiosteoporotic Activity of Anthraquinones From Morinda Officinalis on Osteoblasts and Osteoclasts. Molecules (2009) 14:573–83. doi: 10.3390/molecules14010573

  • CrossRef
  • Google Scholar

• 294

  NimaSKasiwongSRidtitidWThaenmaneeNMahattanadulS. Gastrokinetic Activity of Morinda Citrifolia Aqueous Fruit Extract and Its Possible Mechanism of Action in Human and Rat Models. J Ethnopharmacol (2012) 142:354–61. doi: 10.1016/j.jep.2012.04.044

  • CrossRef
  • Google Scholar

• 295

  AwaadASAl-RifaiAAEl-MeligyRMAlafeefyAMZainME. New Activities for Isolated Compounds From Convolvulus Austro-Aegyptiacus as Anti-Ulcerogenic, Anti-Helicobacter Pylori and Their Mimic Synthesis Using Bio-Guided Fractionation. Phyther Res (2015) 29:1311–6. doi: 10.1002/ptr.5379

  • CrossRef
  • Google Scholar

• 296

  AhnMJHurSJKimEHLeeSHShinJSKimMKet al. Scopoletin From Cirsium Setidens Increases Melanin Synthesis via CREB Phosphorylation in B16F10 Cells. Korean J Physiol Pharmacol (2014) 18:307–11. doi: 10.4196/kjpp.2014.18.4.307

  • CrossRef
  • Google Scholar

• 297

  KimDSChaSBParkMCParkSAKimHSWooWHet al. Scopoletin Stimulates Melanogenesis via cAMP/Pka Pathway and Partially P38 Activation. Biol Pharm Bull (2017) 40:2068–74. doi: 10.1248/bpb.b16-00690

  • CrossRef
  • Google Scholar

• 298

  HeriniainaRMDongJKalavaguntaPKWuHLYanDSShangJ. Effects of Six Compounds With Different Chemical Structures on Melanogenesis. Chin J Nat Med (2018) 16:766–73. doi: 10.1016/S1875-5364(18)30116-X

  • CrossRef
  • Google Scholar

• 299

  SrilathaKReddyKP. Sciatic Nerve Structural and Functional Recovery With Extract of Phyllanthus Amarus and Esculetin in STZ-Induced Hyperglycemic Rats. Ann Neurosci (2019) 26:17–29. doi: 10.1177/0972753120911840

  • CrossRef
  • Google Scholar

• 300

  ShinEChoiKMYooHSLeeCKHwangBYLeeMK. Inhibitory Effects of Coumarins From the Stem Barks of Fraxinus Rhynchophylla on Adipocyte Differentiation in 3T3-L1 Cells. Biol Pharm Bull (2010) 33:1610–4. doi: 10.1248/bpb.33.1610

  • CrossRef
  • Google Scholar

• 301

  YangJYDella-FeraMABaileCA. Esculetin Induces Mitochondria-Mediated Apoptosis in 3T3-L1 Adipocytes. Apoptosis (2006) 11:1371–8. doi: 10.1007/s10495-006-7691-5

  • CrossRef
  • Google Scholar

• 302

  YangJYDella-FeraMAHartzellDLNelson-DooleyCHausmanDBBaileCA. Esculetin Induces Apoptosis and Inhibits Adipogenesis in 3T3-L1 Cells. Obesity (2006) 14:1691–9. doi: 10.1038/oby.2006.194

  • CrossRef
  • Google Scholar

• 303

  KadakolAGoruSKMalekVGaikwadAB. Esculetin Ameliorates Vascular Perturbation by Intervening in the Occupancy of H2BK120Ub at At1, At2, Tgfβ1 and Mcp1 Promoter Gene in Thoracic Aorta of IR and T2D Rats. BioMed Pharmacother (2017) 95:1461–8. doi: 10.1016/j.biopha.2017.09.067

  • CrossRef
  • Google Scholar

• 304

  SungYYKimDSKimHK. Viola Mandshurica Ethanolic Extract Prevents High-Fat-Diet-Induced Obesity in Mice by Activating AMP-Activated Protein Kinase. Environ Toxicol Pharmacol (2014) 38:41–50. doi: 10.1016/j.etap.2014.04.028

  • CrossRef
  • Google Scholar

• 305

  PrabakaranDAshokkumarN. Protective Effect of Esculetin on Hyperglycemia-Mediated Oxidative Damage in the Hepatic and Renal Tissues of Experimental Diabetic Rats. Biochimie (2013) 95:366–73. doi: 10.1016/j.biochi.2012.10.008

  • CrossRef
  • Google Scholar

• 306

  ChoiRYHamJRLeeMK. Esculetin Prevents Non-Alcoholic Fatty Liver in Diabetic Mice Fed High-Fat Diet. Chem Biol Interact (2016) 260:13–21. doi: 10.1016/j.cbi.2016.10.013

  • CrossRef
  • Google Scholar

• 307

  KimYParkYNamkoongSLeeJ. Esculetin Inhibits the Inflammatory Response by Inducing Heme Oxygenase-1 in Cocultured Macrophages and Adipocytes. Food Funct (2014) 5:2371–7. doi: 10.1039/c4fo00351a

  • CrossRef
  • Google Scholar

• 308

  KimYLeeJ. Esculetin Inhibits Adipogenesis and Increases Antioxidant Activity During Adipocyte Differentiation in 3T3-L1 Cells. Prev Nutr Food Sci (2017) 22:118–23. doi: 10.3746/pnf.2017.22.2.118

  • CrossRef
  • Google Scholar

• 309

  PandeyARajPGoruSKKadakolAMalekVSharmaNet al. Esculetin Ameliorates Hepatic Fibrosis in High Fat Diet Induced Non-Alcoholic Fatty Liver Disease by Regulation of FoxO1 Mediated Pathway. Pharmacol Rep (2017) 69:666–72. doi: 10.1016/j.pharep.2017.02.005

  • CrossRef
  • Google Scholar

• 310

  KadakolAMalekVGoruSKPandeyABagalSGaikwadAB. Esculetin Attenuates Alterations in Ang II and Acetylcholine Mediated Vascular Reactivity Associated With Hyperinsulinemia and Hyperglycemia. Biochem Biophys Res Commun (2015) 461:342–7. doi: 10.1016/j.bbrc.2015.04.036

  • CrossRef
  • Google Scholar

• 311

  KarmaseAJagtapSBhutaniKK. Anti Adipogenic Activity of Aegle Marmelos Correa. Phytomedicine (2013) 20:1267–71. doi: 10.1016/j.phymed.2013.07.011

  • CrossRef
  • Google Scholar

• 312

  YangZGJiaLNShenYOhmuraAKitanakaS. Inhibitory Effects of Constituents From Euphorbia Lunulata on Differentiation of 3T3-L1 Cells and Nitric Oxide Production in RAW264.7 Cells. Molecules (2011) 16:8305–18. doi: 10.3390/molecules16108305

  • CrossRef
  • Google Scholar

• 313

  PanSLHuangYWGuhJHChangYLPengCYTengCM. Esculetin Inhibits Ras-Mediated Cell Proliferation and Attenuates Vascular Restenosis Following Angioplasty in Rats. Biochem Pharmacol (2003) 65:1897–905. doi: 10.1016/S0006-2952(03)00161-8

  • CrossRef
  • Google Scholar

• 314

  JuniorAGToloueiSELdos Reis LíveroFAGasparottoFBoeingTde SouzaP. Natural Agents Modulating ACE-2: A Review of Compounds With Potential Against SARS-CoV-2 Infections. Curr Pharm Des (2021) 27:1588–96. doi: 10.2174/1381612827666210114150607

  • CrossRef
  • Google Scholar

• 315

  HsiaCWLinKCLeeTYHsiaCHChouDSJayakumarTet al. Esculetin, A Coumarin Derivative, Prevents Thrombosis: Inhibitory Signaling on Plcγ2-PKC-AKT Activation in Human Platelets. Int J Mol Sci (2019) 20:2731. doi: 10.3390/ijms20112731

  • CrossRef
  • Google Scholar

• 316

  LeeSJLeeUSKimWJMoonSK. Inhibitory Effect of Esculetin on Migration, Invasion and Matrix Metalloproteinase-9 Expression in TNF-α-Induced Vascular Smooth Muscle Cells. Mol Med Rep (2011) 4:337–41. doi: 10.3892/mmr.2011.420

  • CrossRef
  • Google Scholar

• 317

  HeYLiCMaQChenS. Esculetin Inhibits Oxidative Stress and Apoptosis in H9c2 Cardiomyocytes Following Hypoxia/Reoxygenation Injury. Biochem Biophys Res Commun (2018) 501:139–44. doi: 10.1016/j.bbrc.2018.04.195

  • CrossRef
  • Google Scholar

• 318

  SubramaniamSREllisEM. Esculetin-Induced Protection of Human Hepatoma HepG2 Cells Against Hydrogen Peroxide Is Associated With the Nrf2-Dependent Induction of the NAD(P)H: Quinone Oxidoreductase 1 Gene. Toxicol Appl Pharmacol (2011) 250:130–6. doi: 10.1016/j.taap.2010.09.025

  • CrossRef
  • Google Scholar

• 319

  AbdallahHFaragMOsmanSKimDHKangKPanCHet al. Isolation of Major Phenolics From Launaea Spinosa and Their Protective Effect on HepG2 Cells Damaged With T-BHP. Pharm Biol (2016) 54:536–41. doi: 10.3109/13880209.2015.1052885

  • CrossRef
  • Google Scholar

• 320

  TienYCLiaoJCChiuCSHuangTHHuangCYChangWTet al. Esculetin Ameliorates Carbon Tetrachloride-Mediated Hepatic Apoptosis in Rats. Int J Mol Sci (2011) 12:4053–67. doi: 10.3390/ijms12064053

  • CrossRef
  • Google Scholar

• 321

  KimADHanXPiaoMJHewageSRKMHyunCLChoSJet al. Esculetin Induces Death of Human Colon Cancer Cells via the Reactive Oxygen Species-Mediated Mitochondrial Apoptosis Pathway. Environ Toxicol Pharmacol (2015) 39:982–9. doi: 10.1016/j.etap.2015.03.003

  • CrossRef
  • Google Scholar

• 322

  KimWKByunWSChungHJOhJParkHJChoiJSet al. Esculetin Suppresses Tumor Growth and Metastasis by Targeting Axin2/E-Cadherin Axis in Colorectal Cancer. Biochem Pharmacol (2018) 152:71–83. doi: 10.1016/j.bcp.2018.03.009

  • CrossRef
  • Google Scholar

• 323

  LeeRHJeonYJChoJHJangJYKongIKKimSHet al. Esculetin Exerts Anti-Proliferative Effects Against Non-Small-Cell Lung Carcinoma by Suppressing Specificity Protein 1 In Vitro. Gen Physiol Biophys (2017) 36:31–9. doi: 10.4149/gpb_2016024

  • CrossRef
  • Google Scholar

• 324

  LeeSYLimTGChenHJungSKLeeHJLeeMHet al. Esculetin Suppresses Proliferation of Human Colon Cancer Cells by Directly Targeting β-Catenin. Cancer Prev Res (2013) 6:1356–64. doi: 10.1158/1940-6207.CAPR-13-0241

  • CrossRef
  • Google Scholar

• 325

  LiHWangQWangYXuZHanZ. Esculetin Inhibits the Proliferation of Human Lung Cancer Cells by Targeting Epithelial-to-Mesenchymal Transition of the Cells. Cell Mol Biol (2019) 65:95–8. doi: 10.14715/cmb/2019.65.7.16

  • CrossRef
  • Google Scholar

• 326

  PanHWangBHLvWJiangYHeL. Esculetin Induces Apoptosis in Human Gastric Cancer Cells Through a Cyclophilin D-Mediated Mitochondrial Permeability Transition Pore Associated With ROS. Chem Biol Interact (2015) 242:51–60. doi: 10.1016/j.cbi.2015.09.015

  • CrossRef
  • Google Scholar

• 327

  ParkCJinCYKimGYChoiIWKwonTKChoiBTet al. Induction of Apoptosis by Esculetin in Human Leukemia U937 Cells Through Activation of JNK and ERK. Toxicol Appl Pharmacol (2008) 227:219–28. doi: 10.1016/j.taap.2007.10.003

  • CrossRef
  • Google Scholar

• 328

  ParkCJinCYKwonHJHwangHJKimGYChoiIWet al. Induction of Apoptosis by Esculetin in Human Leukemia U937 Cells: Roles of Bcl-2 and Extracellular-Regulated Kinase Signaling. Toxicol Vitr (2010) 24:486–94. doi: 10.1016/j.tiv.2009.09.017

  • CrossRef
  • Google Scholar

• 329

  RubioVGarcía-PérezAIHerráezATejedorMCDiezJC. Esculetin Modulates Cytotoxicity Induced by Oxidants in NB4 Human Leukemia Cells. Exp Toxicol Pathol (2017) 69:700–12. doi: 10.1016/j.etp.2017.08.001

  • CrossRef
  • Google Scholar

• 330

  AroraRSawneySSainiVSteffiCTiwariMSalujaD. Esculetin Induces Antiproliferative and Apoptotic Response in Pancreatic Cancer Cells by Directly Binding to KEAP1. Mol Cancer (2016) 15:1–15. doi: 10.1186/s12943-016-0550-2

  • CrossRef
  • Google Scholar

• 331

  SawneySAroraRAggarwalKKSalujaD. Esculetin Downregulates the Expression of AML1-ETO and C-Kit in Kasumi-1 Cell Line by Decreasing Half-Life of mRNA. J Oncol (2015) 2015:781473. doi: 10.1155/2015/781473

  • CrossRef
  • Google Scholar

• 332

  TurkekulKColpanRDBaykulTOzdemirMDErdoganS. Esculetin Inhibits the Survival of Human Prostate Cancer Cells by Inducing Apoptosis and Arresting the Cell Cycle. J Cancer Prev (2018) 23:10–7. doi: 10.15430/jcp.2018.23.1.10

  • CrossRef
  • Google Scholar

• 333

  WangGLuMYaoYWangJLiJ. Esculetin Exerts Antitumor Effect on Human Gastric Cancer Cells Through IGF-1/PI3K/Akt Signaling Pathway. Eur J Pharmacol (2017) 814:207–15. doi: 10.1016/j.ejphar.2017.08.025

  • CrossRef
  • Google Scholar

• 334

  YangJXiaoYLHeXRQiuGFHuXM. Aesculetin-Induced Apoptosis Through a ROS-Mediated Mitochondrial Dysfunction Pathway in Human Cervical Cancer Cells. J Asian Nat Prod Res (2010) 12:185–93. doi: 10.1080/10286020903427336

  • CrossRef
  • Google Scholar

• 335

  ZhangGXuYZhouHF. Esculetin Inhibits Proliferation, Invasion, and Migration of Laryngeal Cancer In Vitro and In Vivo by Inhibiting Janus Kinas (JAK)-Signal Transducer and Activator of Transcription-3 (STAT3) Activation. Med Sci Monit (2019) 25:7853–63. doi: 10.12659/MSM.916246

  • CrossRef
  • Google Scholar

• 336

  WuSTLiuBAiZZHongZCYouPTWuHZet al. Esculetin Inhibits Cancer Cell Glycolysis by Binding Tumor PGK2, GPD2, and GPI. Front Pharmacol (2020) 11:379. doi: 10.3389/fphar.2020.00379

  • CrossRef
  • Google Scholar

• 337

  ChangHTChouCTLinYSShiehPKuoDHJanCRet al. Esculetin, a Natural Coumarin Compound, Evokes Ca2+ Movement and Activation of Ca2+-Associated Mitochondrial Apoptotic Pathways That Involved Cell Cycle Arrest in ZR-75-1 Human Breast Cancer Cells. Tumor Biol (2016) 37:4665–78. doi: 10.1007/s13277-015-4286-1

  • CrossRef
  • Google Scholar

• 338

  ChuCYTsaiYYWangCJLinWLTsengTH. Induction of Apoptosis by Esculetin in Human Leukemia Cells. Eur J Pharmacol (2001) 416:25–32. doi: 10.1016/S0014-2999(01)00859-7

  • CrossRef
  • Google Scholar

• 339

  DuanJShiJMaXXuanYLiPWangHet al. Esculetin Inhibits Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma Cells. BioMed Pharmacother (2020) 125:110031. doi: 10.1016/j.biopha.2020.110031

  • CrossRef
  • Google Scholar

• 340

  GongJZhangWGFengXFShaoMJXingC. Aesculetin (6,7-Dihydroxycoumarin) Exhibits Potent and Selective Antitumor Activity in Human Acute Myeloid Leukemia Cells (THP-1) via Induction of Mitochondrial Mediated Apoptosis and Cancer Cell Migration Inhibition. J BUON (2017) 22:1563–9.

  • Google Scholar

• 341

  Karatug KacarABahadoriFKepekci TekkeliSETopcuGBolkentS. Investigation of Cell Death Mechanism and Activity of Esculetin-Loaded PLGA Nanoparticles on Insulinoma Cells In Vitro. J Pharm Pharmacol (2020) 72:592–606. doi: 10.1111/jphp.13228

  • CrossRef
  • Google Scholar

• 342

  KawaiiSTomonoYOgawaKSugiuraMYanoMYoshizawaY. The Antiproliferative Effect of Coumarins on Several Cancer Cell Lines. Anticancer Res (2001) 21:917–24.

  • Google Scholar

• 343

  WangXYangCZhangQWangCZhouXZhangXet al. In Vitro Anticancer Effects of Esculetin Against Human Leukemia Cell Lines Involves Apoptotic Cell Death, Autophagy, G0/G1 Cell Cycle Arrest and Modulation of Raf/MEK/ERK Signalling Pathway. J BUON (2019) 24:1686–91.

  • Google Scholar

• 344

  ChoJHShinJCChoJJChoiYHShimJHChaeJ. Esculetin (6, 7-Dihydroxycoumarin): A Potential Cancer Chemopreventive Agent Through Suppression of Sp1 in Oral Squamous Cancer Cells. Int J Oncol (2015) 46:265–71. doi: 10.3892/ijo.2014.2700

  • CrossRef
  • Google Scholar

• 345

  LiJLiSWangXWangH. Esculetin Induces Apoptosis of SMMC-7721 Cells Through IGF-1/PI3K/Akt-Mediated Mitochondrial Pathways. Can J Physiol Pharmacol (2017) 95:787–94. doi: 10.1139/cjpp-2016-0548

  • CrossRef
  • Google Scholar

• 346

  SharmaSHThulasingamSChellappanDRChinnaswamyPNagarajanS. Morin and Esculetin Supplementation Modulates C-Myc Induced Energy Metabolism and Attenuates Neoplastic Changes in Rats Challenged With the Procarcinogen 1,2 - Dimethylhydrazine. Eur J Pharmacol (2017) 796:20–31. doi: 10.1016/j.ejphar.2016.12.019

  • CrossRef
  • Google Scholar

• 347

  WangCJHsiehYJChuCYLinYLTsengTH. Inhibition of Cell Cycle Progression in Human Leukemia HL-60 Cells by Esculetin. Cancer Lett (2002) 183:163–8. doi: 10.1016/S0304-3835(02)00031-9

  • CrossRef
  • Google Scholar

• 348

  ParkS-SParkS-KJung-HyurkLChoiYHKimWJMoonSK. Esculetin Inhibits Cell Proliferation Through the Ras/ERK1/2 Pathway in Human Colon Cancer Cells. Oncol Rep (2010) 25:223–30. doi: 10.3892/or_00001064

  • CrossRef
  • Google Scholar

• 349

  LacyA. Studies on Coumarins and Coumarin-Related Compounds to Determine Their Therapeutic Role in the Treatment of Cancer. Curr Pharm Des (2005) 10:3797–811. doi: 10.2174/1381612043382693

  • CrossRef
  • Google Scholar

• 350

  FylaktakidouKHadjipavlou-LitinaDLitinasKNicolaidesD. Natural and Synthetic Coumarin Derivatives With Anti-Inflammatory / Antioxidant Activities. Curr Pharm Des (2005) 10:3813–33. doi: 10.2174/1381612043382710

  • CrossRef
  • Google Scholar

• 351

  HongSHJeongHKHanMHParkCChoiYH. Esculetin Suppresses Lipopolysaccharide-Induced Inflammatory Mediators and Cytokines by Inhibiting Nuclear Factor-κb Translocation in RAW 264.7 Macrophages. Mol Med Rep (2014) 10:3241–6. doi: 10.3892/mmr.2014.2613

  • CrossRef
  • Google Scholar

• 352

  KimARJinQJinHGKoHJWooER. Phenolic Compounds With IL-6 Inhibitory Activity From Aster Yomena. Arch Pharm Res (2014) 37:845–51. doi: 10.1007/s12272-013-0236-x

  • CrossRef
  • Google Scholar

• 353

  KimSHKangKAZhangRPiaoMJKoDOWangZHet al. Protective Effect of Esculetin Against Oxidative Stress-Induced Cell Damage via Scavenging Reactive Oxygen Species. Acta Pharmacol Sin (2008) 29:1319–26. doi: 10.1111/j.1745-7254.2008.00878.x

  • CrossRef
  • Google Scholar

• 354

  KwonOSChoiJSIslamMNKimYSKimHP. Inhibition of 5-Lipoxygenase and Skin Inflammation by the Aerial Parts of Artemisia Capillaris and Its Constituents. Arch Pharm Res (2011) 34:1561–9. doi: 10.1007/s12272-011-0919-0

  • CrossRef
  • Google Scholar

• 355

  NazemiyehHKazemiEMZareKJodariMNaharLSarkerSD. Free Radical Scavengers From the Aerial Parts of Euphorbia Petiolata. J Nat Med (2010) 64:187–90. doi: 10.1007/s11418-009-0382-0

  • CrossRef
  • Google Scholar

• 356

  ChenTGuoQWangHZhangHWangCZhangPet al. Effects of Esculetin on Lipopolysaccharide (LPS)-Induced Acute Lung Injury via Regulation of RhoA/Rho Kinase/NF-κb Pathways In Vivo and In Vitro. Free Radic Res (2015) 49:1459–68. doi: 10.3109/10715762.2015.1087643

  • CrossRef
  • Google Scholar

• 357

  LeeHCLiuFCTsaiCNChouAHLiaoCCYuHP. Esculetin Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice Via Modulation of the AKT/ERK/NF-κb and Rorγt/IL-17 Pathways. Inflammation (2020) 43:962–74. doi: 10.1007/s10753-020-01182-4

  • CrossRef
  • Google Scholar

• 358

  RzodkiewiczPGąsińskaEGajewskiMBujalska-ZadroznyMSzukiewiczDMaślińskiS. Esculetin Reduces Leukotriene B4 Level in Plasma of Rats With Adjuvant-Induced Arthritis. Reumatologia (2016) 54:161–4. doi: 10.5114/reum.2016.62469

  • CrossRef
  • Google Scholar

• 359

  RzodkiewiczPGasinskaEMaslinskiSBujalska-ZadroznyM. Antinociceptive Properties of Esculetin in Non-Inflammatory and Inflammatory Models of Pain in Rats. Clin Exp Pharmacol Physiol (2015) 42:213–9. doi: 10.1111/1440-1681.12346

  • CrossRef
  • Google Scholar

• 360

  WitaicenisASeitoLNDi StasiLC. Intestinal Anti-Inflammatory Activity of Esculetin and 4-Methylesculetin in the Trinitrobenzenesulphonic Acid Model of Rat Colitis. Chem Biol Interact (2010) 186:211–8. doi: 10.1016/j.cbi.2010.03.045

  • CrossRef
  • Google Scholar

• 361

  ChengY-JTianX-LZengY-ZLanNGuoL-FLiuK-Fet al. Esculetin Protects Against Early Sepsis via Attenuating Inflammation by Inhibiting NF-κb and STAT1/STAT3 Signaling. Chin J Nat Med (2021) 19:432–41. doi: 10.1016/S1875-5364(21)60042-0

  • CrossRef
  • Google Scholar

• 362

  HanMHParkCLeeDSHongSHChoiIWKimGYet al. Cytoprotective Effects of Esculetin Against Oxidative Stress Are Associated With the Upregulation of Nrf2-Mediated NQO1 Expression via the Activation of the ERK Pathway. Int J Mol Med (2017) 39:380–6. doi: 10.3892/ijmm.2016.2834

  • CrossRef
  • Google Scholar

• 363

  KanekoTTaharaSTakabayashiF. Inhibitory Effect of Natural Coumarin Compounds, Esculetin and Esculin, on Oxidative DNA Damage and Formation of Aberrant Crypt Foci and Tumors Induced by 1,2-Dimethylhydrazine in Rat Colons. Biol Pharm Bull (2007) 30:2052–7. doi: 10.1248/bpb.30.2052

  • CrossRef
  • Google Scholar

• 364

  KanekoTTaharaSTakabayashiF. Suppression of Lipid Hydroperoxide-Induced Oxidative Damage to Cellular DNA by Esculetin. Biol Pharm Bull (2003) 26:840–4. doi: 10.1248/bpb.26.840

  • CrossRef
  • Google Scholar

• 365

  LinWLWangCJTsaiYYLiuCLHwangJMTsengTH. Inhibitory Effect of Esculetin on Oxidative Damage Induced by T-Butyl Hydroperoxide in Rat Liver. Arch Toxicol (2000) 74:467–72. doi: 10.1007/s002040000148

  • CrossRef
  • Google Scholar

• 366

  YumSJeongSLeeSKimWNamJJungY. HIF-Prolyl Hydroxylase Is a Potential Molecular Target for Esculetin-Mediated Anti-Colitic Effects. Fitoterapia (2015) 103:55–62. doi: 10.1016/j.fitote.2015.03.013

  • CrossRef
  • Google Scholar

• 367

  LeeC-RShinE-JKimH-CChoiY-SShinTWieM-B. Esculetin Inhibits N -Methyl- D -Aspartate Neurotoxicity via Glutathione Preservation in Primary Cortical Cultures. Lab Anim Res (2011) 27:259. doi: 10.5625/lar.2011.27.3.259

  • CrossRef
  • Google Scholar

• 368

  Martín-AragónSVillarÁBenedíJ. Age-Dependent Effects of Esculetin on Mood-Related Behavior and Cognition From Stressed Mice Are Associated With Restoring Brain Antioxidant Status. Prog Neuropsychopharmacol Biol Psychiatry (2016) 65:1–16. doi: 10.1016/j.pnpbp.2015.08.007

  • CrossRef
  • Google Scholar

• 369

  SubramaniamSREllisEM. Neuroprotective Effects of Umbelliferone and Esculetin in a Mouse Model of Parkinson’s Disease. J Neurosci Res (2013) 91:453–61. doi: 10.1002/jnr.23164

  • CrossRef
  • Google Scholar

• 370

  SulakhiyaKKeshavlalGPBezbaruahBBDwivediSGurjarSSMundeNet al. Lipopolysaccharide Induced Anxiety- and Depressive-Like Behaviour in Mice Are Prevented by Chronic Pre-Treatment of Esculetin. Neurosci Lett (2016) 611:106–11. doi: 10.1016/j.neulet.2015.11.031

  • CrossRef
  • Google Scholar

• 371

  ZhuLNangCLuoFPanHZhangKLiuJet al. Esculetin Attenuates Lipopolysaccharide (LPS)-Induced Neuroinflammatory Processes and Depressive-Like Behavior in Mice. Physiol Behav (2016) 163:184–92. doi: 10.1016/j.physbeh.2016.04.051

  • CrossRef
  • Google Scholar

• 372

  WangCPeiAChenJYuHSunMLLiuCFet al. A Natural Coumarin Derivative Esculetin Offers Neuroprotection on Cerebral Ischemia/Reperfusion Injury in Mice. J Neurochem (2012) 121:1007–13. doi: 10.1111/j.1471-4159.2012.07744.x

  • CrossRef
  • Google Scholar

• 373

  KartDReçberTNemutluESagirogluM. Sub-Inhibitory Concentrations of Ciprofloxacin Alone and Combinations With Plant-Derived Compounds Against P. Aeruginosa Biofilms and Their Effects on the Metabolomic Profile of P. Aeruginosa Biofilms. Antibiotics (2021) 10:414. doi: 10.3390/antibiotics10040414

  • CrossRef
  • Google Scholar

• 374

  LeeJHKimYGChoHSRyuSYChoMHLeeJ. Coumarins Reduce Biofilm Formation and the Virulence of Escherichia Coli O157:H7. Phytomedicine (2014) 21:1037–42. doi: 10.1016/j.phymed.2014.04.008

  • CrossRef
  • Google Scholar

• 375

  TianLWPeiYZhangYJWangYFYangCR. 7-O-Methylkaempferol and -Quercetin Glycosides From the Whole Plant of Nervilia Fordii. J Nat Prod (2009) 72:1057–60. doi: 10.1021/np800760p

  • CrossRef
  • Google Scholar

• 376

  LiLGreeneIReadheadBMenonMCKiddBAUzilovAVet al. Novel Therapeutics Identification for Fibrosis in Renal Allograft Using Integrative Informatics Approach. Sci Rep (2017) 7:1–14. doi: 10.1038/srep39487

  • CrossRef
  • Google Scholar

• 377

  LiJMZhangXWangXXieYCKongLD. Protective Effects of Cortex Fraxini Coumarines Against Oxonate-Induced Hyperuricemia and Renal Dysfunction in Mice. Eur J Pharmacol (2011) 666:196–204. doi: 10.1016/j.ejphar.2011.05.021

  • CrossRef
  • Google Scholar

• 378

  SurseVMGuptaJTikooK. Esculetin Induced Changes in Mmp13 and Bmp6 Gene Expression and Histone H3 Modifications Attenuate Development of Glomerulosclerosis in Diabetic Rats. J Mol Endocrinol (2011) 46:245–54. doi: 10.1530/JME-10-0154

  • CrossRef
  • Google Scholar

• 379

  TürkEOzan TekeliIÖzkanHUyarACellatMKuzuMet al. The Protective Effect of Esculetin Against Aluminium Chloride-Induced Reproductive Toxicity in Rats. Andrologia (2021) 53:e13930. doi: 10.1111/and.13930

  • CrossRef
  • Google Scholar

• 380

  HongyanL. Esculetin Attenuates Th2 and Th17 Responses in an Ovalbumin-Induced Asthmatic Mouse Model. Inflammation (2016) 39:735–43. doi: 10.1007/s10753-015-0300-4

  • CrossRef
  • Google Scholar

• 381

  LeungKNLeungPYKongLPLeungP. Immunomodulatory Effects of Esculetin (6,7-Dihydroxycoumarin) on Murine Lymphocytes and Peritoneal Macrophages. Cell Mol Immunol (2005) 2:181–8.

  • Google Scholar

• 382

  MabalirajanUDindaAKSharmaSKGhoshB. Esculetin Restores Mitochondrial Dysfunction and Reduces Allergic Asthma Features in Experimental Murine Model. J Immunol (2009) 183:2059–67. doi: 10.4049/jimmunol.0900342

  • CrossRef
  • Google Scholar

• 383

  SunBWangBXuM. Esculetin Inhibits Histamine-Induced Expression of Inflammatory Cytokines and Mucin in Nasal Epithelial Cells. Clin Exp Pharmacol Physiol (2019) 46:821–7. doi: 10.1111/1440-1681.13128

  • CrossRef
  • Google Scholar

• 384

  BaekJMParkSHCheonYHAhnSJLeeMSOhJet al. Esculetin Attenuates Receptor Activator of Nuclear Factor Kappa-B Ligand-Mediated Osteoclast Differentiation Through C-Fos/nuclear Factor of Activated T-Cells C1 Signaling Pathway. Biochem Biophys Res Commun (2015) 461:334–41. doi: 10.1016/j.bbrc.2015.04.034

  • CrossRef
  • Google Scholar

• 385

  NaWLeeEJKangMKKimYHKimDYOhHet al. Aesculetin Inhibits Osteoclastic Bone Resorption Through Blocking Ruffled Border Formation and Lysosomal Trafficking. Int J Mol Sci (2020) 21:1–17. doi: 10.3390/ijms21228581

  • CrossRef
  • Google Scholar

• 386

  LiuMLiYPanJLiuHWangSJuDet al. Effect of Esculetin on Bone Metabolism in Ovariectomized Rats. J Tradit Chin Med = Chung i Tsa Chih Ying Wen Pan (2018) 38:896–903.

  • Google Scholar

• 387

  OzalSATurkekulKGurluVGucluHErdoganS. Esculetin Protects Human Retinal Pigment Epithelial Cells From Lipopolysaccharide-Induced Inflammation and Cell Death. Curr Eye Res (2018) 43:1169–76. doi: 10.1080/02713683.2018.1481517

  • CrossRef
  • Google Scholar

• 388

  JiangDHuJLiuX. Topical Administration of Esculetin as a Potential Therapy for Experimental Dry Eye Syndrome. Eye (2017) 31:1724–32. doi: 10.1038/eye.2017.117

  • CrossRef
  • Google Scholar

• 389

  ElliottSRowanADCarrèreSKoshyPCatterallJBCawstonTE. Esculetin Inhibits Cartilage Resorption Induced by Interleukin 1α in Combination With Oncostatin M. Ann Rheum Dis (2001) 60:158–65. doi: 10.1136/ard.60.2.158

  • CrossRef
  • Google Scholar

• 390

  HosseiniARazaviBMBanachMHosseinzadehH. Quercetin and Metabolic Syndrome: A Review. Phyther Res (2021) ptr.7144. doi: 10.1002/ptr.7144

  • CrossRef
  • Google Scholar

• 391

  ShabbirURubabMDaliriEBMChelliahRJavedAOhDH. Curcumin, Quercetin, Catechins and Metabolic Diseases: The Role of Gut Microbiota. Nutrients (2021) 13:1–24. doi: 10.3390/nu13010206

  • CrossRef
  • Google Scholar

• 392

  SatoSMukaiY. Modulation of Chronic Inflammation by Quercetin: The Beneficial Effects on Obesity. J Inflamm Res (2020) 13:421–31. doi: 10.2147/JIR.S228361

  • CrossRef
  • Google Scholar

• 393

  EbrahimpourSZakeriMEsmaeiliA. Crosstalk Between Obesity, Diabetes, and Alzheimer’s Disease: Introducing Quercetin as an Effective Triple Herbal Medicine. Ageing Res Rev (2020) 62:101095. doi: 10.1016/j.arr.2020.101095

  • CrossRef
  • Google Scholar

• 394

  MunhozACMFrodeTS. Isolated Compounds From Natural Products With Potential Antidiabetic Activity - A Systematic Review. Curr Diabetes Rev (2017) 14(1):36–106. doi: 10.2174/1573399813666170505120621

  • CrossRef
  • Google Scholar

• 395

  GongGGuanYYZhangZLRahmanKWangSJZhouSet al. Isorhamnetin: A Review of Pharmacological Effects. BioMed Pharmacother (2020) 128:110301. doi: 10.1016/j.biopha.2020.110301

  • CrossRef
  • Google Scholar

• 396

  AhnJLeeHKimSParkJHaT. The Anti-Obesity Effect of Quercetin Is Mediated by the AMPK and MAPK Signaling Pathways. Biochem Biophys Res Commun (2008) 373:545–9. doi: 10.1016/j.bbrc.2008.06.077

  • CrossRef
  • Google Scholar

• 397

  JiangHHoriuchiYHironaoKYKitakazeTYamashitaYAshidaH. Prevention Effect of Quercetin and Its Glycosides on Obesity and Hyperglycemia Through Activating Ampkα in High-Fat Diet-Fed ICR Mice. J Clin Biochem Nutr (2020) 67:74–83. doi: 10.3164/jcbn.20-47

  • CrossRef
  • Google Scholar

• 398

  DagherOMuryPThorin-TrescasesNNolyPEThorinECarrierM. Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases. Front Cardiovasc Med (2021) 8:658400. doi: 10.3389/fcvm.2021.658400

  • CrossRef
  • Google Scholar

• 399

  MirsafaeiLReinerŽShafabakhshRAsemiZ. Molecular and Biological Functions of Quercetin as a Natural Solution for Cardiovascular Disease Prevention and Treatment. Plant Foods Hum Nutr (2020) 75:307–15. doi: 10.1007/s11130-020-00832-0

  • CrossRef
  • Google Scholar

• 400

  DengQLiXXFangYChenXXueJ. Therapeutic Potential of Quercetin as an Antiatherosclerotic Agent in Atherosclerotic Cardiovascular Disease: A Review. Evidence-Based Complement Altern Med (2020) 2020:5926381. doi: 10.1155/2020/5926381

  • CrossRef
  • Google Scholar

• 401

  DabeekWMMarraMV. Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans. Nutrients (2019) 11:2288. doi: 10.3390/nu11102288

  • CrossRef
  • Google Scholar

• 402

  FerenczyovaKKalocayovaBBartekovaM. Potential Implications of Quercetin and Its Derivatives in Cardioprotection. Int J Mol Sci (2020) 21:1585. doi: 10.3390/ijms21051585

  • CrossRef
  • Google Scholar

• 403

  FarghaliHKemeloMKCanováNK. SIRT1 Modulators in Experimentally Induced Liver Injury. Oxid Med Cell Longev (2019) 2019:8765954. doi: 10.1155/2019/8765954

  • CrossRef
  • Google Scholar

• 404

  BaeMParkYKLeeJY. Food Components With Antifibrotic Activity and Implications in Prevention of Liver Disease. J Nutr Biochem (2018) 55:1–11. doi: 10.1016/j.jnutbio.2017.11.003

  • CrossRef
  • Google Scholar

• 405

  AlmatroodiSAAlsahliMAAlmatroudiAVermaAKAloliqiAAllemailemKSet al. Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer Through the Modulation of Various Cell Signaling Pathways. Molecules (2021) 26:1315. doi: 10.3390/molecules26051315

  • CrossRef
  • Google Scholar

• 406

  Orfali G diCDuarteACBonadioVMartinezNPde AraújoMEMBPrivieroFBMet al. Review of Anticancer Mechanisms of Isoquercitin. World J Clin Oncol (2016) 7:189–99. doi: 10.5306/wjco.v7.i2.189

  • CrossRef
  • Google Scholar

• 407

  JantanIHaqueMAArshadLHarikrishnanHSeptamaAWMohamed-HusseinZA. Dietary Polyphenols Suppress Chronic Inflammation by Modulation of Multiple Inflammation-Associated Cell Signaling Pathways. J Nutr Biochem (2021) 93:108634. doi: 10.1016/j.jnutbio.2021.108634

  • CrossRef
  • Google Scholar

• 408

  WangYTaoBWanYSunYWangLSunJet al. Drug Delivery Based Pharmacological Enhancement and Current Insights of Quercetin With Therapeutic Potential Against Oral Diseases. BioMed Pharmacother (2020) 128:110372. doi: 10.1016/j.biopha.2020.110372

  • CrossRef
  • Google Scholar

• 409

  HuangYYWangZHDengLHWangHZhengQ. Oral Administration of Quercetin or Its Derivatives Inhibit Bone Loss in Animal Model of Osteoporosis. Oxid Med Cell Longev (2020) 2020:6080597. doi: 10.1155/2020/6080597

  • CrossRef
  • Google Scholar

• 410

  GhorbaniA. Mechanisms of Antidiabetic Effects of Flavonoid Rutin. BioMed Pharmacother (2017) 96:305–12. doi: 10.1016/j.biopha.2017.10.001

  • CrossRef
  • Google Scholar

• 411

  HabtemariamSLentiniG. The Therapeutic Potential of Rutin for Diabetes: An Update. Mini-Rev Med Chem (2015) 15:524–8. doi: 10.2174/138955751507150424103721

  • CrossRef
  • Google Scholar

• 412

  HosseinzadehHNassiri-AslM. Review of the Protective Effects of Rutin on the Metabolic Function as an Important Dietary Flavonoid. J Endocrinol Invest (2014) 37:783–8. doi: 10.1007/s40618-014-0096-3

  • CrossRef
  • Google Scholar

• 413

  LimSHYuJSLeeHSChoiCIKimKH. Antidiabetic Flavonoids From Fruits of Morus Alba Promoting Insulin-Stimulated Glucose Uptake via Akt and Amp-Activated Protein Kinase Activation in 3t3-L1 Adipocytes. Pharmaceutics (2021) 13:526. doi: 10.3390/pharmaceutics13040526

  • CrossRef
  • Google Scholar

• 414

  YuanXWeiGYouYHuangYLeeHJDongMet al. Rutin Ameliorates Obesity Through Brown Fat Activation. FASEB J (2017) 31:333–45. doi: 10.1096/fj.201600459RR

  • CrossRef
  • Google Scholar

• 415

  LiangWZhangDKangJMengXYangJYangLet al. Protective Effects of Rutin on Liver Injury in Type 2 Diabetic Db/Db Mice. BioMed Pharmacother (2018) 107:721–8. doi: 10.1016/j.biopha.2018.08.046

  • CrossRef
  • Google Scholar

• 416

  Mainzen PrincePSKamalakkannanN. Rutin Improves Glucose Homeostasis in Streptozotocin Diabetic Tissues by Altering Glycolytic and Gluconeogenic Enzymes. J Biochem Mol Toxicol (2006) 20:96–102. doi: 10.1002/jbt.20117

  • CrossRef
  • Google Scholar

• 417

  ManzoniAGPassosDFLeitempergerJWStorckTRDoleskiPHJantschMHet al. Hyperlipidemia-Induced Lipotoxicity and Immune Activation in Rats Are Prevented by Curcumin and Rutin. Int Immunopharmacol (2020) 81:106217. doi: 10.1016/j.intimp.2020.106217

  • CrossRef
  • Google Scholar

• 418

  PrasadRPrasadSB. Histoprotective Effect of Rutin Against Cisplatin-Induced Toxicities in Tumor-Bearing Mice: Rutin Lessens Cisplatin-Induced Toxicities. Hum Exp Toxicol (2021) 40:245–58. doi: 10.1177/0960327120947793

  • CrossRef
  • Google Scholar

• 419

  CaglayanCKandemirFMDarendelioğluEYıldırımSKucuklerSDortbudakMB. Rutin Ameliorates Mercuric Chloride-Induced Hepatotoxicity in Rats via Interfering With Oxidative Stress, Inflammation and Apoptosis. J Trace Elem Med Biol (2019) 56:60–8. doi: 10.1016/j.jtemb.2019.07.011

  • CrossRef
  • Google Scholar

• 420

  ElsawyHBadrGMSedkyAAbdallahBMAlzahraniAMAbdel-MoneimAM. Rutin Ameliorates Carbon Tetrachloride (CCl4)-Induced Hepatorenal Toxicity and Hypogonadism in Male Rats. PeerJ (2019) 7:e7011. doi: 10.7717/peerj.7011

  • CrossRef
  • Google Scholar

• 421

  LiSLiJPanRChengJCuiQChenJet al. Sodium Rutin Extends Lifespan and Health Span in Mice Including Positive Impacts on Liver Health. Br J Pharmacol (2021) 8. doi: 10.1111/bph.15410

  • CrossRef
  • Google Scholar

• 422

  ImaniAMalekiNBohlouliSKouhsoltaniMSharifiSMaleki DizajS. Molecular Mechanisms of Anticancer Effect of Rutin. Phyther Res (2021) 35:2500–13. doi: 10.1002/ptr.6977

  • CrossRef
  • Google Scholar

• 423

  NouriZFakhriSNouriKWallaceCEFarzaeiMHBishayeeA. Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach. Cancers (Basel) (2020) 12:1–34. doi: 10.3390/cancers12082276

  • CrossRef
  • Google Scholar

• 424

  RakshitSShuklaPVermaAKumar NiralaSBhadauriaM. Protective Role of Rutin Against Combined Exposure to Lipopolysaccharide and D-Galactosamine-Induced Dysfunctions in Liver, Kidney, and Brain: Hematological, Biochemical, and Histological Evidences. J Food Biochem (2021) 45:e13605. doi: 10.1111/jfbc.13605

  • CrossRef
  • Google Scholar

• 425

  La CasaCVillegasIAlarcón de la LastraCMotilvaVMartín CaleroMJ. Evidence for Protective and Antioxidant Properties of Rutin, a Natural Flavone, Against Ethanol Induced Gastric Lesions. J Ethnopharmacol (2000) 71:45–53. doi: 10.1016/S0378-8741(99)00174-9

  • CrossRef
  • Google Scholar

• 426

  HartoghDJDTsianiE. Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol. Biomolecules (2019) 9:99. doi: 10.3390/biom9030099

  • CrossRef
  • Google Scholar

• 427

  NyaneNATlailaTBMalefaneTGNdwandweDEOwiraPMO. Metformin-Like Antidiabetic, Cardio-Protective and Non-Glycemic Effects of Naringenin: Molecular and Pharmacological Insights. Eur J Pharmacol (2017) 803:103–11. doi: 10.1016/j.ejphar.2017.03.042

  • CrossRef
  • Google Scholar

• 428

  SharmaMAkhtarNSambhavKSheteGBansalASharmaS. Emerging Potential of Citrus Flavanones as an Antioxidant in Diabetes and Its Complications. Curr Top Med Chem (2014) 15:187–95. doi: 10.2174/1568026615666141209163013

  • CrossRef
  • Google Scholar

• 429

  LiuSDongJBianQ. A Dual Regulatory Effect of Naringenin on Bone Homeostasis in Two Diabetic Mice Models. Tradit Med Mod Med (2020) 03:101–8. doi: 10.1142/s2575900020500093

  • CrossRef
  • Google Scholar

• 430

  Heidary MoghaddamRSamimiZMoradiSZLittlePJXuSFarzaeiMH. Naringenin and Naringin in Cardiovascular Disease Prevention: A Preclinical Review. Eur J Pharmacol (2020) 887:173535. doi: 10.1016/j.ejphar.2020.173535

  • CrossRef
  • Google Scholar

• 431

  MulvihillEEBurkeACHuffMW. Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis. Annu Rev Nutr (2016) 36:275–99. doi: 10.1146/annurev-nutr-071715-050718

  • CrossRef
  • Google Scholar

• 432

  Hernández-AquinoEMurielP. Beneficial Effects of Naringenin in Liver Diseases: Molecular Mechanisms. World J Gastroenterol (2018) 24:1679–707. doi: 10.3748/wjg.v24.i16.1679

  • CrossRef
  • Google Scholar

• 433

  MemarianiZAbbasSQul HassanSSAhmadiAChabraA. Naringin and Naringeninin as Anticancer Agents and Adjuvants in Cancer Combination Therapy; Efficacy and Molecular Mechanisms of Action, a Comprehensive Narrative Review. Pharmacol Res (2020) 171:105264. doi: 10.1016/j.phrs.2020.105264

  • CrossRef
  • Google Scholar

• 434

  ZaidunNHThentZCLatiffAA. Combating Oxidative Stress Disorders With Citrus Flavonoid: Naringenin. Life Sci (2018) 208:111–22. doi: 10.1016/j.lfs.2018.07.017

  • CrossRef
  • Google Scholar

• 435

  TutunchiHNaeiniFOstadrahimiAHosseinzadeh-AttarMJ. Naringenin, a Flavanone With Antiviral and Anti-Inflammatory Effects: A Promising Treatment Strategy Against COVID-19. Phyther Res (2020) 34:3137–47. doi: 10.1002/ptr.6781

  • CrossRef
  • Google Scholar

• 436

  AlbercaRWTeixeiraFMEBeserraDRde OliveiraEAAndrade MM deSPietrobonAJet al. Perspective: The Potential Effects of Naringenin in COVID-19. Front Immunol (2020) 11:570919. doi: 10.3389/fimmu.2020.570919

  • CrossRef
  • Google Scholar

• 437

  ChinLHHonCMChellappanDKChellianJMadheswaranTZeeshanFet al. Molecular Mechanisms of Action of Naringenin in Chronic Airway Diseases. Eur J Pharmacol (2020) 879:173139. doi: 10.1016/j.ejphar.2020.173139

  • CrossRef
  • Google Scholar

• 438

  MaseAMakinoBTsuchiyaNYamamotoMKaseYTakedaSet al. Active Ingredients of Traditional Japanese (Kampo) Medicine, Inchinkoto, in Murine Concanavalin A-Induced Hepatitis. J Ethnopharmacol (2010) 127:742–9. doi: 10.1016/j.jep.2009.11.029

  • CrossRef
  • Google Scholar

• 439

  ChuCYTsengTHHwangJMChouFPWangCJ. Protective Effects of Capillarisin on Tert-Butylhydroperoxide-Induced Oxidative Damage in Rat Primary Hepatocytes. Arch Toxicol (1999) 73:263–8. doi: 10.1007/s002040050615

  • CrossRef
  • Google Scholar

• 440

  LeeJHChiangSYNamDChungWSLeeJNaYSet al. Capillarisin Inhibits Constitutive and Inducible STAT3 Activation Through Induction of SHP-1 and SHP-2 Tyrosine Phosphatases. Cancer Lett (2014) 345:140–8. doi: 10.1016/j.canlet.2013.12.008

  • CrossRef
  • Google Scholar

• 441

  TsuiKHChangYLFengTHHouCPLinYHYangPSet al. Capillarisin Blocks Prostate-Specific Antigen Expression on Activation of Androgen Receptor in Prostate Carcinoma Cells. Prostate (2018) 78:242–9. doi: 10.1002/pros.23463

  • CrossRef
  • Google Scholar

• 442

  TsuiKHChangYLYangPSHouCPLinYHLinBWet al. The Inhibitory Effects of Capillarisin on Cell Proliferation and Invasion of Prostate Carcinoma Cells. Cell Prolif (2018) 51(2):e12429. doi: 10.1111/cpr.12429

  • CrossRef
  • Google Scholar

• 443

  ChenNJHaoFYLiuHZhaoHLiJM. Capillarisin Exhibits Anticancer Effects by Inducing Apoptosis, Cell Cycle Arrest and Mitochondrial Membrane Potential Loss in Osteosarcoma Cancer Cells (HOS). Drug Res (Stuttg) (2014) 65:422–7. doi: 10.1055/s-0034-1387728

  • CrossRef
  • Google Scholar

• 444

  HanSLeeJHKimCNamDChungWSLeeSGet al. Capillarisin Inhibits iNOS, COX-2 Expression, and Proinflammatory Cytokines in LPS-Induced RAW 264.7 Macrophages via the Suppression of ERK, JNK, and NF-κb Activation. Immunopharmacol Immunotoxicol (2013) 35:34–42. doi: 10.3109/08923973.2012.736522

  • CrossRef
  • Google Scholar

• 445

  KhanSShehzadOChunJChoiRJParkSIslamMNet al. Anti-Hyperalgesic and Anti-Allodynic Activities of Capillarisin via Suppression of Inflammatory Signaling in Animal Model. J Ethnopharmacol (2014) 152:478–86. doi: 10.1016/j.jep.2014.01.028

  • CrossRef
  • Google Scholar

• 446

  KhanSChoiRJShehzadOKimHPIslamMNChoiJSet al. Molecular Mechanism of Capillarisin-Mediated Inhibition of MyD88/TIRAP Inflammatory Signaling in In Vitro and In Vivo Experimental Models. J Ethnopharmacol (2013) 145:626–37. doi: 10.1016/j.jep.2012.12.001

  • CrossRef
  • Google Scholar

• 447

  KimJLimJKangBYJungKChoiHJ. Capillarisin Augments Anti-Oxidative and Anti-Inflammatory Responses by Activating Nrf2/HO-1 Signaling. Neurochem Int (2017) 105:11–20. doi: 10.1016/j.neuint.2017.01.018

  • CrossRef
  • Google Scholar

• 448

  ZhaoTWangQ. Capillarisin Protects SH-SY5Y Cells Against Bupivacaine-Induced Apoptosis via ROS-Mediated PI3K/PKB Pathway. Life Sci (2020) 259:118279. doi: 10.1016/j.lfs.2020.118279

  • CrossRef
  • Google Scholar

• 449

  YuZTangLChenLLiJWuWHuC. Capillarisin Suppresses Lipopolysaccharide-Induced Inflammatory Mediators in BV2 Microglial Cells by Suppressing TLR4-Mediated NF-κb and MAPKs Signaling Pathway. Neurochem Res (2015) 40:1095–101. doi: 10.1007/s11064-015-1567-4

  • CrossRef
  • Google Scholar

• 450

  KimHKChoiBRBakYOZhaoCLeeSWJeonJHet al. The Role of Capillarisin From Artemisia Capillaris on Penile Erection. Phyther Res (2012) 26:800–5. doi: 10.1002/ptr.3635

  • CrossRef
  • Google Scholar

• 451

  PengGLongX. Capillarisin Exerts Antiasthmatic Activity in Neonatal Rats via Modulating the Matrix Remodeling. Pak J Pharm Sci (2020) 33:1907–15. doi: 10.36721/PJPS.2020.33.4.SUP.1907-1915.1

  • CrossRef
  • Google Scholar

• 452

  KimMChunJJungHAChoiJSKimYS. Capillarisin Attenuates Exercise-Induced Muscle Damage Through MAPK and NF-κb Signaling. Phytomedicine (2017) 32:30–6. doi: 10.1016/j.phymed.2017.04.007

  • CrossRef
  • Google Scholar

• 453

  PimpleyVPatilSSrinivasanKDesaiNMurthyPS. The Chemistry of Chlorogenic Acid From Green Coffee and Its Role in Attenuation of Obesity and Diabetes. Prep Biochem Biotechnol (2020) 50:969–78. doi: 10.1080/10826068.2020.1786699

  • CrossRef
  • Google Scholar

• 454

  Farias-PereiraRParkCSParkY. Mechanisms of Action of Coffee Bioactive Components on Lipid Metabolism. Food Sci Biotechnol (2019) 28:1287–96. doi: 10.1007/s10068-019-00662-0

  • CrossRef
  • Google Scholar

• 455

  YamagataK. Do Coffee Polyphenols Have a Preventive Action on Metabolic Syndrome Associated Endothelial Dysfunctions? An Assessment of the Current Evidence. Antioxidants (2018) 7:26. doi: 10.3390/antiox7020026

  • CrossRef
  • Google Scholar

• 456

  AliSSAhmadWANWBudinSBZainalabidinS. Implication of Dietary Phenolic Acids on Inflammation in Cardiovascular Disease. Rev Cardiovasc Med (2020) 21:225–40. doi: 10.31083/J.RCM.2020.02.49

  • CrossRef
  • Google Scholar

• 457

  SilvaHLopesNMF. Cardiovascular Effects of Caffeic Acid and Its Derivatives: A Comprehensive Review. Front Physiol (2020) 11:595516. doi: 10.3389/fphys.2020.595516

  • CrossRef
  • Google Scholar

• 458

  LiLSuCChenXWangQJiaoWLuoHet al. Chlorogenic Acids in Cardiovascular Disease: A Review of Dietary Consumption, Pharmacology, and Pharmacokinetics. J Agric Food Chem (2020) 68:6464–84. doi: 10.1021/acs.jafc.0c01554

  • CrossRef
  • Google Scholar

• 459

  ChoiJParkJKLeeKTParkKKKimWBLeeJHet al. In Vivo Antihepatotoxic Effects of Ligularia Fischeri Var. Spiciformis and the Identification of the Active Component, 3,4-Dicaffeoylquinic Acid. J Med Food (2005) 8:348–52. doi: 10.1089/jmf.2005.8.348

  • CrossRef
  • Google Scholar

• 460

  Monteiro EspíndolaKMFerreiraRGMosquera NarvaezLERocha Silva RosarioACMachado Da SilvaAHBispo SilvaAGet al. Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma. Front Oncol (2019) 9:541. doi: 10.3389/fonc.2019.00541

  • CrossRef
  • Google Scholar

• 461

  BułdakRJHejmoTOsowskiMBułdakŁKuklaMPolaniakRet al. The Impact of Coffee and Its Selected Bioactive Compounds on the Development and Progression of Colorectal Cancer In Vivo and In Vitro. Molecules (2018) 23:3309. doi: 10.3390/molecules23123309

  • CrossRef
  • Google Scholar

• 462

  LiangNKittsDD. Role of Chlorogenic Acids in Controlling Oxidative and Inflammatory Stress Conditions. Nutrients (2015) 8(1):16. doi: 10.3390/nu8010016

  • CrossRef
  • Google Scholar

• 463

  KimHLeeYS. Identification of New Dicaffeoylquinic Acids From Chrysanthemum Morifolium and Their Antioxidant Activities. Planta Med (2005) 71:871–6. doi: 10.1055/s-2005-873115

  • CrossRef
  • Google Scholar

• 464

  IzutaHNaraharaYShimazawaMMishimaSKondoSIHaraH. 1,1-Diphenyl-2-Picrylhydrazyl Radical Scavenging Activity of Bee Products and Their Constituents Determined by ESR. Biol Pharm Bull (2009) 32:1947–51. doi: 10.1248/bpb.32.1947

  • CrossRef
  • Google Scholar

• 465

  FukutomiROhishiTKoyamaYPervinMNakamuraYIsemuraM. Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases. Molecules (2021) 26:415. doi: 10.3390/molecules26020415

  • CrossRef
  • Google Scholar

• 466

  HabtemariamS. Protective Effects of Caffeic Acid and the Alzheimer’s Brain: An Update. Mini-Rev Med Chem (2016) 17:667–74. doi: 10.2174/1389557516666161130100947

  • CrossRef
  • Google Scholar

• 467

  SocalaKSzopaASerefkoAPoleszakEWlazP. Neuroprotective Effects of Coffee Bioactive Compounds: A Review. Int J Mol Sci (2020) 22:1–64. doi: 10.3390/IJMS22010107

  • CrossRef
  • Google Scholar

• 468

  KhanFBamunuarachchiNITabassumNKimYM. Caffeic Acid and Its Derivatives: Antimicrobial Drugs Toward Microbial Pathogens. J Agric Food Chem (2021) 69(10):2979–3004. doi: 10.1021/acs.jafc.0c07579

  • CrossRef
  • Google Scholar

• 469

  Godlewska-żyłkiewiczBŚwisłockaRKalinowskaMGolonkoAŚwiderskiGArciszewskaŻet al. Biologically Active Compounds of Plants: Structure-Related Antioxidant, Microbiological and Cytotoxic Activity of Selected Carboxylic Acids. Mater (Basel) (2020) 13:1–37. doi: 10.3390/ma13194454

  • CrossRef
  • Google Scholar

• 470

  ZhaoYGengCAMaYBHuangXYChenHCaoTWet al. UFLC/MS-IT-TOF Guided Isolation of Anti-HBV Active Chlorogenic Acid Analogues From Artemisia Capillaris as a Traditional Chinese Herb for the Treatment of Hepatitis. J Ethnopharmacol (2014) 156:147–54. doi: 10.1016/j.jep.2014.08.043

  • CrossRef
  • Google Scholar

• 471

  YangZZYuYTLinHRLiaoDCCuiXHWangHB. Lonicera Japonica Extends Lifespan and Healthspan in Caenorhabditis Elegans. Free Radic Biol Med (2018) 129:310–22. doi: 10.1016/j.freeradbiomed.2018.09.035

  • CrossRef
  • Google Scholar

• 472

  IkedaRYanagisawaMTakahashiNKawadaTKumazawaSYamaotsuNet al. Brazilian Propolis-Derived Components Inhibit TNF-α-Mediated Downregulation of Adiponectin Expression via Different Mechanisms in 3T3-L1 Adipocytes. Biochim Biophys Acta - Gen Subj (2011) 1810:695–703. doi: 10.1016/j.bbagen.2011.04.007

  • CrossRef
  • Google Scholar

• 473

  KitamuraH. Effects of Propolis Extract and Propolis-Derived Compounds on Obesity and Diabetes: Knowledge From Cellular and Animal Models. Molecules (2019) 24(23):4394. doi: 10.3390/molecules24234394

  • CrossRef
  • Google Scholar

• 474

  ChoiS-SChaB-YIidaKLeeY-SYonezawaTTeruyaTet al. Artepillin C, as a Pparγ Ligand, Enhances Adipocyte Differentiation and Glucose Uptake in 3T3-L1 Cells. Biochem Pharmacol (2011) 81:925–33. doi: 10.1016/J.BCP.2011.01.002

  • CrossRef
  • Google Scholar

• 475

  UedaMHayashibaraKAshidaH. Propolis Extract Promotes Translocation of Glucose Transporter 4 and Glucose Uptake Through Both PI3K- and AMPK-Dependent Pathways in Skeletal Muscle. BioFactors (2013) 39:457–66. doi: 10.1002/biof.1085

  • CrossRef
  • Google Scholar

• 476

  NakashimaKMurakamiTTanabeHInoueM. Identification of a Naturally Occurring Retinoid X Receptor Agonist From Brazilian Green Propolis. Biochim Biophys Acta - Gen Subj (2014) 1840:3034–41. doi: 10.1016/j.bbagen.2014.06.011

  • CrossRef
  • Google Scholar

• 477

  UmedaMHiramotoMWatanabeATsunodaNImaiT. Arginine-Induced Insulin Secretion in Endoplasmic Reticulum. Biochem Biophys Res Commun (2015) 466:717–22. doi: 10.1016/j.bbrc.2015.09.006

  • CrossRef
  • Google Scholar

• 478

  De OliveiraPFDe Souza LimaIMMunariCCBastosJKDa Silva FilhoAATavaresDC. Comparative Evaluation of Antiproliferative Effects of Brazilian Green Propolis, Its Main Source Baccharis Dracunculifolia, and Their Major Constituents Artepillin C and Baccharin. Planta Med (2014) 80:490–2. doi: 10.1055/s-0034-1368298

  • CrossRef
  • Google Scholar

• 479

  SouzaRPBonfim-MendonçaPSDamkeGMZFde-Assis CarvalhoARBRattiBADembogurskiDSOet al. Artepillin C Induces Selective Oxidative Stress and Inhibits Migration and Invasion in a Comprehensive Panel of Human Cervical Cancer Cell Lines. Anticancer Agents Med Chem (2018) 18:1750–60. doi: 10.2174/1871520618666180604092930

  • CrossRef
  • Google Scholar

• 480

  MarutaHAhnMR. From Bench (Laboratory) to Bed (Hospital/Home): How to Explore Effective Natural and Synthetic PAK1-Blockers/Longevity-Promoters for Cancer Therapy. Eur J Med Chem (2017) 142:229–43. doi: 10.1016/j.ejmech.2017.07.043

  • CrossRef
  • Google Scholar

• 481

  KumazakiMShinoharaHTaniguchiKYamadaNOhtaSIchiharaKet al. Propolis Cinnamic Acid Derivatives Induce Apoptosis Through Both Extrinsic and Intrinsic Apoptosis Signaling Pathways and Modulate of miRNA Expression. Phytomedicine (2014) 21:1070–7. doi: 10.1016/j.phymed.2014.04.006

  • CrossRef
  • Google Scholar

• 482

  ChiuH-FHanY-CShenY-CGolovinskaiaOVenkatakrishnanKWangC-K. Chemopreventive and Chemotherapeutic Effect of Propolis and Its Constituents: A Mini-Review. J Cancer Prev (2020) 25:70–8. doi: 10.15430/jcp.2020.25.2.70

  • CrossRef
  • Google Scholar

• 483

  MishimaSOnoYArakiYAkaoYNozawaY. Two Related Cinnamic Acid Derivatives From Brazilian Honey Bee Propolis, Baccharin and Drupanin, Induce Growth Inhibition in Allografted Sarcoma S-180 in Mice. Biol Pharm Bull (2005) 28:1025–30. doi: 10.1248/bpb.28.1025

  • CrossRef
  • Google Scholar

• 484

  AkaoYMaruyamaHMatsumotoKOhguchiKNishizawaKSakamotoTet al. Cell Growth Inhibitory Effect of Cinnamic Acid Derivatives From Propolis on Human Tumor Cell Lines. Biol Pharm Bull (2003) 26:1057–9. doi: 10.1248/bpb.26.1057

  • CrossRef
  • Google Scholar

• 485

  AhnMRKunimasaKOhtaTKumazawaSKamihiraMKajiKet al. Suppression of Tumor-Induced Angiogenesis by Brazilian Propolis: Major Component Artepillin C Inhibits In Vitro Tube Formation and Endothelial Cell Proliferation. Cancer Lett (2007) 252:235–43. doi: 10.1016/j.canlet.2006.12.039

  • CrossRef
  • Google Scholar

• 486

  PaulinoNAbreuSRLUtoYKoyamaDNagasawaHHoriHet al. Anti-Inflammatory Effects of a Bioavailable Compound, Artepillin C, in Brazilian Propolis. Eur J Pharmacol (2008) 587:296–301. doi: 10.1016/j.ejphar.2008.02.067

  • CrossRef
  • Google Scholar

• 487

  ShimizuKAshidaHMatsuuraYKanazawaK. Antioxidative Bioavailability of Artepillin C in Brazilian Propolis. Arch Biochem Biophys (2004) 424:181–8. doi: 10.1016/j.abb.2004.02.021

  • CrossRef
  • Google Scholar

• 488

  CostaPAlmeidaMOLemosMArrudaCCasotiRSomensiLBet al. Artepillin C, Drupanin, Aromadendrin-4′-O-Methyl-Ether and Kaempferide From Brazilian Green Propolis Promote Gastroprotective Action by Diversified Mode of Action. J Ethnopharmacol (2018) 226:82–9. doi: 10.1016/j.jep.2018.08.006

  • CrossRef
  • Google Scholar

• 489

  ShimizuYSuzukiT. Brazilian Propolis Extract Reduces Intestinal Barrier Defects and Inflammation in a Colitic Mouse Model. Nutr Res (2019) 69:30–41. doi: 10.1016/j.nutres.2019.07.003

  • CrossRef
  • Google Scholar

• 490

  de Oliveira DembogurskiDSSilva TrentinDBoarettoAGRigoGVda SilvaRCTascaTet al. Brown Propolis-Metabolomic Innovative Approach to Determine Compounds Capable of Killing Staphylococcus Aureus Biofilm and Trichomonas Vaginalis. Food Res Int (2018) 111:661–73. doi: 10.1016/j.foodres.2018.05.033

  • CrossRef
  • Google Scholar

• 491

  PrzybyłekIKarpińskiTM. Antibacterial Properties of Propolis. Mol (2019) 24:2047. doi: 10.3390/MOLECULES24112047

  • CrossRef
  • Google Scholar

• 492

  TakedaKNagamatsuKOkumuraK. A Water-Soluble Derivative of Propolis Augments the Cytotoxic Activity of Natural Killer Cells. J Ethnopharmacol (2018) 218:51–8. doi: 10.1016/j.jep.2018.02.035

  • CrossRef
  • Google Scholar

• 493

  YanaseSLuoYMarutaH. PAK1-Deficiency/Down-Regulation Reduces Brood Size, Activates HSP16.2 Gene and Extends Lifespan in Caenorhabditis Elegans. Drug Discov Ther (2013) 7:29–35. doi: 10.5582/ddt.2013.v7.1.29

  • CrossRef
  • Google Scholar

• 494

  HattoriHOkudaKMuraseTShigetsuraYNariseKSemenzaGLet al. Isolation, Identification, and Biological Evaluation of HIF-1-Modulating Compounds From Brazilian Green Propolis. Bioorg Med Chem (2011) 19:5392–401. doi: 10.1016/j.bmc.2011.07.060

  • CrossRef
  • Google Scholar

• 495

  CorbettJT. The Scopoletin Assay for Hydrogen Peroxide A Review and a Better Method. J Biochem Biophys Methods (1989) 18:297–307. doi: 10.1016/0165-022X(89)90039-0

  • CrossRef
  • Google Scholar

• 496

  AndreaeWA. A Sensitive Method for the Estimation of Hydrogen Peroxide in Biological Materials [9]. Nature (1955) 175:859–60. doi: 10.1038/175859a0

  • CrossRef
  • Google Scholar

• 497

  MarquezLADunfordHB. Transient and Steady-State Kinetics of the Oxidation of Scopoletin by Horseradish Peroxidase Compounds I, II and III in the Presence of NADH. Eur J Biochem (1995) 233:364–71. doi: 10.1111/j.1432-1033.1995.364_1.x

  • CrossRef
  • Google Scholar

• 498

  BoverisAMartinoEStoppaniAOM. Evaluation of the Horseradish Peroxidase-Scopoletin Method for the Measurement of Hydrogen Peroxide Formation in Biological Systems. Anal Biochem (1977) 80:145–58. doi: 10.1016/0003-2697(77)90634-0

  • CrossRef
  • Google Scholar

• 499

  LeeBCLeeSYLeeHJSimGSKimJHKimJHet al. Anti-Oxidative and Photo-Protective Effects of Coumarins Isolated From Fraxinus Chinensis. Arch Pharm Res (2007) 30:1293–301. doi: 10.1007/BF02980270

  • CrossRef
  • Google Scholar

• 500

  CobleyJNFiorelloMLBaileyDM. 13 Reasons Why the Brain Is Susceptible to Oxidative Stress. Redox Biol (2018) 15:490–503. doi: 10.1016/j.redox.2018.01.008

  • CrossRef
  • Google Scholar

• 501

  HalvorsenBBrudeIDrevonCANysomJOseLChristiansenENet al. Effect of Homocysteine on Copper Ion-Catalyzed, Azo Compound-Initiated, and Mononuclear Cell-Mediated Oxidative Modification of Low Density Lipoprotein. J Lipid Res (1996) 37:1591–600. doi: 10.1016/s0022-2275(20)39141-0

  • CrossRef
  • Google Scholar

• 502

  OgiharaHOgiharaTMikiMYasudaHMinoM. Plasma Copper and Antioxidant Status in Wilson’s Disease. Pediatr Res (1995) 37:219–26. doi: 10.1203/00006450-199502000-00016

  • CrossRef
  • Google Scholar

• 503

  BushAIGoldsteinLE. Specific Metal-Catalysed Protein Oxidation Reactions in Chronic Degenerative Disorders of Ageing: Focus on Alzheimer’s Disease and Age-Related Cataracts. Novartis Found Symp (2001) 235:26–43. doi: 10.1002/0470868694.ch4

  • CrossRef
  • Google Scholar

• 504

  FuruhashiM. New Insights Into Purine Metabolism in Metabolic Diseases: Role of Xanthine Oxidoreductase Activity. Am J Physiol - Endocrinol Metab (2020) 319:E827–34. doi: 10.1152/AJPENDO.00378.2020

  • CrossRef
  • Google Scholar

• 505

  GlantzounisGTsimoyiannisEKappasAGalarisD. Uric Acid and Oxidative Stress. Curr Pharm Des (2005) 11:4145–51. doi: 10.2174/138161205774913255

  • CrossRef
  • Google Scholar

• 506

  ChangWSChiangHC. Structure-Activity Relationship of Coumarins in Xanthine Oxidase Inhibition. Anticancer Res (1995) 15:1969–73.

  • Google Scholar

• 507

  KushiyamaANakatsuYMatsunagaYYamamotoyaTMoriKUedaKet al. Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis. Mediators Inflamm (2016) 2016:8603164. doi: 10.1155/2016/8603164

  • CrossRef
  • Google Scholar

• 508

  OkuyamaTShirakawaJNakamuraTMuraseTMiyashitaDInoueRet al. Association of the Plasma Xanthine Oxidoreductase Activity With the Metabolic Parameters and Vascular Complications in Patients With Type 2 Diabetes. Sci Rep (2021) 11:3768. doi: 10.1038/s41598-021-83234-9

  • CrossRef
  • Google Scholar

• 509

  MiyataYTanakaHShimadaASatoTItoAYamanouchiTet al. Regulation of Adipocytokine Secretion and Adipocyte Hypertrophy by Polymethoxyflavonoids, Nobiletin and Tangeretin. Life Sci (2011) 88:613–8. doi: 10.1016/j.lfs.2011.01.024

  • CrossRef
  • Google Scholar

• 510

  ArdenghiJVPrettoJBSouzaMMJuniorACSoldiCPizzolattiMGet al. Antinociceptive Properties of Coumarins, Steroid and Dihydrostyryl-2-Pyrones From Polygala Sabulosa (Polygalaceae) in Mice. J Pharm Pharmacol (2010) 58:107–12. doi: 10.1211/jpp.58.1.0013

  • CrossRef
  • Google Scholar

• 511

  LuoCXuXWeiXFengWHuangHLiuHet al. Natural Medicines for the Treatment of Fatigue: Bioactive Components, Pharmacology, and Mechanisms. Pharmacol Res (2019) 148:104409. doi: 10.1016/j.phrs.2019.104409

  • CrossRef
  • Google Scholar

• 512

  MoganaRAdhikariADebnathSHazraSHazraBTeng-JinKet al. The Antiacetylcholinesterase and Antileishmanial Activities of Canarium Patentinervium Miq. BioMed Res Int (2014) 2014:903529. doi: 10.1155/2014/903529

  • CrossRef
  • Google Scholar

• 513

  MulaMPiniSCassanoGB. The Role of Anticonvulsant Drugs in Anxiety Disorders: A Critical Review of the Evidence. J Clin Psychopharmacol (2007) 27:263–72. doi: 10.1097/jcp.0b013e318059361a

  • CrossRef
  • Google Scholar

• 514

  JangJHParkJEHanJS. Scopoletin Increases Glucose Uptake Through Activation of PI3K and AMPK Signaling Pathway and Improves Insulin Sensitivity in 3T3-L1 Cells. Nutr Res (2020) 74:52–61. doi: 10.1016/j.nutres.2019.12.003

  • CrossRef
  • Google Scholar

• 515

  HuangWWenZWangMXuBZhouBLiX. Anticomplement and Antitussive Activities of Major Compound Extracted From Chimonanthus Nitens Oliv. Leaf. BioMed Chromatogr (2020) 34(2):e4736. doi: 10.1002/bmc.4736

  • CrossRef
  • Google Scholar

• 516

  CereijoRGavaldà-NavarroACairóMQuesada-LópezTVillarroyaJMorón-RosSet al. CXCL14, a Brown Adipokine That Mediates Brown-Fat-To-Macrophage Communication in Thermogenic Adaptation. Cell Metab (2018) 28:750–63.e6. doi: 10.1016/j.cmet.2018.07.015

  • CrossRef
  • Google Scholar

• 517

  YangIJLeeDUShinHM. Anti-Inflammatory and Antioxidant Effects of Coumarins Isolated From Foeniculum Vulgare in Lipopolysaccharide-Stimulated Macrophages and 12-O-Tetradecanoylphorbol-13-Acetate-Stimulated Mice. Immunopharmacol Immunotoxicol (2015) 37:308–17. doi: 10.3109/08923973.2015.1038751

  • CrossRef
  • Google Scholar

• 518

  LeemaGTamizhselviR. Protective Effect of Scopoletin Against Cerulein-Induced Acute Pancreatitis and Associated Lung Injury in Mice. Pancreas (2018) 47:577–85. doi: 10.1097/MPA.0000000000001034

  • CrossRef
  • Google Scholar

• 519

  LiangCJuWPeiSTangYXiaoY. Pharmacological Activities and Synthesis of Esculetin and Its Derivatives: A Mini-Review. J Lipid Res (2017) 58:519–28. doi: 10.3390/molecules22030387

  • CrossRef
  • Google Scholar

• 520

  OhSYKimYHKangMKLeeEJKimDYOhHet al. Aesculetin Attenuates Alveolar Injury and Fibrosis Induced by Close Contact of Alveolar Epithelial Cells With Blood-Derived Macrophages via Il-8 Signaling. Int J Mol Sci (2020) 21:1–17. doi: 10.3390/ijms21155518

  • CrossRef
  • Google Scholar

• 521

  SinghLKaurAGargSSinghAPBhattiR. Protective Effect of Esculetin, Natural Coumarin in Mice Model of Fibromyalgia: Targeting Pro-Inflammatory Cytokines and MAO-A. Neurochem Res (2020) 45:2364–74. doi: 10.1007/s11064-020-03095-y

  • CrossRef
  • Google Scholar

• 522

  PruccoliLMorroniFSitaGHreliaPTarozziA. Esculetin as a Bifunctional Antioxidant Prevents and Counteracts the Oxidative Stress and Neuronal Death Induced by Amyloid Protein in Sh-Sy5y Cells. Antioxidants (2020) 9:1–16. doi: 10.3390/antiox9060551

  • CrossRef
  • Google Scholar

• 523

  ChenYZhangQLiuHLuCLiangCLQiuFet al. Esculetin Ameliorates Psoriasis-Like Skin Disease in Mice by Inducing CD4+Foxp3+ Regulatory T Cells. Front Immunol (2018) 9:2092. doi: 10.3389/fimmu.2018.02092

  • CrossRef
  • Google Scholar

• 524

  KimADMadduma HewageSRKPiaoMJKangKAChoSJHyunJW. Esculetin Induces Apoptosis in Human Colon Cancer Cells by Inducing Endoplasmic Reticulum Stress. Cell Biochem Funct (2015) 33:487–94. doi: 10.1002/cbf.3146

  • CrossRef
  • Google Scholar

• 525

  ChoiYJLeeCMParkSHNamMJ. Esculetin Induces Cell Cycle Arrest and Apoptosis in Human Colon Cancer LoVo Cells. Environ Toxicol (2019) 34:1129–36. doi: 10.1002/tox.22815

  • CrossRef
  • Google Scholar

• 526

  KimYRParkBKKimYHShimIKangICLeeMY. Antidepressant Effect of Fraxinus Rhynchophylla Hance Extract in a Mouse Model of Chronic Stress-Induced Depression. BioMed Res Int (2018) 2018:8249563. doi: 10.1155/2018/8249563

  • CrossRef
  • Google Scholar

• 527

  NakanoMImamuraHSasaokaNYamamotoMUemuraNShudoTet al. ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson’s Disease. EBioMedicine (2017) 22:225–41. doi: 10.1016/j.ebiom.2017.07.024

  • CrossRef
  • Google Scholar

• 528

  XuWWangJJuBLanXYingXStienD. Seven Compounds From Portulaca Oleracea L. And Their Anticholinesterase Activities. Nat Prod Res (2021) 30:1–7. doi: 10.1080/14786419.2021.1916928

  • CrossRef
  • Google Scholar

• 529

  LiuYLHoDKCassadyJMCookVMBairdWM. Isolation of Potential Cancer Chemopreventive Agents From Eriodictyon Californicum. J Nat Prod (1992) 55:357–63. doi: 10.1021/np50081a012

  • CrossRef
  • Google Scholar

• 530

  MirzahosseiniGManayiAKhanaviMSafaviMSalariAMadjid AnsariAet al. Bio-Guided Isolation of Centaurea Bruguierana Subsp. Belangerana Cytotoxic Components. Nat Prod Res (2019) 33:1687–90. doi: 10.1080/14786419.2018.1428590

  • CrossRef
  • Google Scholar

• 531

  SenATuranSOBitisL. Bioactivity-Guided Isolation of Anti-Proliferative Compounds From Endemic Centaurea Kilaea. Pharm Biol (2016) 55:541–6. doi: 10.1080/13880209.2016.1255980

  • CrossRef
  • Google Scholar

• 532

  Yeon ParkJYoung KimHShibamotoTSu JangTCheon LeeSSuk ShimJet al. Beneficial Effects of a Medicinal Herb, Cirsium Japonicum Var. Maackii, Extract and Its Major Component, Cirsimaritin on Breast Cancer Metastasis in MDA-MB-231 Breast Cancer Cells. Bioorg Med Chem Lett (2017) 27:3968–73. doi: 10.1016/j.bmcl.2017.07.070

  • CrossRef
  • Google Scholar

• 533

  PathakGSinghSKumariPRazaWHussainYMeenaA. Cirsimaritin, a Lung Squamous Carcinoma Cells (NCIH-520) Proliferation Inhibitor. J Biomol Struct Dyn (2021) 39:3312–23. doi: 10.1080/07391102.2020.1763198

  • CrossRef
  • Google Scholar

• 534

  QuanZGuJDongPLuJWuXWuWet al. Reactive Oxygen Species-Mediated Endoplasmic Reticulum Stress and Mitochondrial Dysfunction Contribute to Cirsimaritin-Induced Apoptosis in Human Gallbladder Carcinoma GBC-SD Cells. Cancer Lett (2010) 295:252–9. doi: 10.1016/j.canlet.2010.03.008

  • CrossRef
  • Google Scholar

• 535

  XuJHLoYMChangWCHuangDWWuJSBJhangYYet al. Identification of Bioactive Components From Ruellia Tuberosa L. On Improving Glucose Uptake in TNF-α-Induced Insulin-Resistant Mouse FL83B Hepatocytes. Evidence-Based Complement Altern Med (2020) 2020:6644253. doi: 10.1155/2020/6644253

  • CrossRef
  • Google Scholar

• 536

  BowerAMReal HernandezLMBerhowMADe MejiaEG. Bioactive Compounds From Culinary Herbs Inhibit a Molecular Target for Type 2 Diabetes Management, Dipeptidyl Peptidase IV. J Agric Food Chem (2014) 62:6147–58. doi: 10.1021/jf500639f

  • CrossRef
  • Google Scholar

• 537

  LeeDKimKHLeeJHwangGSLeeHLHahmDHet al. Protective Effect of Cirsimaritin Against Streptozotocin-Induced Apoptosis in Pancreatic Beta Cells. J Pharm Pharmacol (2017) 69:875–83. doi: 10.1111/jphp.12719

  • CrossRef
  • Google Scholar

• 538

  KelmMANairMGStrasburgGMDeWittDL. Antioxidant and Cyclooxygenase Inhibitory Phenolic Compounds From Ocimum Sanctum Linn. Phytomedicine (2000) 7:7–13. doi: 10.1016/S0944-7113(00)80015-X

  • CrossRef
  • Google Scholar

• 539

  Ben SghaierMSkandraniINasrNFrancaMGDChekir-GhediraLGhediraK. Flavonoids and Sesquiterpenes From Tecurium Ramosissimum Promote Antiproliferation of Human Cancer Cells and Enhance Antioxidant Activity: A Structure-Activity Relationship Study. Environ Toxicol Pharmacol (2011) 32:336–48. doi: 10.1016/j.etap.2011.07.003

  • CrossRef
  • Google Scholar

• 540

  ShinMSParkJYLeeJYooHHHahmDHLeeSCet al. Anti-Inflammatory Effects and Corresponding Mechanisms of Cirsimaritin Extracted From Cirsium Japonicum Var. Maackii Maxim. Bioorg Med Chem Lett (2017) 27:3076–80. doi: 10.1016/j.bmcl.2017.05.051

  • CrossRef
  • Google Scholar

• 541

  MiskiMUlubelenAJohanssonCMabryTJ. Antibacterial Activity Studies of Flavonoids From Salvia Palaestina. J Nat Prod (1983) 46:874–5. doi: 10.1021/np50030a007

  • CrossRef
  • Google Scholar

• 542

  Quintanilla-LiceaRVargas-VillarrealJVerde-StarMJRivas-GalindoVMTorres-HernándezÁD. Antiprotozoal Activity Against Entamoeba Histolytica of Flavonoids Isolated From Lippia Graveolens Kunth. Molecules (2020) 25:2464. doi: 10.3390/molecules25112464

  • CrossRef
  • Google Scholar

• 543

  YanHWangHMaLMaXYinJWuSet al. Cirsimaritin Inhibits Influenza A Virus Replication by Downregulating the NF-κb Signal Transduction Pathway. Virol J (2018) 15:1–9. doi: 10.1186/s12985-018-0995-6

  • CrossRef
  • Google Scholar

• 544

  KavvadiasDMonscheinVSandPRiedererPSchreierP. Constituents of Sage (Salvia Officinalis) With In Vitro Affinity to Human Brain Benzodiazepine Receptor. Planta Med (2003) 69:113–7. doi: 10.1055/s-2003-37712

  • CrossRef
  • Google Scholar

• 545

  González-TrujanoMEHernández-SánchezLYOcoteroVMDorazco-GonzálezAFeferPGAguirre-HernándezE. Pharmacological Evaluation of the Anxiolytic-Like Effects of Lippia Graveolens and Bioactive Compounds. Pharm Biol (2017) 55:1569–76. doi: 10.1080/13880209.2017.1310908

  • CrossRef
  • Google Scholar

• 546

  AbdelhalimAKarimNChebibMAburjaiTKhanIJohnstonGARet al. Antidepressant, Anxiolytic and Antinociceptive Activities of Constituents From Rosmarinus Officinalis. J Pharm Pharm Sci (2015) 18:448–59. doi: 10.18433/j3pw38

  • CrossRef
  • Google Scholar

• 547

  AmakuraYYoshimuraMTakaokaMTodaHTsutsumiTMatsudaRet al. Characterization of Natural Aryl Hydrocarbon Receptor Agonists From Cassia Seed and Rosemary. Molecules (2014) 19:4956–66. doi: 10.3390/molecules19044956

  • CrossRef
  • Google Scholar

• 548

  WangJPChangLCHsuMFChenSCKuoSC. Inhibition of Formyl-Methionyl-Leucyl-Phenylalanine-Stimulated Respiratory Burst by Cirsimaritin Involves Inhibition of Phospholipase D Signaling in Rat Neutrophils. Naunyn Schmiedebergs Arch Pharmacol (2002) 366:307–14. doi: 10.1007/s00210-002-0631-1

  • CrossRef
  • Google Scholar

• 549

  YokozawaTDongEKawaiYGembaMShimizuM. Protective Effects of Some Flavonoids on the Renal Cellular Membrane. Exp Toxicol Pathol (1999) 51:9–14. doi: 10.1016/S0940-2993(99)80050-5

  • CrossRef
  • Google Scholar

• 550

  HasratJADe BruyneTDe BackerJPVauquelinGVlietinckAJ. Cirsimarin and Cirsimaritin, Flavonoids of Microtea Debilis (Phytolaccaceae) With Adenosine Antagonistic Properties in Rats: Leads for New Therapeutics in Acute Renal Failure. J Pharm Pharmacol (1997) 49:1150–6. doi: 10.1111/j.2042-7158.1997.tb06059.x

  • CrossRef
  • Google Scholar

• 551

  LeeTYChenFYChangHHLinHC. The Effect of Capillarisin on Glycochenodeoxycholic Acid-Induced Apoptosis and Heme Oxygenase-1 in Rat Primary Hepatocytes. Mol Cell Biochem (2009) 325:53–9. doi: 10.1007/s11010-008-0019-8

  • CrossRef
  • Google Scholar

• 552

  LeeSOJeongYJKimMKimCHLeeIS. Suppression of PMA-Induced Tumor Cell Invasion by Capillarisin via the Inhibition of NF-κb-Dependent MMP-9 Expression. Biochem Biophys Res Commun (2008) 366:1019–24. doi: 10.1016/j.bbrc.2007.12.068

  • CrossRef
  • Google Scholar

• 553

  BastosJKDe SousaJPBLeiteMFJorgeRFResendeDODa Silva FilhoAAet al. Seasonality Role on the Phenolics From Cultivated Baccharis Dracunculifolia. Evidence-Based Complement Altern Med (2011) 2011:464289. doi: 10.1093/ecam/nep077

  • CrossRef
  • Google Scholar

• 554

  JorgeRFurtadoNAJCSousaJPBDa Silva FilhoAAGregório JuniorLEMartinsCHGet al. Brazilian Propolis: Seasonal Variation of the Prenylated P-Coumaric Acids and Antimicrobial Activity. Pharm Biol (2008) 46:889–93. doi: 10.1080/13880200802370373

  • CrossRef
  • Google Scholar

• 555

  CarrãoDBDe AlbuquerqueNCPMarquesLMMCrottiAEMPilonACBolzaniVDSet al. In Vitro Metabolism of Artepillin C by Rat and Human Liver Microsomes. Planta Med (2017) 83:737–45. doi: 10.1055/s-0042-124359

  • CrossRef
  • Google Scholar

• 556

  BoudreauAPoulevARibnickyDMRaskinIRathinasabapathyTRichardAJet al. Distinct Fractions of an Artemisia Scoparia Extract Contain Compounds With Novel Adipogenic Bioactivity. Front Nutr (2019) 6:18. doi: 10.3389/fnut.2019.00018

  • CrossRef
  • Google Scholar

• 557

  RibnickyDKimSBPoulevAWangYBoudreauARaskinIet al. Prenylated Coumaric Acids From Artemisia Scoparia Beneficially Modulate Adipogenesis. J Nat Prod (2021) 84(4):1078–86. doi: 10.1021/acs.jnatprod.0c01149

  • CrossRef
  • Google Scholar

• 558

  LinSXiaoYQZhangQWShiJGWangZM. Studies on Chemical Constituents in Bud of Artemisia Scoparia (III). Zhongguo Zhongyao Zazhi (2004) 29:431.

  • Google Scholar

• 559

  OkunoIUchidaKNakamuraMSakurawiK. Studies on Choleretic Constituents in Artemisia Capillaris Thunb. Chem Pharm Bull (1988) 36:769–75. doi: 10.1248/cpb.36.769

  • CrossRef
  • Google Scholar

• 560

  KitagawaIFukudaYYoshiharaMYamaharaJYoshikawaM. Capillartemisin A and B, Two New Choleretic Principles From Artemisiae Capillaris Herba. Chem Pharm Bull (1983) 31:352–5. doi: 10.1248/cpb.31.352

  • CrossRef
  • Google Scholar

• 561

  WashioKShimamotoYKitamuraH. Brazilian Propolis Extract Increases Leptin Expression in Mouse Adipocytes. BioMed Res (2015) 36:343–6. doi: 10.2220/biomedres.36.343

  • CrossRef
  • Google Scholar

• 562

  IioAOhguchiKInoueHMaruyamaHArakiYNozawaYet al. Ethanolic Extracts of Brazilian Red Propolis Promote Adipocyte Differentiation Through Pparγ Activation. Phytomedicine (2010) 17:974–9. doi: 10.1016/j.phymed.2010.03.001

  • CrossRef
  • Google Scholar

• 563

  KitamuraHNaoeYKimuraSMiyamotoTOkamotoSTodaCet al. Beneficial Effects of Brazilian Propolis on Type 2 Diabetes in Ob/Ob Mice. Adipocyte (2013) 2:227–36. doi: 10.4161/adip.25608

  • CrossRef
  • Google Scholar

• 564

  MunakataRTakemuraTTatsumiKMoriyoshiEYanagiharaKSugiyamaAet al. Isolation of Artemisia Capillaris Membrane-Bound Di-Prenyltransferase for Phenylpropanoids and Redesign of Artepillin C in Yeast. Commun Biol (2019) 2:384. doi: 10.1038/s42003-019-0630-0

  • CrossRef
  • Google Scholar

• 565

  ClarkeTCBlackLIStussmanBJBarnesPMNahinRL. Trends in the Use of Complementary Health Approaches Among Adults: United States, 2002–2012. Natl Health Stat Rep (2015) (79):1–16.

  • Google Scholar

• 566

  BrittonERKelloggJJKvalheimOMCechNB. Biochemometrics to Identify Synergists and Additives From Botanical Medicines: A Case Study With Hydrastis Canadensis (Goldenseal). J Nat Prod (2018) 81:484–93. doi: 10.1021/acs.jnatprod.7b00654

  • CrossRef
  • Google Scholar

• 567

  SorkinBCKuszakAJBlossGFukagawaNKHoffmanFAJafariMet al. Improving Natural Product Research Translation: From Source to Clinical Trial. FASEB J (2020) 34:41–65. doi: 10.1096/fj.201902143R

  • CrossRef
  • Google Scholar

• 568

  LogendraSRibnickyDMYangHPoulevAMaJKennellyEJet al. Bioassay-Guided Isolation of Aldose Reductase Inhibitors From Artemisia Dracunculus. Phytochemistry (2006) 67:1539–46. doi: 10.1016/j.phytochem.2006.05.015

  • CrossRef
  • Google Scholar

• 569

  EisenmanSWPoulevAStruweLRaskinIRibnickyDM. Qualitative Variation of Anti-Diabetic Compounds in Different Tarragon (Artemisia Dracunculus L.) Cytotypes. Fitoterapia (2011) 82:1062–74. doi: 10.1016/j.fitote.2011.07.003

  • CrossRef
  • Google Scholar

• 570

  BaellJB. Feeling Nature’s PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS). J Nat Prod (2016) 79:616–28. doi: 10.1021/acs.jnatprod.5b00947

  • CrossRef
  • Google Scholar